Guidelines for Severe Uncontrolled Asthma | Archivos de Bronconeumología

array:23 ["pii" => "S1579212915000774" "issn" => "15792129" "doi" => "10.1016/j.arbr.2015.03.010" "estado" => "S300" "fechaPublicacion" => "2015-05-01" "aid" => "1109" "copyright" => "SEPAR" "copyrightAnyo" => "2014" "documento" => "article" "subdocumento" => "fla" "cita" => "Arch Bronconeumol. 2015;51:235-46" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 9859 "formatos" => array:3 [ "EPUB" => 205 "HTML" => 7917 "PDF" => 1737 ] ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S030028961400492X" "issn" => "03002896" "doi" => "10.1016/j.arbres.2014.12.007" "estado" => "S300" "fechaPublicacion" => "2015-05-01" "aid" => "1109" "copyright" => "SEPAR" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Arch Bronconeumol. 2015;51:235-46" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 34957 "formatos" => array:3 [ "EPUB" => 159 "HTML" => 30958 "PDF" => 3840 ] ] "es" => array:13 [ "idiomaDefecto" => true "cabecera" => "Artículo especial" "titulo" => "Normativa sobre asma grave no controlada" "tienePdf" => "es" "tieneTextoCompleto" => "es" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "235" "paginaFinal" => "246" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Guidelines for Severe Uncontrolled Asthma" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 3333 "Ancho" => 2391 "Tamanyo" => 880392 ] ] "descripcion" => array:1 [ "es" => "Evaluación y calidad de la evidencia e implicación de las recomendaciones según GRADE." ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Carolina Cisneros Serrano, Carlos Melero Moreno, Carlos Almonacid Sánchez, Miguel Perpiñá Tordera, César Picado Valles, Eva Martínez Moragón, Luis Pérez de Llano, José Gregorio Soto Campos, Isabel Urrutia Landa, Gloria García Hernández" "autores" => array:10 [ 0 => array:2 [ "nombre" => "Carolina" "apellidos" => "Cisneros Serrano" ] 1 => array:2 [ "nombre" => "Carlos" "apellidos" => "Melero Moreno" ] 2 => array:2 [ "nombre" => "Carlos" "apellidos" => "Almonacid Sánchez" ] 3 => array:2 [ "nombre" => "Miguel" "apellidos" => "Perpiñá Tordera" ] 4 => array:2 [ "nombre" => "César" "apellidos" => "Picado Valles" ] 5 => array:2 [ "nombre" => "Eva" "apellidos" => "Martínez Moragón" ] 6 => array:2 [ "nombre" => "Luis" "apellidos" => "Pérez de Llano" ] 7 => array:2 [ "nombre" => "José Gregorio" "apellidos" => "Soto Campos" ] 8 => array:2 [ "nombre" => "Isabel" "apellidos" => "Urrutia Landa" ] 9 => array:2 [ "nombre" => "Gloria" "apellidos" => "García Hernández" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S1579212915000774" "doi" => "10.1016/j.arbr.2015.03.010" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212915000774?idApp=UINPBA00003Z" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S030028961400492X?idApp=UINPBA00003Z" "url" => "/03002896/0000005100000005/v2_201504291226/S030028961400492X/v2_201504291226/es/main.assets" ] ] "itemSiguiente" => array:18 [ "pii" => "S1579212915000646" "issn" => "15792129" "doi" => "10.1016/j.arbr.2015.02.031" "estado" => "S300" "fechaPublicacion" => "2015-05-01" "aid" => "1018" "copyright" => "SEPAR" "documento" => "simple-article" "subdocumento" => "crp" "cita" => "Arch Bronconeumol. 2015;51:e23-4" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 2649 "formatos" => array:3 [ "EPUB" => 161 "HTML" => 1734 "PDF" => 754 ] ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "Case Report" "titulo" => "Thrombotic Microangiopathy Associated With Tacrolimus in Lung Transplantation" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "e23" "paginaFinal" => "e24" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Microangiopatía trombótica asociada a tacrolimus en trasplante pulmonar" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Juan Pablo Reig Mezquida, Amparo Solé Jover, Emilio Ansótegui Barrera, Juan Escrivá Peiró, Maria Desamparados Pastor Colom, Juan Pastor Guillem" "autores" => array:6 [ 0 => array:2 [ "nombre" => "Juan Pablo" "apellidos" => "Reig Mezquida" ] 1 => array:2 [ "nombre" => "Amparo" "apellidos" => "Solé Jover" ] 2 => array:2 [ "nombre" => "Emilio" "apellidos" => "Ansótegui Barrera" ] 3 => array:2 [ "nombre" => "Juan" "apellidos" => "Escrivá Peiró" ] 4 => array:2 [ "nombre" => "Maria Desamparados" "apellidos" => "Pastor Colom" ] 5 => array:2 [ "nombre" => "Juan" "apellidos" => "Pastor Guillem" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0300289614002774" "doi" => "10.1016/j.arbres.2014.07.004" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289614002774?idApp=UINPBA00003Z" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212915000646?idApp=UINPBA00003Z" "url" => "/15792129/0000005100000005/v2_201504270531/S1579212915000646/v2_201504270531/en/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S1579212915000580" "issn" => "15792129" "doi" => "10.1016/j.arbr.2015.02.025" "estado" => "S300" "fechaPublicacion" => "2015-05-01" "aid" => "955" "copyright" => "SEPAR" "documento" => "article" "subdocumento" => "ssu" "cita" => "Arch Bronconeumol. 2015;51:227-34" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 7110 "formatos" => array:3 [ "EPUB" => 175 "HTML" => 5628 "PDF" => 1307 ] ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "Review" "titulo" => "Chronic Obstructive Pulmonary Disease and Left Ventricle" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "227" "paginaFinal" => "234" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Enfermedad pulmonar obstructiva crónica y ventrículo izquierdo" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1796 "Ancho" => 2353 "Tamanyo" => 245278 ] ] "descripcion" => array:1 [ "en" => "Figure summarizing the pathophysiological mechanisms involved and their effects on the left ventricle in COPD. CF: cardiac frequency; FEV1: forced expiratory volume in the first second; IC/TLC: ratio between the inspiratory capacity and total lung capacity; PH: pulmonary hypertension; RV: right ventricle; RVol: residual volume." ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Karina Portillo, Jorge Abad-Capa, Juan Ruiz-Manzano" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Karina" "apellidos" => "Portillo" ] 1 => array:2 [ "nombre" => "Jorge" "apellidos" => "Abad-Capa" ] 2 => array:2 [ "nombre" => "Juan" "apellidos" => "Ruiz-Manzano" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0300289614001240" "doi" => "10.1016/j.arbres.2014.03.012" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289614001240?idApp=UINPBA00003Z" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212915000580?idApp=UINPBA00003Z" "url" => "/15792129/0000005100000005/v2_201504270531/S1579212915000580/v2_201504270531/en/main.assets" ] "en" => array:20 [ "idiomaDefecto" => true "cabecera" => "Special article" "titulo" => "Guidelines for Severe Uncontrolled Asthma" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "235" "paginaFinal" => "246" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Carolina Cisneros Serrano, Carlos Melero Moreno, Carlos Almonacid Sánchez, Miguel Perpiñá Tordera, César Picado Valles, Eva Martínez Moragón, Luis Pérez de Llano, José Gregorio Soto Campos, Isabel Urrutia Landa, Gloria García Hernández" "autores" => array:10 [ 0 => array:4 [ "nombre" => "Carolina" "apellidos" => "Cisneros Serrano" "email" => array:1 [ 0 => "Carol9199@yahoo.es" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "*" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "Carlos" "apellidos" => "Melero Moreno" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "b" "identificador" => "aff0010" ] ] ] 2 => array:3 [ "nombre" => "Carlos" "apellidos" => "Almonacid Sánchez" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "c" "identificador" => "aff0015" ] ] ] 3 => array:3 [ "nombre" => "Miguel" "apellidos" => "Perpiñá Tordera" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "d" "identificador" => "aff0020" ] ] ] 4 => array:3 [ "nombre" => "César" "apellidos" => "Picado Valles" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "e" "identificador" => "aff0025" ] ] ] 5 => array:3 [ "nombre" => "Eva" "apellidos" => "Martínez Moragón" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "f" "identificador" => "aff0030" ] ] ] 6 => array:3 [ "nombre" => "Luis" "apellidos" => "Pérez de Llano" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "g" "identificador" => "aff0035" ] ] ] 7 => array:3 [ "nombre" => "José Gregorio" "apellidos" => "Soto Campos" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "h" "identificador" => "aff0040" ] ] ] 8 => array:3 [ "nombre" => "Isabel" "apellidos" => "Urrutia Landa" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "i" "identificador" => "aff0045" ] ] ] 9 => array:3 [ "nombre" => "Gloria" "apellidos" => "García Hernández" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "j" "identificador" => "aff0050" ] ] ] ] "afiliaciones" => array:10 [ 0 => array:3 [ "entidad" => "Servicio de Neumología, Hospital Universitario La Princesa, Madrid, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Servicio de Neumología, Hospital Universitario 12 de Octubre, Madrid, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Servicio de Neumología, Hospital Universitario de Guadalajara, Guadalajara, Spain" "etiqueta" => "c" "identificador" => "aff0015" ] 3 => array:3 [ "entidad" => "Servicio de Neumología, Hospital Universitario y Politécnico La Fe, Valencia, Spain" "etiqueta" => "d" "identificador" => "aff0020" ] 4 => array:3 [ "entidad" => "Servicio de Neumología y Alergia Respiratoria, Hospital Clinic, Universitat de Barcelona, Barcelona, Spain" "etiqueta" => "e" "identificador" => "aff0025" ] 5 => array:3 [ "entidad" => "Servicio de Neumología, Hospital Universitario Dr. Peset, Valencia, Spain" "etiqueta" => "f" "identificador" => "aff0030" ] 6 => array:3 [ "entidad" => "Servicio de Neumología, Hospital Lucus Augusti, Lugo, Spain" "etiqueta" => "g" "identificador" => "aff0035" ] 7 => array:3 [ "entidad" => "Servicio de Neumología, Hospital de Galdakao-Usansolo, Galdakao, Spain" "etiqueta" => "h" "identificador" => "aff0040" ] 8 => array:3 [ "entidad" => "UGC Neumología y Alergia, Hospital de Jerez, Cádiz, Spain" "etiqueta" => "i" "identificador" => "aff0045" ] 9 => array:3 [ "entidad" => "Servicio de Pediatría, Hospital Universitario 12 de Octubre, Madrid, Spain" "etiqueta" => "j" "identificador" => "aff0050" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Normativa sobre asma grave no controlada" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0015" "etiqueta" => "Fig. 3" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr3.jpeg" "Alto" => 1822 "Ancho" => 2829 "Tamanyo" => 231541 ] ] "descripcion" => array:1 [ "en" => "Treatment proposal for severe, uncontrolled asthma according to phenotype. ACOS: asthma/COPD overlap syndrome; AERD: aspirin-exacerbated respiratory disease; CAFL: chronic airflow limitation." ] ] ] "textoCompleto" => "IntroductionAsthma is a worldwide problem, and severe uncontrolled asthma (SUCA) in particular has far-reaching socioeconomic repercussions. For this reason, all healthcare professionals treating these patients must be aware of the situation, and have the proper tools for providing the best approach to this problem.The first obstacle encountered is the exact terminology for defining these patients, since there is no common agreement.“Difficult-to-treat asthma” is a term used for patients who find it difficult to achieve control as a result of poor compliance, incorrect inhalation techniques, exposure to allergens or other triggers, or associated comorbidities. The term “refractory or treatment-resistant asthma” refers to subjects who, when a diagnosis of asthma has been confirmed and comorbidities identified and treated, require treatment with high-dose inhaled corticosteroids (IC) plus another second controller (long-acting β2-agonist [LABA] and/or systemic corticosteroids [SC]) to prevent their asthma becoming uncontrolled, or who remain uncontrolled despite this therapy. SUCA includes patients with refractory asthma and those with incomplete response to treatment.<a class="elsevierStyleCrossRef" href="#bib0365">1</a>MethodologyThese guidelines were drawn up following SEPAR recommendations for the development of guidelines. All citations used by the various authors, experts in severe asthma, were recorded in an EndNote database and classified according to their levels of evidence, using the Grading of Recommendations (GRADE) approach.<a class="elsevierStyleCrossRef" href="#bib0370">2</a>Among the studies selected from a systematic search as a basis for these guidelines, very few were identified as randomized controlled trials with a low risk of bias that would provide direct, consistent and precise evidence. Most recommendations proposed are based on indirect evidence, retrieved from studies performed in moderate persistent asthma, and to a lesser extent, studies in patients with severe asthma. The result is imprecise levels of evidence and recommendations, although all the studies were evaluated and classified using the GRADE system.Quality of evidence was classified as high, moderate, low and very low, based on different considerations for presence of direct bias (and the direction), consistency and directness of the estimates (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>).<elsevierMultimedia ident="fig0005"></elsevierMultimedia>DefinitionThe definition set out in the ATS/ERS consensus statement<a class="elsevierStyleCrossRef" href="#bib0365">1</a> was used throughout this paper. This defines severe asthma as “asthma requiring treatment with high-dose IC, plus a second controller and/or SC to prevent it from becoming uncontrolled or that remains uncontrolled despite this therapy” (evidence D-R2). Severe uncontrolled asthma is defined in <a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>.<elsevierMultimedia ident="tbl0005"></elsevierMultimedia>EpidemiologyThe lack of well-designed studies using homogeneous definitions means that available data on the epidemiology of severe asthma are disparate, particularly in adults. Severe asthma varies in prevalence between one country and another (18% in Western Europe, 19% in the United States and 32% in Central Europe)<a class="elsevierStyleCrossRef" href="#bib0375">3</a> and about 50% of these severe patients are thought to have poor disease control.<a class="elsevierStyleCrossRef" href="#bib0375">3</a> In Spain in 2011, the prevalence of severe uncontrolled asthma, according to medical criteria, was reported to be 3.9% of all asthma cases<a class="elsevierStyleCrossRef" href="#bib0380">4</a> (evidence C). Moreover, this small proportion of patients is responsible for much higher use of resources than other asthmatic patients<a class="elsevierStyleCrossRef" href="#bib0385">5</a> (evidence D-R2).GeneticsAsthma is a complex syndrome resulting from the interaction of numerous genes and environmental exposure. The lack of studies in severe asthma make it impossible to determine precisely which genes are responsible for making an individual susceptible to developing severe asthma. Currently, genome wide association approaches (GWAS) are analyzing hundreds of thousands of polymorphisms located throughout the genome in the search for variants associated with susceptibility to developing severe asthma<a class="elsevierStyleCrossRef" href="#bib0390">6</a> (evidence C-R2). Single nucleotide polymorphisms (SNPs) in the interleukin-4 receptor subunit alpha (IL4Rα) are associated with poorer lung function, higher immunoglobulin E (IgE) levels, severe asthma exacerbations and tissue inflammation<a class="elsevierStyleCrossRef" href="#bib0395">7</a> (evidence C-R2). An IL-6 receptor (IL6R) variant is associated with severe asthma phenotypes and poorer lung function<a class="elsevierStyleCrossRef" href="#bib0400">8</a> (evidence C-R2). Other genetic mutations associated with severe asthma are variations in genes involved in tumor necrosis factor (TNF) and multiple SNPs in the RAD50-IL13 regions of chromosome 5q31.1 and the HLA-DR/DQ region of chromosome 6p21.3, respectively<a class="elsevierStyleCrossRef" href="#bib0405">9</a> (evidence C-R2).Severe Asthma PhenotypesClinicians have identified markedly different asthma patient subtypes or profiles, suggesting that asthma remains a poorly classified syndrome.Several studies that merge objective clinical variables have been performed in an attempt to categorize patients into clinical phenotypes, or on their pathophysiological basis (endotypes)<a class="elsevierStyleCrossRef" href="#bib0410">10</a> which, in the case of SUCA, will have therapeutic implications (evidence D-R2).These studies share several multivariate statistical techniques, especially cluster analyses<a class="elsevierStyleCrossRefs" href="#bib0415">11–13</a> (evidence C-R2). The overall conclusion is that there are at least 4 reasonably well defined phenotypes/endotypes in severe asthma, characterized according to natural history, pathobiology, clinical features and therapeutic response.Severe Allergic AsthmaAbout 40%–50% of cases of severe asthma are due to allergies. They begin in infancy, are clearly atopic and appear to progress from mild-moderate asthma, although some patients present the severe form from onset. The most severe cases within this cluster are those with a greater number of positive skin pricks or higher IgE levels in blood, those with a family history of asthma, and a longer time since disease onset. However, not all patients have eosinophil predominance; indeed, the most severe forms of the phenotype (in terms of lung function, frequency and intensity of symptoms and use of healthcare resources) are accompanied by increases in both eosinophils and neutrophils in sputum<a class="elsevierStyleCrossRef" href="#bib0430">14</a> (evidence C-R2).From a pathobiological point of view, severe allergic asthma is orchestrated by the activation of type 2 helper T-cells (Th2), the production of specific cytokines, IL-4, IL-5 and IL-13, and B-cell isotype switching to produce IgE, although it must be pointed out that not all atopic asthmas have a highly active Th2 component (“high” Th2 endotype). Periostine and fractionated exhaled nitric oxide (FeNO) have been shown to be good biomarkers in this “high” Th2 variant<a class="elsevierStyleCrossRef" href="#bib0435">15</a> (evidence C-R2).Late Onset Eosinophilic AsthmaOver 25% of cases of severe asthma are thought to belong to this phenotype. They are characterized by persistent eosinophils in bronchial biopsies and induced sputum, despite high-dose IC or SC. Levels of eosinophils and cysteinyl leukotrienes are higher than in severe allergic asthma. In general, the disease occurs in patients older than 20 years, and may be preceded by symptoms of chronic rhinosinusitis and nasal polyps. A subgroup of these patients also develops intolerance to non-steroidal anti-inflammatory drugs (NSAIDs), designated as “aspirin-exacerbated respiratory disease” (AERD). Clinical symptoms are florid from onset, airway obstruction is considerable and exacerbations are frequent. These patients are generally less atopic than those in whom the disease appears at younger ages and they have little family history of asthma, but their IgE levels and FeNO measurements may be equally high. Its pathogenesis is related to changes in arachidonic acid metabolism (decreased production of prostaglandin E2 and increased cysteinyl leukotriene synthesis), associated with inflammation that appears to related with Th2 activation.<a class="elsevierStyleCrossRef" href="#bib0435">15</a>Severe Non-Atopic Asthma in the Obese AdultThis population mainly comprises women with a high body mass index and abundant clinical signs and symptoms. Onset occurs between 50 and 60 years of age, or even later. Sputum eosinophilia is not always detected; exacerbations are frequent and lung function is not overly compromised. The genetic basis and etiology of the disease are not well understood, nor is the role of hormonal factors, although onset after natural or surgical menopause has often been reported. The association between asthma and obesity raises numerous questions, and a number of mechanisms have been proposed as its cause: immunoinflammatory factors, mechanical factors, loss of corticosteroid efficacy, vitamin D deficiency, and the additional burden of other comorbidities, such as obstructive sleep apnea–hypopnea syndrome<a class="elsevierStyleCrossRef" href="#bib0440">16</a> (evidence D-R2).Adult-Onset Neutrophilic AsthmaThe natural history of adult-onset neutrophilic asthma is not well understood. Increased matrix metalloproteinase-9 levels have been found in bronchoalveolar lavage, and a history of smoking and chronic airflow limitation (CAFL) with significant air trapping have also been observed. SC provide little disease control. Neutrophil predominance in the airways may be due to modifications in the expression of genes responsible for their activation and mobilization, concomitant diseases (bronchiolitis obliterans), or residual airway inflammation after continuous use of SC, inhibiting neutrophil apoptosis.<a class="elsevierStyleCrossRef" href="#bib0435">15</a>Diagnosis of the Patient With Severe Uncontrolled AsthmaDiagnosis of SUCA requires systematic stepwise assessment to ensure that no relevant areas are left unexplored. According to the previous SEPAR guidelines<a class="elsevierStyleCrossRef" href="#bib0445">17</a> (evidence D-R2) and the recommendations of the current consensus statements<a class="elsevierStyleCrossRefs" href="#bib0365">1,18,19</a> (evidence D-R2), this assessment must be performed in accredited units or in reference centers, by professionals with documented clinical experience in the management of these patients, in follow-up visits over a period of not less than 6 months (<a class="elsevierStyleCrossRef" href="#fig0010">Fig. 2</a>).<elsevierMultimedia ident="fig0010"></elsevierMultimedia>Step 1: Determine if the Patient has AsthmaA diagnosis reached in the past by other clinicians and provided by the patient must not be accepted unless the objective test results necessary for confirming the diagnosis are available. This attitude has been supported in several studies which found that a previous diagnosis of asthma was overturned in almost one third of patients after a new systematic assessment<a class="elsevierStyleCrossRef" href="#bib0460">20</a> (evidence D-R2).Clinical History and Tests to Confirm AsthmaRe-assessment is recommended, with a full clinical history investigating the onset of symptoms, their variability over time, and their association with specific triggers that would raise the suspicion of asthma or any other confounding disease. Variable airflow obstruction should be confirmed with standard lung function testing (LFT), according to the recently revised criteria in the latest GINA update<a class="elsevierStyleCrossRef" href="#bib0465">21</a> (evidence D-R2GPC).Differential DiagnosisCorrect differential diagnosis (DD) should consider other diseases that might mimic asthma, but are not true asthma, also known as “pseudo-asthmas or false asthmas”. Diseases that can mimic asthma are listed in <a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>.<elsevierMultimedia ident="tbl0010"></elsevierMultimedia>False asthmas are often diagnosed months or even years after the onset of clinical symptoms. This delay in diagnosis often leads to excessive use of anti-asthmatic medications, including SC, that cause major side effects (osteoporosis, glaucoma, obesity, hypertension). These patients also repeatedly attend the emergency department, where they are given high dose combinations of anti-asthma drugs, even if these are obviously ineffective in controlling the disease.<a class="elsevierStyleCrossRef" href="#bib0450">18</a>The diagnostic tests to be performed in DD are shown in <a class="elsevierStyleCrossRef" href="#tbl0015">Table 3</a>.<elsevierMultimedia ident="tbl0015"></elsevierMultimedia>Upper Airway DiseaseIn this group, diseases with an organic origin must be distinguished from functional conditions.Organic CausesStridor suggests that the obstruction is located in the upper airways, perhaps due to altered morphology (flattening) of the flow-volume loops. If this is suspected in an asthma patient who does not respond to treatment, end-inspiratory and expiratory computed tomography (CT) is justified to quantify the degree of tracheo- and bronchomalacia. Another alternative is fiberoptic bronchoscopy.Functional CausesSome individuals, for reasons unknown, have vocal cords that remain partially closed during inhalation, causing a sensation of dyspnea in the form of acute asphyxia, often accompanied by stridor. Vocal cord dysfunction can occur without any apparent triggering factor, or as a reaction to various stimuli, such as physical exercise, as is often seen in athletes<a class="elsevierStyleCrossRef" href="#bib0470">22</a> (evidence D-R2). It occurs in children and adults and is more common in women and subjects with high scores on anxiety questionnaires. Despite the apparent severity of some episodes, it rarely leads to loss of consciousness and, in the vast majority of cases, abates in minutes. Up to 50% of patients referred to a DCA specialist clinic have vocal cord dysfunction<a class="elsevierStyleCrossRef" href="#bib0475">23</a> (evidence C-R2). Ideally, the diagnosis is confirmed from poor functioning of the cords, when an episode coincides with laryngoscopy or video laryngo-stroboscopy. As this is not always possible, the event can be induced by methacholine challenge testing. If dysfunction occurs during exercise, it can be reproduced in the laboratory by means of an exercise tolerance test.<a class="elsevierStyleCrossRef" href="#bib0470">22</a>These patients are often subjected to unnecessary endotracheal intubation: if there is no resistance to ventilation after tube placement, the patient can be extubated after a few minutes and recovery is rapid.Lower Airway Diseases. Chronic obstructive pulmonary disease (COPD) is a condition that presents with exacerbations that mimic persistent asthma with a partially reversible obstructive component. An asthmatic smoker can simultaneously develop COPD; this presentation is known as asthma/COPD overlap syndrome (ACOS).<a class="elsevierStyleCrossRef" href="#bib0465">21</a> Clinical history, radiological examinations, and LFT can help differentiate between asthma and COPD. In these cases, lesions indicative of emphysema, absent in asthma, may be seen on CT. LFT may show marked reversibility, associated with other findings more typical of COPD/emphysema, such as air trapping or reduced carbon monoxide diffusion capacity (DLCO). SC testing may also be performed.<a class="elsevierStyleCrossRef" href="#bib0450">18</a>Lower airway compromise due to other diseases, such as bronchiolitis obliterans, should be suspected in patients with a mosaic pattern on CT or signs suggestive of hyperinflation on LFT. Lung biopsy should be considered for confirming diagnosis in these patients.Functional Dyspnea. Dyspnea is a subjective sensation of breathlessness that can be described by the patient in a variety of ways: difficulty inhaling, difficulty exhaling, chest tightness. Dyspnea not associated with any organic disease is called functional dyspnea or breathing dysfunction<a class="elsevierStyleCrossRef" href="#bib0480">24</a> (evidence C-R2).This entity can vary widely in intensity, from a feeling of moderate difficulty in filling the lungs to acute hyperventilation attacks. About 10%–20% of the general population suffer sighing dyspnea, but for unknown reasons, this figure rises to 30%–40% in asthma sufferers. Functional dyspnea is more common in women, particularly those with high scores on anxiety questionnaires.<a class="elsevierStyleCrossRef" href="#bib0480">24</a> When sighing dyspnea occurs along with asthma, severity is often misjudged, and the condition is over-treated. To distinguish between dyspnea caused by asthma or a functional disorder, objective data on the degree of lung function compromise must be collected and peak expiratory flow must be determined to help correlate symptoms and changes in lung function. Functional dyspnea and vocal cord dysfunction may occur concomitantly in some patients.Diseases Affecting Other Organs. Left heart failure may cause apparent worsening of asthma. Onset of atrial fibrillation or mildly decompensated hypertensive heart disease or coronary artery disease can turn well-controlled bronchial asthma into a treatment-refractory problem. In these cases, correcting the arrhythmia or heart failure can lead to stabilization of the asthma.Step 2: Identify Factors for Poor Control and Evaluate Concomitant DiseasesCheck ComplianceNumerous studies have confirmed that lack of treatment compliance or poor adherence is more common than thought. Up to 46% of asthma patients fail to comply adequately with their prescribed treatment<a class="elsevierStyleCrossRef" href="#bib0485">25</a> (evidence C-R2).Measuring treatment compliance is a complex task in any chronic disease, and perhaps even more so when adherence to an inhaled medication is being evaluated. In practice, compliance is determined according to clinical judgment, therapeutic response or validated questionnaires, although these methods are all known to overestimate the level of treatment adherence. FeNO has been proposed for measuring compliance, given the good response of this marker to inhaled corticosteroids, and various procedures for determining this parameter have been described (<a class="elsevierStyleCrossRef" href="#fig0010">Fig. 2</a>).Check Inhalation TechniqueErrors in inhalation technique are much more common than might be imagined. A recent study<a class="elsevierStyleCrossRef" href="#bib0490">26</a> (evidence D-R2) found that critical errors were being made by 12% of metered dose inhaler (MDI) users, 35% of Diskus® and HandiHaler® users and 44% of Turbuhaler® users. Incorrect inhaler use was associated with increased hospital admission, visits to emergency departments, SC treatment and antibiotics, and worse scores in the Asthma Control Test (ACT).In this respect, GEMA recommends the use of MDI with a chamber to improve the distribution and amount of drug reaching the bronchial Tree<a class="elsevierStyleCrossRef" href="#bib0495">27</a> (evidence D-R2GPC).Inhalation technique training and verification is a necessary step in the education of asthma patients. The inhalation device must be selected on the basis of various considerations: patient preference, peak inspiratory flow, device resistance, and local adverse effects.Check Environmental and/or Workplace ExposureNo established consensus statement is available for identifying exposure to environmental triggers, even if these are known to play an important role in patients with severe asthma. The role of exposure to agents in the workplace must also be taken into account (over 200 have been identified), particularly in adult-onset asthma. Exposure to allergens known to trigger allergies should be avoided, although the evidence remains insufficient.<a class="elsevierStyleCrossRef" href="#bib0465">21</a>Check Bronchoconstrictor DrugsIn some patients, uncontrolled asthma may be due to the use of medications (NSAIDs, angiotensin-converting enzyme inhibitors [ACEIs], non-selective beta-blockers) that can cause persistent asthma symptoms.<a class="elsevierStyleCrossRef" href="#bib0450">18</a>Evaluate ComorbiditiesSome conditions or diseases occur more commonly in asthma patients than in the general population (<a class="elsevierStyleCrossRef" href="#tbl0020">Table 4</a>). While these relationships are known to contribute to insufficient asthma control, they have not been precisely identified, and still need to be fully characterized.<elsevierMultimedia ident="tbl0020"></elsevierMultimedia>Although the impact of treatment of comorbidities on severe asthma remains to be determined, they should be treated as appropriate to improve them as far as possible.<a class="elsevierStyleCrossRef" href="#bib0365">1</a>Step 3: Identify Severe Asthma PhenotypesTo date, there is no generally accepted definition of what has become known as asthma phenotypes, but there does seem to be consensus with regard to certain clinical profiles of patients with distinct pathophysiological characteristics that cause them to respond better to certain medications. Attempting to define these phenotypes may be of use in optimizing treatment, and to this end, certain clinical characteristics may be of interest, e.g., age of onset, obesity, NSAID intolerance, in addition to laboratory parameters, such as eosinophils in induced sputum and blood, FeNO determinations, and skin prick tests (<a class="elsevierStyleCrossRef" href="#fig0010">Fig. 2</a>).Treatment of Severe Uncontrolled AsthmaUntil recently, few clinical trials were specifically designed for evaluating the efficacy of different treatments in the SUCA population. Now, however, the identification of new therapeutic targets has led to the development of studies with some scientific evidence of efficacy in these patients, albeit with short follow-up.Corticosteroid InsensitivityAlthough SC are very effective in controlling inflammation in asthma, the spectrum of response to these agents among asthmatics is broad, and a small percentage of subjects fail to respond at all, despite the administration of high doses. Total resistance to SC is uncommon; partial resistance or “lack of sensitivity” is more common among severe asthmatics, making high SC doses necessary, although not even with these is full control achieved. Some patients do improve notably with the use of SC, but when they are discontinued, the asthma worsens (corticosteroid-dependent asthma). In a study of 102 SUCA children, only 11% did not respond to an intramuscular (IM) dose of triamcinolone, suggesting that 89% had some degree of response to SC<a class="elsevierStyleCrossRef" href="#bib0500">28</a> (evidence D-R2). Accordingly, the recent ATS/ERS consensus<a class="elsevierStyleCrossRef" href="#bib0365">1</a> uses the expression “SC insensitivity” instead of “resistance”, and we have adhered to this nomenclature in these guidelines.From a clinical point of view, SC-insensitive asthma is defined by forced expiratory volume in the first second (FEV1) less than 75% of the predicted value and a response <15% and 200ml after the administration of a 2-week cycle of 40mg/day prednisone or prednisolone<a class="elsevierStyleCrossRef" href="#bib0505">29</a> (evidence D-R2). These patients have normal plasma cortisol and adrenal suppression response to exogenous cortisol, so they are prone to the side effects of these agents. Factors contributing to asthma insensitivity to SC are not well defined. Some studies report weak associations between certain genetic changes and environmental factors (continuous exposure to allergens, smoking, NSAID intolerance, low vitamin D levels, and chlamydia, mycoplasma or viral infections), but these cannot be considered as clearly established risk factors. The most significant environmental factor in SC insensitivity is exposure to tobacco smoke. This may act by various mechanisms: by altering the inflammatory pattern (increased neutrophils and CD8 lymphocytes and reduced eosinophil levels), by impairing mucociliary function, thus allowing excessive mucous deposition in the airways, or by tobacco-induced oxidative stress, which inactivates histone deacetylase, reducing nuclear translocation and the number of corticosteroid receptors and their affinity<a class="elsevierStyleCrossRef" href="#bib0510">30</a> (evidence D-R2).SC act at different levels, but their greatest anti-inflammatory effect is produced by inhibition of the genetic transcription of numerous genes that code for proinflammatory proteins (cytokines, chemokines, adhesion molecules) and by increased transcription of anti-inflammatory mediators. They act by binding to a specific intracytoplasmic receptor with 2 molecular isoforms (α and β). The β receptor cannot bind to the hormone, and, as such, is inactive<a class="elsevierStyleCrossRef" href="#bib0515">31</a> (evidence D-R2). Lack of sensitivity to SC cannot be explained by pharmacokinetic changes or malabsorption, and is probably due to a range of different mechanisms<a class="elsevierStyleCrossRef" href="#bib0520">32</a> (evidence C-R2) (<a class="elsevierStyleCrossRef" href="#tbl0025">Table 5</a>).<elsevierMultimedia ident="tbl0025"></elsevierMultimedia>Inhaled CorticosteroidsResponse to IC varies notably among individuals<a class="elsevierStyleCrossRef" href="#bib0415">11</a> (evidence C-R2). However, there is some evidence to suggest that SUCA patients may respond to higher doses than normally recommended<a class="elsevierStyleCrossRef" href="#bib0525">33</a> (evidence A-R1). Although some studies support the greater therapeutic efficacy of fine particle IC (related with their effect on the peripheral airways), there is no evidence of their superiority in SUCA<a class="elsevierStyleCrossRef" href="#bib0530">34</a> (evidence C-R2).Among the new glucocorticoids, ciclesonide has fewer local and systemic side effects since it is a prodrug converted to its active form in the lung parenchyma<a class="elsevierStyleCrossRef" href="#bib0535">35</a> (evidence B-R2). New steroids, known as “dissociated” compounds (mapracorat), that aim to separate the anti-inflammatory mechanisms from the side effects, are currently under development<a class="elsevierStyleCrossRef" href="#bib0540">36</a> (evidence D-R2).Systemic CorticosteroidsThe best time for introducing maintenance treatment with SC is not well defined, nor is there evidence that continuous treatment with low-dose SC is more effective than cycles of SC in reducing the number of exacerbations. IM triamcinolone administration (Trigon® depot 40mg) in asthmatics with corticosteroid insensitivity improves control, reduces eosinophils in sputum, increases FEV1 and prevents exacerbations. Reasons for its efficacy may include reinforced compliance or the higher dosage of triamcinolone compared to other corticosteroids used in the clinic<a class="elsevierStyleCrossRef" href="#bib0545">37</a> (C-R2).Long-Acting β2-Adrenergic AgonistsAdding a LABA to an IC has been shown to be more effective than doubling the dose of the IC or adding an antileukotriene, although there may be notable variability in response, which needs to be monitored<a class="elsevierStyleCrossRef" href="#bib0550">38</a> (evidence A-R1). Formoterol as a complete agonist has greater intrinsic efficacy and causes a greater number of adverse effects<a class="elsevierStyleCrossRef" href="#bib0555">39</a> (evidence D-R2), the most common of which are tachycardia and hypokalemia, which can be more pronounced in individuals homozygous for arginine in position 16 of β2-AR.Long-Acting AnticholinergicsRecent studies have shown that long-acting anticholinergics (LAMA) may be useful in patients with severe asthma and concomitant CAFL<a class="elsevierStyleCrossRef" href="#bib0560">40</a> (evidence B-R2), in cases of ACOS, in severe asthma with a non-eosinophilic inflammatory profile<a class="elsevierStyleCrossRef" href="#bib0565">41</a> (evidence D-R2), and in asthmatics with the ArgGly variant in codon 16 of the β2-receptor<a class="elsevierStyleCrossRef" href="#bib0570">42</a> (evidence B-R2). There is an increasing trend in the use of LAMA as a treatment for bronchial asthma, and some CPG suggest their use in the higher stages of severity, when control cannot be achieved.Vitamin DLevels of 25-hydroxyvitamin D<30ng/ml are related with asthma severity, increased risk of exacerbations and poor lung function, and are also implicated in the mechanisms of steroid insensitivity. However, no definitive results are available to support supplementation with this vitamin<a class="elsevierStyleCrossRef" href="#bib0575">43</a> (evidence D-R2).MacrolidesTreatment with macrolides for 3 weeks or more in severe asthma is not associated with a significant improvement in FEV1, although improvement has been reported in morning PEF, symptom control, bronchial hyperreactivity, and health-related quality of life (HRQoL)<a class="elsevierStyleCrossRef" href="#bib0580">44</a> (evidence D-R2). There is insufficient evidence on generalized use for reducing the number of exacerbations, although some studies recommend macrolides in the severe neutrophilic asthma phenotype<a class="elsevierStyleCrossRef" href="#bib0585">45</a> (evidence B-R2).AntileukotrienesPatients with AERD generally have excessive basal leukotriene production, so would appear to be ideal candidates for antileukotriene treatment<a class="elsevierStyleCrossRef" href="#bib0590">46</a> (evidence C-R2). Some recent studies report findings in air trapping and radiological changes on CT that suggest montelukast may be useful, in general, in patients with severe asthma, so it may tried as an add-on therapy in these patients<a class="elsevierStyleCrossRef" href="#bib0595">47</a> (evidence C-R2).OmalizumabAnti-IgE treatment has shown clinical efficacy in inflammatory response markers, frequency of exacerbations, visits to emergency departments, severity of symptoms, use of IC, and HRQoL. Omalizumab is indicated for improving asthma control when administered as add-on treatment in adults and older children (over 6 years of age) with persistent severe uncontrolled allergic asthma with perennial allergies, reduced lung function and documented severe exacerbations, despite appropriate treatment for their level of severity<a class="elsevierStyleCrossRef" href="#bib0600">48</a> (evidence B-R2). Data from non-atopic patients receiving omalizumab have been published, which could open a new avenue for treatment in this patient group<a class="elsevierStyleCrossRef" href="#bib0605">49</a> (evidence D-R2).ThermoplastyAlthough early clinical studies performed in asthmatics classified as moderate and severe have not shown particularly favorable results, due to adverse events and the lack of effect on bronchial hyperreactivity<a class="elsevierStyleCrossRef" href="#bib0610">50</a> (evidence B-R2), it is not yet clear which subgroup of patients might benefit from this technique. A recent study, with a 5-year follow-up, showed a sustained improvement in disease control (reduction in number of severe exacerbations and visits to the emergency room) and confirmed the safety of the procedure<a class="elsevierStyleCrossRef" href="#bib0615">51</a> (evidence B-R2). It is currently recommended only in experienced units and in the research setting<a class="elsevierStyleCrossRefs" href="#bib0365">1,52</a> (evidence D-R2)<a class="elsevierStyleCrossRef" href="#bib0625">53</a> (evidence B-R2).Theophylline and Phosphodiesterase-4 InhibitorsAlthough no controlled trials have been performed in severe asthma, theophylline as a single agent has relatively weak anti-inflammatory activity, but at low doses it can markedly enhance the action of corticosteroids on the expression of inflammatory genes<a class="elsevierStyleCrossRef" href="#bib0630">54</a> (evidence D-R2).Data are also available on the utility of the new phosphodiesterase-4 inhibitors (roflumilast) in asthmatics<a class="elsevierStyleCrossRef" href="#bib0635">55</a> (evidence B-R2) and the 2014 Spanish COPD Guidelines (GesEPOC) update continues to suggest these drugs as add-on treatment in ACOS patients with uncontrolled symptoms<a class="elsevierStyleCrossRef" href="#bib0640">56</a> (evidence D-R2CPG).Other TreatmentsStudies have confirmed the unfavorable risk/benefit profile of etanercept, methotrexate and cyclosporin.An anti-IL5 monoclonal antibody, mepolizumab, has been recently investigated in patients with eosinophilic asthma, showing significant improvements in HRQoL, exacerbations and symptoms<a class="elsevierStyleCrossRef" href="#bib0645">57</a> (evidence A-R1)<a class="elsevierStyleCrossRef" href="#bib0650">58</a> (evidence B-R2) and reduced use of SC<a class="elsevierStyleCrossRef" href="#bib0655">59</a> (evidence B-R2). Studies with reslizumab and benralizumab (anti-IL-5 receptor) are opening up new prospects<a class="elsevierStyleCrossRef" href="#bib0660">60</a> (evidence B-R2).Another immune activation pathway in asthma is IL-13. Molecules are already under development with this target in mind: tralokinumab and lebrikizumab with anti-IL-13 effect, and dupilumab<a class="elsevierStyleCrossRef" href="#bib0665">61</a> (evidence B-R2) which is directed against the alpha subunit of the IL-4 receptor, a target shared by both IL-4 and IL-13. Lebrikizumab showed a greater positive effect in patients with elevated pre-treatment levels of circulating periostine<a class="elsevierStyleCrossRef" href="#bib0670">62</a> (evidence B-R2). Trials have been conducted with pitrakinra, an IL-4 mutein, that works as an antagonist by inhibiting IL-4 and IL-13 binding to the shared IL-4Rα/IL-13Rα1 complex<a class="elsevierStyleCrossRef" href="#bib0675">63</a> (evidence B-R2). Daclizumab, a humanized IgG1 monoclonal antibody against the IL-2R-α chain of activated T-lymphocytes, has been shown to be useful in moderate and severe asthma inadequately controlled on IC<a class="elsevierStyleCrossRef" href="#bib0680">64</a> (evidence B-R2).Molecules that act on the IL-17 (brodalumab) and the IL-17A receptor (secukinumab) in neutrophilic asthma are currently under investigation, since IL-17 induces IL-8 expression, the main neutrophil-attracting factor, but results to date have been disappointing<a class="elsevierStyleCrossRef" href="#bib0685">65</a> (evidence B-R2).Phenotype-based TreatmentIf the inflammatory phenotype is identified, treatment response can be predicted. In this respect, there is sufficient data to confirm that eosinophilic inflammation has a high predictive value for response to IC in patients with this type of airway disease, irrespective of their diagnosis. There is evidence for adjusting treatment in SUCA patients on the basis of induced sputum testing (in experienced clinics), although this could not be shown for FeNO<a class="elsevierStyleCrossRef" href="#bib0690">66</a> (evidence A-R1).Triamcinolone could be an alternative in patients with refractory eosinophilia,<a class="elsevierStyleCrossRef" href="#bib0500">28</a> and its effect may be enhanced with low-dose theophylline.<a class="elsevierStyleCrossRef" href="#bib0630">54</a> Therapeutic options, such as omalizumab, are available, and mepolizumab, reslizumab, lebrikizumab or dupilumab could be used in this patient group in the near future.Some selected patients with neutrophilic asthma may be candidates for macrolide treatment.<a class="elsevierStyleCrossRef" href="#bib0580">44</a>Tiotropium is another alternative for patients with CAFL.<a class="elsevierStyleCrossRef" href="#bib0565">41</a> Finally, thermoplasty can be considered in carefully selected patients in experienced units (<a class="elsevierStyleCrossRef" href="#fig0015">Fig. 3</a>).<elsevierMultimedia ident="fig0015"></elsevierMultimedia>Severe Uncontrolled Asthma in ChildhoodLess than 5% of asthmatic children have SUCA. However, the care of children with SUCA accounts for more than twice the direct (medication, visit to the emergency room, hospitalization) and indirect resources (missing school, parents’ absenteeism from work, etc.) used by the others<a class="elsevierStyleCrossRef" href="#bib0695">67</a> (evidence B-R1).Since there are insufficient follow-up studies, no clear relationship can be established between asthma phenotypes in children and in adults, but severe asthma in childhood does seem to continue into adulthood, and very few individuals manage to control their disease.<a class="elsevierStyleCrossRef" href="#bib0385">5</a>Most children referred to specialists for SUCA may belong to one of the following groups, or indeed more, as there may be some overlap, or a patient may be classified into different groups at different ages:Persistent asthma, occurring most days, for at least 3 months, despite high-dose IC and other controllers, such as LABA, montelukast, and less frequently, low-dose oral theophylline or long-term SC.Recurrent severe exacerbations requiring at least ICU admission or 2 hospital admissions, or more than 2 courses of SC in the last year, despite appropriate background treatment for asthma.CAFL due to anatomical reduction of airway caliber, occurring either before birth (maternal smoking, hypertension or gestational diabetes) or postnatal (viral infections, reflux aspiration), detected by lack of improvement in respiratory function (FEV1<−1.96 of the Z score) after administration of 1 dose of IM triamcinolone or 2 weeks of oral SC (although the choice of SC and dose remain unclear)<a class="elsevierStyleCrossRef" href="#bib0700">68</a> (evidence D-R2).As in adults, if a child presents with apparent SUCA, a number of considerations must be made:Is the Diagnosis of Asthma Correct?Other diagnostic possibilities must be considered, and extra tests performed, according to the degree of suspicion (<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>).Are the Prescribed Treatment and Compliance Adequate?SUCA was ruled out in 75% of children after a review of inhalation techniques and treatment compliance<a class="elsevierStyleCrossRef" href="#bib0705">69</a> (evidence D-R2).Are There Aggravating Environmental Factors?Both repeated exposure to airborne allergens to which the child is sensitized and exposure to tobacco smoke or atmospheric pollution contribute to poor asthma control, due to increased bronchial reactivity and reduced response to SC. If these factors are combined with a respiratory viral infection, severe asthma exacerbations may be easily triggered.Are There Comorbidities?Rhinosinusitis, obesity, gastroesophageal reflux and psychosocial factors worsen asthma, although their degree of influence and mechanism of action are disputed. Food allergies behave more as a marker for severity, while breathing dysfunction syndromes may present concomitantly and lead to overtreatment if they are not correctly identified.After analyzing the above-mentioned factors, an attempt should be made to determine if the patient has corticosteroid-sensitive SUCA (the most common pediatric presentation), or not (even if the patient has an eosinophilic inflammatory pattern in the airway), or if they have a neutrophilic or mixed pattern, or if there is CAFL.To this end, the various tests listed in <a class="elsevierStyleCrossRef" href="#tbl0030">Table 6</a> should be scheduled in a series of visits. In the first visit, allergy tests should be repeated, to determine if the patient has become sensitized to other airborne allergens, and cotinine in saliva should be analyzed to detect exposure to tobacco smoke<a class="elsevierStyleCrossRef" href="#bib0710">70</a> (evidence D-R2CPG).<elsevierMultimedia ident="tbl0030"></elsevierMultimedia>To confirm corticosteroid response, and since there is no agreement as regards the optimal dose, duration and route of administration in children, we suggest using triamcinolone, 40–80mg IM, depending on age and weight<a class="elsevierStyleCrossRef" href="#bib0715">71</a> (evidence D-R2). Response should be confirmed 2 weeks later (<a class="elsevierStyleCrossRef" href="#tbl0035">Table 7</a>). Responders are patients who improve in all 3 domains, non-responders are those who do not improve in any domains, and partial responders are those who improve in 1 or 2 domains. The latter category is the most common.<a class="elsevierStyleCrossRef" href="#bib0545">37</a><elsevierMultimedia ident="tbl0035"></elsevierMultimedia>Patients who respond to SC may benefit from omalizumab, which has been shown to be safe and effective in comparative trials in children over the age of 6.<a class="elsevierStyleCrossRef" href="#bib0600">48</a> Any other treatment should also be maintained, including SC, until symptoms are controlled.Non-responders who have persistent neutrophilic airway inflammation may benefit from macrolides, although there is insufficient evidence. Use of azithromycin has been suggested with the same regimen as for cystic fibrosis: 250mg/day for children weighing <40kg and 500mg/day for those >40kg, 3 times a week for 6 months, followed by a reevaluation of efficacy<a class="elsevierStyleCrossRef" href="#bib0720">72</a> (evidence A-R1). Low-dose oral theophylline may also be tried: target blood concentrations are 5–10mg/l.Conflict of InterestCarolina Cisneros Serrano has received fees for lectures and participation in advisory boards from Astra-Zeneca, GSK, Boheringer, Novartis, Takeda, ViforPharma and Chiesi. The other authors declare that they do not have any conflict of interests." "textoCompletoSecciones" => array:1 [ "secciones" => array:15 [ 0 => array:3 [ "identificador" => "xres484712" "titulo" => "Abstract" "secciones" => array:1 [ 0 => array:1 [ "identificador" => "abst0005" ] ] ] 1 => array:2 [ "identificador" => "xpalclavsec506944" "titulo" => "Keywords" ] 2 => array:3 [ "identificador" => "xres484713" "titulo" => "Resumen" "secciones" => array:1 [ 0 => array:1 [ "identificador" => "abst0010" ] ] ] 3 => array:2 [ "identificador" => "xpalclavsec506945" "titulo" => "Palabras clave" ] 4 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 5 => array:2 [ "identificador" => "sec0010" "titulo" => "Methodology" ] 6 => array:2 [ "identificador" => "sec0015" "titulo" => "Definition" ] 7 => array:2 [ "identificador" => "sec0020" "titulo" => "Epidemiology" ] 8 => array:2 [ "identificador" => "sec0025" "titulo" => "Genetics" ] 9 => array:3 [ "identificador" => "sec0030" "titulo" => "Severe Asthma Phenotypes" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "sec0035" "titulo" => "Severe Allergic Asthma" ] 1 => array:2 [ "identificador" => "sec0040" "titulo" => "Late Onset Eosinophilic Asthma" ] 2 => array:2 [ "identificador" => "sec0045" "titulo" => "Severe Non-Atopic Asthma in the Obese Adult" ] 3 => array:2 [ "identificador" => "sec0050" "titulo" => "Adult-Onset Neutrophilic Asthma" ] ] ] 10 => array:3 [ "identificador" => "sec0055" "titulo" => "Diagnosis of the Patient With Severe Uncontrolled Asthma" "secciones" => array:3 [ 0 => array:3 [ "identificador" => "sec0060" "titulo" => "Step 1: Determine if the Patient has Asthma" "secciones" => array:3 [ 0 => array:2 [ "identificador" => "sec0065" "titulo" => "Clinical History and Tests to Confirm Asthma" ] 1 => array:2 [ "identificador" => "sec0070" "titulo" => "Differential Diagnosis" ] 2 => array:3 [ "identificador" => "sec0075" "titulo" => "Upper Airway Disease" "secciones" => array:2 [ 0 => array:2 [ "identificador" => "sec0080" "titulo" => "Organic Causes" ] 1 => array:2 [ "identificador" => "sec0085" "titulo" => "Functional Causes" ] ] ] ] ] 1 => array:3 [ "identificador" => "sec0105" "titulo" => "Step 2: Identify Factors for Poor Control and Evaluate Concomitant Diseases" "secciones" => array:5 [ 0 => array:2 [ "identificador" => "sec0110" "titulo" => "Check Compliance" ] 1 => array:2 [ "identificador" => "sec0115" "titulo" => "Check Inhalation Technique" ] 2 => array:2 [ "identificador" => "sec0120" "titulo" => "Check Environmental and/or Workplace Exposure" ] 3 => array:2 [ "identificador" => "sec0125" "titulo" => "Check Bronchoconstrictor Drugs" ] 4 => array:2 [ "identificador" => "sec0130" "titulo" => "Evaluate Comorbidities" ] ] ] 2 => array:2 [ "identificador" => "sec0135" "titulo" => "Step 3: Identify Severe Asthma Phenotypes" ] ] ] 11 => array:3 [ "identificador" => "sec0140" "titulo" => "Treatment of Severe Uncontrolled Asthma" "secciones" => array:13 [ 0 => array:2 [ "identificador" => "sec0145" "titulo" => "Corticosteroid Insensitivity" ] 1 => array:2 [ "identificador" => "sec0150" "titulo" => "Inhaled Corticosteroids" ] 2 => array:2 [ "identificador" => "sec0155" "titulo" => "Systemic Corticosteroids" ] 3 => array:2 [ "identificador" => "sec0160" "titulo" => "Long-Acting β2-Adrenergic Agonists" ] 4 => array:2 [ "identificador" => "sec0165" "titulo" => "Long-Acting Anticholinergics" ] 5 => array:2 [ "identificador" => "sec0170" "titulo" => "Vitamin D" ] 6 => array:2 [ "identificador" => "sec0175" "titulo" => "Macrolides" ] 7 => array:2 [ "identificador" => "sec0180" "titulo" => "Antileukotrienes" ] 8 => array:2 [ "identificador" => "sec0185" "titulo" => "Omalizumab" ] 9 => array:2 [ "identificador" => "sec0190" "titulo" => "Thermoplasty" ] 10 => array:2 [ "identificador" => "sec0195" "titulo" => "Theophylline and Phosphodiesterase-4 Inhibitors" ] 11 => array:2 [ "identificador" => "sec0200" "titulo" => "Other Treatments" ] 12 => array:2 [ "identificador" => "sec0205" "titulo" => "Phenotype-based Treatment" ] ] ] 12 => array:3 [ "identificador" => "sec0210" "titulo" => "Severe Uncontrolled Asthma in Childhood" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "sec0215" "titulo" => "Is the Diagnosis of Asthma Correct?" ] 1 => array:2 [ "identificador" => "sec0220" "titulo" => "Are the Prescribed Treatment and Compliance Adequate?" ] 2 => array:2 [ "identificador" => "sec0225" "titulo" => "Are There Aggravating Environmental Factors?" ] 3 => array:2 [ "identificador" => "sec0230" "titulo" => "Are There Comorbidities?" ] ] ] 13 => array:2 [ "identificador" => "sec0235" "titulo" => "Conflict of Interest" ] 14 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2014-09-19" "fechaAceptado" => "2014-12-06" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec506944" "palabras" => array:4 [ 0 => "Severe asthma" 1 => "Uncontrolled asthma" 2 => "Asthma phenotype" 3 => "Asthma treatment" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec506945" "palabras" => array:4 [ 0 => "Asma grave" 1 => "Asma no controlada" 2 => "Fenotipado del asma" 3 => "Tratamiento del asma" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:2 [ "titulo" => "Abstract" "resumen" => "Since the publication, 9 years ago, of the latest SEPAR (Spanish Society of Pulmonology and Thoracic Surgery) Guidelines on Difficult-to-Control Asthma (DCA), much progress has been made in the understanding of asthmatic disease. These new data need to be reviewed, analyzed and incorporated into the guidelines according to their level of evidence and recommendation. Recently, consensus documents and clinical practice guidelines (CPG) addressing this issue have been published. In these guidelines, specific mention will be made of what the previous DCA guidelines defined as “true difficult-to-control asthma”. This is asthma that remains uncontrolled after diagnosis and a systematic evaluation to rule out factors unrelated to the disease itself that lead to poor control (“false difficult-to-control asthma”), and despite an appropriate treatment strategy (Spanish Guidelines for the Management of Asthma [GEMA] steps 5 and 6): severe uncontrolled asthma. In this respect, the guidelines propose a revised definition, an attempt to classify the various manifestations of this type of asthma, a proposal for a stepwise diagnostic procedure, and phenotype-targeted treatment. A specific section has also been included on DCA in childhood, aimed at assisting healthcare professionals to improve the care of these patients." ] "es" => array:2 [ "titulo" => "Resumen" "resumen" => "Desde la publicación, hace ya 9 años, de la última normativa de la Sociedad Española de Neumología y Cirugía Torácica (SEPAR) sobre asma de control difícil (ACD), se han producido avances en los conocimientos de la enfermedad asmática, que hacen necesario realizar una puesta al día de los datos disponibles e incorporarlos tras su análisis en el nivel de evidencia y recomendación más adecuado. Recientemente han aparecido documentos de consenso y guías de práctica clínica (GPC) que abordan este problema. En esta normativa se hará mención explícita a lo que la previa guía de ACD definía como «verdadera asma de control difícil»; es decir, al asma que tras haber verificado su diagnóstico, realizado un abordaje sistematizado para descartar factores ajenos a la propia enfermedad que conducen a un mal control de la misma («falsa asma de control difícil»), y realizar una estrategia de tratamiento adecuado (escalones 5 y 6 de la Guía española para el manejo del asma [GEMA]), no se consigue alcanzar el control: «asma grave no controlada» (AGNC). En esta línea la normativa propone una revisión de la definición, un intento de clasificación de las diferentes manifestaciones de este tipo de asma, una propuesta del abordaje diagnóstico por pasos y un tratamiento dirigido según fenotipo, conjuntamente con un apartado específico sobre este arquetipo de asma en la infancia, con el objetivo de que pueda servir de ayuda a los profesionales sanitarios y repercutir en el cuidado de estos pacientes." ] ] "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "Please cite this article as: Cisneros Serrano C, Melero Moreno C, Almonacid Sánchez C, Perpiñá Tordera M, Picado Valles C, Martínez Moragón E, et al. Normativa sobre asma grave no controlada. Arch Bronconeumol. 2015;51:235–246." ] ] "multimedia" => array:10 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 3333 "Ancho" => 2391 "Tamanyo" => 820367 ] ] "descripcion" => array:1 [ "en" => "Grading and quality of evidence and implication of recommendations according to GRADE." ] ] 1 => array:7 [ "identificador" => "fig0010" "etiqueta" => "Fig. 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 3333 "Ancho" => 2506 "Tamanyo" => 593743 ] ] "descripcion" => array:1 [ "en" => "Algorithm for evaluation of patient with severe, uncontrolled asthma." ] ] 2 => array:7 [ "identificador" => "fig0015" "etiqueta" => "Fig. 3" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr3.jpeg" "Alto" => 1822 "Ancho" => 2829 "Tamanyo" => 231541 ] ] "descripcion" => array:1 [ "en" => "Treatment proposal for severe, uncontrolled asthma according to phenotype. ACOS: asthma/COPD overlap syndrome; AERD: aspirin-exacerbated respiratory disease; CAFL: chronic airflow limitation." ] ] 3 => array:7 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:2 [ "leyenda" => "ACQ: Asthma Control Questionnaire; ACT: Asthma Control Test; CFC: chlorofluorocarbons; DPI: dry powder inhaler; FEV1: forced expired volume in 1s; FVC: forced vital capacity; GINA: Global Initiative for Asthma; HFA: hydrofluoroalkanes; MDI: measured dose inhaler; NAEPP: National Asthma Education and Prevention Program; ICU: intensive care unit.Adapted from ATS/ERS.<a class="elsevierStyleCrossRef" href="#bib0365">1</a>" "tablatextoimagen" => array:2 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">The ATS/ERS Consensus defines severe asthma as asthma requiring treatment at steps 4–5 of the Global Initiative for Asthma (GINA) clinical practice guidelines, namely high-dose inhaled corticosteroids and a long-acting beta-antagonist, or a leukotriene modifier, or theophylline use in the previous year, or systemic corticosteroids for ≥50% of the last year, to prevent the disease from becoming uncontrolled, or disease that remains uncontrolled despite this treatment \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">The Consensus defines uncontrolled asthma as at least one of the following: \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Poor control of symptoms measured on questionnaires evaluating disease control, such as the ACT and ACQ. ACQ scores >1.5 or ACT ≤19 are considered criteria for poor control according to clinical practice guidelines, such as GINA/National Asthma Education and Prevention Program (NAEPP) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Frequent severe exacerbations: 2 or more exacerbations requiring bursts of systemic corticosteroids for 3 or more days each in the previous year. \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Exacerbations requiring at least 1 hospitalization, ICU admission or need for non-invasive mechanical ventilation in the previous year. \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Airflow limitation: FEV1 remains <80% predicted value after use of an appropriate bronchodilator and FEV1/FVC ratio below the lower limit of normal (when best FEV1 is >80%). \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Controlled asthma that worsens after reducing high-dose inhaled or systemic corticosteroids or new biologics \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab767386.png" ] ] 1 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col">Inhaled Corticosteroid \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " colspan="2" align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Threshold Dose (μg) Considered High</th></tr><tr title="table-row"><th class="td" title="table-head " align="" valign="top" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Age 6–12 years \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Age >12 years \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry " rowspan="2" align="left" valign="top">Beclomethasone dipropionate</td><td class="td" title="table-entry " align="char" valign="top">≥800 (DPI or CFC MDI) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">≥2000 (DPI or CFC MDI) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="char" valign="top">≥320 (HFA MDI) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">≥1000 (HFA MDI) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Budesonide \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">≥800 (MDI or DPI) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">≥1600 (MDI or DPI) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Ciclesonide \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">≥160 (HFA MDI) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">≥320 (HFA MDI) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Fluticasone dipropionate \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">≥500 (HFA MDI or DPI) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">≥1000 (HFA MDI or DPI) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Momethasone furoate \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">≥500 (DPI) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">≥1000 (DPI) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Triamcinolone acetonide \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">≥1200 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">≥2000 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab767383.png" ] ] ] ] "descripcion" => array:1 [ "en" => "Definition of Severe Asthma in Patients Older Than 6 years." ] ] 4 => array:7 [ "identificador" => "tbl0010" "etiqueta" => "Table 2" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:2 [ "leyenda" => "IBD: inflammatory bowel disease." "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col">Adults \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col">Children \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Upper airway diseasesOrganic causesTumors of the tracheaCongenital airway abnormalitiesCongenital vascular abnormalitiesTracheobronchomalaciaIdiopathic relapsing polychondritisTracheal amyloidosisIBD-associated airway stenosisEndothoracic goiterChronic fibrosing mediastinitisFunctional causesVocal cord dysfunctionLower airway diseasesChronic obstructive pulmonary diseaseBronchiolitis obliteransFunctional or psychogenic dyspneaOther organ diseaseLeft heart failure \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Upper airway diseasesAdenotonsillar hypertrophyLaryngomalacia, vocal cord paralysis, laryngeal membraneVocal cord dysfunctionLarge airway obstructionTracheomalacia, bronchomalaciaTracheal or bronchial stenosisForeign bodyVascular ringsLymphadenopathies, tumorsSuppurative lung diseaseCystic fibrosisBronchiectasisPrimary ciliary dyskinesiaPersistent bacterial bronchitisImmune deficienciesAspirative syndromesGastroesophageal refluxUncoordinated swallowingTracheoesophageal fistulaLaryngeal cleftOtherBronchopulmonary dysplasiaBronchiolitis obliteransPulmonary edemaPsychogenic cough \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab767381.png" ] ] ] ] "descripcion" => array:1 [ "en" => "Differential Diagnosis of Asthma in Adults and Children." ] ] 5 => array:7 [ "identificador" => "tbl0015" "etiqueta" => "Table 3" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:2 [ "leyenda" => "ABPA: allergic bronchopulmonary aspergillosis; pANCA: perinuclear anti-neutrophil cytoplasmic antibodies; ECG: electrocardiogram; IgE: immunoglobulin E; BAL: bronchoalveolar lavage; CT: computed tomography. HRCT: high-resolution CT." "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Upper airway organic diseaseBronchial obstruction \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Spirometry with flow-volume loopUpper airway inspiratory/expiratory CTFiberoptic bronchoscopy \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Vocal cord dysfunction \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Laryngoscopy during attack or after methacholine challenge or after ergometry \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Chronic obstructive pulmonary disease (emphysema) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Chest HRCTPlethysmography and diffusion \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Bronchiolitis obliterans \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Inspiratory/expiratory chest HRCTPlethysmography/air trappingTransbronchial/pulmonary biopsy \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Functional dyspnea \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Nijmegen hyperventilation questionnairePsychological assessment \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Left heart failure \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Chest HRCTECG/echocardiogram \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">BronchiectasisCystic fibrosisABPA \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Chest HRCTSweat testTotal and Aspergillus specific IgE/precipitin \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Churg-Strauss syndromePulmonary eosinophilia \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">pANCA/biopsy of affected organ(s)Fiberoptic bronchoscopy (BAL) \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab767387.png" ] ] ] ] "descripcion" => array:1 [ "en" => "Differential Diagnosis of Severe, Uncontrolled Asthma in Adults. Pseudo-Asthmas and Diagnostic Tests." ] ] 6 => array:7 [ "identificador" => "tbl0020" "etiqueta" => "Table 4" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:2 [ "leyenda" => "CPAP: continuous positive airway pressure; PPI: proton pump inhibitors; BMI: body mass index: OSAHS: obstructive sleep apnea–hypopnea syndrome; CT: computed tomography." "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Comorbidity \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Diagnostic tests \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Treatment \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Rhinosinusitis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">RhinoendoscopyCT of paranasal sinuses \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">AntileukotrienesIntranasal corticosteroidsNasal saline washingNasal endoscopic surgery \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Gastroesophageal reflux \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Esophageal pH testing/manometryTherapeutic trial with PPI \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Health and dietary advicePPISurgery \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Obesity \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">BMI \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Weight lossBariatric surgery \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">OSAHS \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Polysomnography \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">CPAPWeight loss, if applicable \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Psychiatric disease \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Assessment by psychologist/psychiatrist \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">PsychotherapySpecific treatment \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Functional dyspnea \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Specific questionnaires(Nijmegen) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">PsychotherapyRespiratory re-education \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Vocal cord dysfunction \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Laryngoscopy during attack or methacholine challenge/exercise test \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Speech therapy rehabilitation \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab767382.png" ] ] ] ] "descripcion" => array:1 [ "en" => "Evaluation and Treatment of Comorbidities." ] ] 7 => array:7 [ "identificador" => "tbl0025" "etiqueta" => "Table 5" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:2 [ "leyenda" => "GC: glucocorticoids.Taken from Reddy and Little.<a class="elsevierStyleCrossRef" href="#bib0520">32</a>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Reduced number of GC receptors \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Increased GC β-receptor expression \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Cytokines inducing suppression of GC activity \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Alteration in the GC receptor affinity \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Reduced GC-receptor nuclear translocation \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Reduced histone acetylation and increased activation of the protein-1 (AP-1) pathway and nuclear factor κB (NF-κB) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Predominantly neutrophil inflammation \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab767388.png" ] ] ] ] "descripcion" => array:1 [ "en" => "Glucocorticoid Resistance Mechanisms in Severe Asthma." ] ] 8 => array:7 [ "identificador" => "tbl0030" "etiqueta" => "Table 6" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:2 [ "leyenda" => "ACT: Asthma Control Test; FeNO: fractional exhaled nitric oxide; IM: intramuscular; BAL: bronchoalveolar lavage." "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="" valign="top" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Visit 1 \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Visit 2(at 2 weeks) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Visit 3(at 2 weeks) \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">ACT questionnaire \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">√ \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">√ \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">√ \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Spirometry and bronchodilator test \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">√ \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">√ \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">√ \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Induced sputum \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">√ \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">√ \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">√ \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">FeNO \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">√ \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">√ \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">√ \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Bronchoscopy with BAL and endobronchial biopsy \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">√ \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Triamcinolone IM \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">√ \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab767384.png" ] ] ] ] "descripcion" => array:1 [ "en" => "Evaluation of Severe Uncontrolled Asthma in Children." ] ] 9 => array:7 [ "identificador" => "tbl0035" "etiqueta" => "Table 7" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:2 [ "leyenda" => "ACT: Asthma Control Test; FeNO: fractional exhaled nitric oxide; FEV1: forced expiratory volume in 1s." "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Clinical response: ACT questionnaire score \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Score >20–25 points or increase ≥5 points \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Lung function tests \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">FEV1 normal or increase >15%Negative bronchodilator test \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Induced sputum \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Normalization of eosinophil count \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">FeNO \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top"><24ppb \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab767385.png" ] ] ] ] "descripcion" => array:1 [ "en" => "Positive Response to Triamcinolone in Children." ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:72 [ 0 => array:3 [ "identificador" => "bib0365" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "K.F. Chung" 1 => "S.E. Wenzel" 2 => "J.L. Brozek" 3 => "A. Bush" 4 => "M. Castro" 5 => "P.J. Sterk" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1183/09031936.00202013" "Revista" => array:6 [ "tituloSerie" => "Eur Respir J" "fecha" => "2014" "volumen" => "43" "paginaInicial" => "343" "paginaFinal" => "373" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24337046" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0370" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "H.J. Schünemann" 1 => "R. Jaeschke" 2 => "D.J. Cook" 3 => "W.F. Bria" 4 => "A.A. El-Solh" 5 => "A. Ernst" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1164/rccm.200602-197ST" "Revista" => array:6 [ "tituloSerie" => "Am J Respir Crit Care Med" "fecha" => "2006" "volumen" => "174" "paginaInicial" => "605" "paginaFinal" => "614" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16931644" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0375" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "K.F. Rabe" 1 => "M. Adachi" 2 => "K. Lai" 3 => "J.B. Soriano" 4 => "P.A. Vermeire" 5 => "K.B. Weiss" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jaci.2004.04.042" "Revista" => array:6 [ "tituloSerie" => "J Allergy Clin Immunol" "fecha" => "2004" "volumen" => "114" "paginaInicial" => "40" "paginaFinal" => "47" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15241342" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0380" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prevalence of uncontrolled severe persistent asthma in pneumology and allergy hospital units in Spain" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "S. Quirce" 1 => "V. Plaza" 2 => "C. Picado" 3 => "M. Vennera" 4 => "J. Casafont" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Investig Allergol Clin Immunol" "fecha" => "2011" "volumen" => "21" "paginaInicial" => "466" "paginaFinal" => "471" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21995180" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0385" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Extent, patterns, and burden of uncontrolled disease in severe or difficult-to-treat asthma" "autores" => array:1 [ 0 => array:3 [ "colaboracion" => "TENOR Study Group" "etal" => false "autores" => array:5 [ 0 => "S.D. Sullivan" 1 => "L. Rasouliyan" 2 => "P.A. Russo" 3 => "T. Kamath" 4 => "B.E. Chipps" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1398-9995.2006.01254.x" "Revista" => array:6 [ "tituloSerie" => "Allergy" "fecha" => "2007" "volumen" => "62" "paginaInicial" => "126" "paginaFinal" => "133" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17298420" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0390" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Genome-wide association studies for discovery of genes involved in asthma" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "L. Akhabir" 1 => "A.J. Sandford" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1440-1843.2011.01939.x" "Revista" => array:6 [ "tituloSerie" => "Respirology" "fecha" => "2011" "volumen" => "16" "paginaInicial" => "396" "paginaFinal" => "406" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21276132" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0395" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "IL4R alpha mutations are associated with asthma exacerbations and mast cell/IgE expression" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S.E. Wenzel" 1 => "S. Balzar" 2 => "E. Ampleford" 3 => "G.A. Hawkins" 4 => "W.W. Busse" 5 => "W.J. Calhoun" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1164/rccm.200607-909OC" "Revista" => array:6 [ "tituloSerie" => "Am J Respir Crit Care Med" "fecha" => "2007" "volumen" => "175" "paginaInicial" => "570" "paginaFinal" => "576" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17170387" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0400" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The IL6R variation Asp(358)Ala is a potential modifier of lung function in subjects with asthma" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "G.A. Hawkins" 1 => "M.B. Robinson" 2 => "A.T. Hastie" 3 => "X. Li" 4 => "H. Li" 5 => "W.C. Moore" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jaci.2012.03.018" "Revista" => array:6 [ "tituloSerie" => "J Allergy Clin Immunol" "fecha" => "2012" "volumen" => "130" "paginaInicial" => "510" "paginaFinal" => "515" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22554704" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0405" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Genome-wide association study of asthma identifies RAD50-IL13 and HLA-DR/DQ regions" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "X. Li" 1 => "T.D. Howard" 2 => "S.L. Zheng" 3 => "T. Haselkorn" 4 => "S.P. Peters" 5 => "D.A. Meyers" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jaci.2009.11.018" "Revista" => array:6 [ "tituloSerie" => "J Allergy Clin Immunol" "fecha" => "2010" "volumen" => "125" "paginaInicial" => "328" "paginaFinal" => "335" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20159242" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0410" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Untangling asthma phenotypes and endotypes" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "I. Agache" 1 => "C. Akdis" 2 => "M. Jutel" 3 => "J.C. Virchow" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1398-9995.2012.02832.x" "Revista" => array:6 [ "tituloSerie" => "Allergy" "fecha" => "2012" "volumen" => "67" "paginaInicial" => "835" "paginaFinal" => "846" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22594878" …1 ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0415" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cluster analysis and clinical asthma phenotypes" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1164/rccm.200711-1754OC" "Revista" => array:6 [ "tituloSerie" => "Am J Respir Crit Care Med" "fecha" => "2008" "volumen" => "178" "paginaInicial" => "218" "paginaFinal" => "234" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0420" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1164/rccm.200906-0896OC" "Revista" => array:6 [ "tituloSerie" => "Am J Respir Crit Care Med" "fecha" => "2010" "volumen" => "181" "paginaInicial" => "315" "paginaFinal" => "323" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0425" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Identifying adult asthma phenotypes using a clustering approach" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1183/09031936.00120810" "Revista" => array:6 [ "tituloSerie" => "Eur Respir J" "fecha" => "2011" "volumen" => "38" "paginaInicial" => "310" "paginaFinal" => "317" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0430" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Ana-lyses of asthma severity phenotypes and inflammatory proteins in subjects stratified by sputum granulocytes" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jaci.2010.02.008" "Revista" => array:6 [ "tituloSerie" => "J Allergy Clin Immunol" "fecha" => "2010" "volumen" => "125" "paginaInicial" => "1028" "paginaFinal" => "1036" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0435" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Complex phenotypes in asthma: current definitions" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ …1] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.pupt.2013.07.003" "Revista" => array:6 [ "tituloSerie" => "Pulm Pharmacol Ther" "fecha" => "2013" "volumen" => "26" "paginaInicial" => "710" "paginaFinal" => "715" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0440" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Linking obesity and asthma" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ …1] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/nyas.12357" "Revista" => array:6 [ "tituloSerie" => "Ann NY Acad Sci" "fecha" => "2014" "volumen" => "1311" "paginaInicial" => "31" "paginaFinal" => "41" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0445" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Normativa para el asma de control difícil" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Arch Bronconeumol" "fecha" => "2005" "volumen" => "41" "paginaInicial" => "513" "paginaFinal" => "523" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0450" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Diagnosis and definition of severe refractory asthma: an international consensus statement from the Innovative Medicine Initiative (IMI)" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/thx.2010.153643" "Revista" => array:6 [ "tituloSerie" => "Thorax" "fecha" => "2011" "volumen" => "66" "paginaInicial" => "910" "paginaFinal" => "917" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0455" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Consensus document on the diagnosis of severe uncontrolled asthma" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Investig Allergol Clin Immunol" "fecha" => "2012" "volumen" => "22" "paginaInicial" => "460" "paginaFinal" => "475" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0460" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Systematic assessment of difficult-to-treat asthma" "autores" => array:1 [ 0 => array:3 [ "colaboracion" => "Asthma and Allergy Research Group of the National Heart and Lung Institute" "etal" => false "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Eur Respir J" "fecha" => "2003" "volumen" => "20" "paginaInicial" => "478" "paginaFinal" => "483" ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0465" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Global strategy for asthma management and prevention" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ …1] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Libro" => array:1 [ "fecha" => "2014" ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib0470" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Vocal cord dysfunction in athletes: clinical presentation and review of the literature" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ …2] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3810/psm.2012.05.1961" "Revista" => array:6 [ "tituloSerie" => "Phys Sportsmed" "fecha" => "2012" "volumen" => "40" "paginaInicial" => "22" "paginaFinal" => "27" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib0475" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Abnormal vocal cord function in difficult-to-treat asthma" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1164/rccm.201010-1604OC" "Revista" => array:6 [ "tituloSerie" => "Am J Respir Crit Care Med" "fecha" => "2011" "volumen" => "184" "paginaInicial" => "50" "paginaFinal" => "56" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib0480" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Psychological profile of patients with bronchial asthma and functional dyspnea: a comparison with a non-asthmatic population and impact on the disease" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ …5] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.arbres.2010.10.003" "Revista" => array:6 [ "tituloSerie" => "Arch Bronconeumol" "fecha" => "2011" "volumen" => "47" "paginaInicial" => "73" "paginaFinal" => "78" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib0485" "etiqueta" => "25" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Patients with asthma who do not fill their inhaled corticosteroids: a study of primary nonadherence" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jaci.2007.08.020" "Revista" => array:6 [ "tituloSerie" => "J Allergy Clin Immunol" "fecha" => "2007" "volumen" => "120" "paginaInicial" => "1153" "paginaFinal" => "1159" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib0490" "etiqueta" => "26" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Inhaler mishandling remains common in real life and is associated with reduced disease control" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ …3] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.rmed.2011.01.005" "Revista" => array:6 [ "tituloSerie" => "Respir Med" "fecha" => "2011" "volumen" => "105" "paginaInicial" => "930" "paginaFinal" => "938" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 26 => array:3 [ "identificador" => "bib0495" "etiqueta" => "27" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Guía española para el manejo del asma (GEMA). Available from: <a href="http://www.gemasma.com/">www.gemasma.com</a> [accessed 28.07.14]." ] ] ] 27 => array:3 [ "identificador" => "bib0500" "etiqueta" => "28" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Corticosteroid responsiveness and clinical characteristics in childhood difficult asthma" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1183/09031936.00186508" "Revista" => array:6 [ "tituloSerie" => "Eur Respir J" "fecha" => "2009" "volumen" => "34" "paginaInicial" => "1052" "paginaFinal" => "1059" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 28 => array:3 [ "identificador" => "bib0505" "etiqueta" => "29" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Glucocorticoid resistance asthma" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ …3] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Am J Respir Crit Care Med" "fecha" => "1995" "volumen" => "152" "paginaInicial" => "125" "paginaFinal" => "140" ] ] ] ] ] ] 29 => array:3 [ "identificador" => "bib0510" "etiqueta" => "30" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Asthma and cigarette smoking" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ …1] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1183/09031936.04.00039004" "Revista" => array:6 [ "tituloSerie" => "Eur Respir J" "fecha" => "2004" "volumen" => "24" "paginaInicial" => "822" "paginaFinal" => "833" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 30 => array:3 [ "identificador" => "bib0515" "etiqueta" => "31" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mecanismos moleculares de los glucocorticoides" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ …3] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Arch Bronconeumol" "fecha" => "2005" "volumen" => "41" "paginaInicial" => "34" "paginaFinal" => "41" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 31 => array:3 [ "identificador" => "bib0520" "etiqueta" => "32" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Glucocorticoid-resistant asthma: more than meets the eye" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ …2] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3109/02770903.2013.831870" "Revista" => array:6 [ "tituloSerie" => "J Asthma" "fecha" => "2013" "volumen" => "50" "paginaInicial" => "1036" "paginaFinal" => "1044" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 32 => array:3 [ "identificador" => "bib0525" "etiqueta" => "33" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Fluticasone at different doses for chronic asthma in adults and children" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/14651858.CD003534.pub3" "Revista" => array:3 [ "tituloSerie" => "Cochrane Database Syst Rev" "fecha" => "2008" "paginaInicial" => "CD003534" ] ] ] ] ] ] 33 => array:3 [ "identificador" => "bib0530" "etiqueta" => "34" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effects of extra-fine inhaled beclomethasone/formoterol on both large and small airways in asthma" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1398-9995.2009.02306.x" "Revista" => array:6 [ "tituloSerie" => "Allergy" "fecha" => "2010" "volumen" => "65" "paginaInicial" => "897" "paginaFinal" => "902" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 34 => array:3 [ "identificador" => "bib0535" "etiqueta" => "35" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Randomized comparison of ciclesonide 160 and microg/day in severe asthma" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.pupt.2007.11.002" "Revista" => array:6 [ "tituloSerie" => "Pulm Pharmacol Ther" "fecha" => "2008" "volumen" => "21" "paginaInicial" => "489" "paginaFinal" => "498" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 35 => array:3 [ "identificador" => "bib0540" "etiqueta" => "36" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Targeting inflammation using selective glucocorticoid receptor modulators" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ …3] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.coph.2010.04.007" "Revista" => array:6 [ "tituloSerie" => "Curr Opin Pharmacol" "fecha" => "2010" "volumen" => "10" "paginaInicial" => "497" "paginaFinal" => "504" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 36 => array:3 [ "identificador" => "bib0545" "etiqueta" => "37" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "High-dose intramuscular triamcinolone in severe, chronic, life-threatening asthma" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJM199102283240903" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "1991" "volumen" => "324" "paginaInicial" => "585" "paginaFinal" => "589" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 37 => array:3 [ "identificador" => "bib0550" "etiqueta" => "38" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/14651858.CD005533.pub2" "Revista" => array:3 [ "tituloSerie" => "Cochrane Database Syst Rev" "fecha" => "2005" "paginaInicial" => "CD005533" ] ] ] ] ] ] 38 => array:3 [ "identificador" => "bib0555" "etiqueta" => "39" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical implications of the intrinsic efficacy of beta-adrenoceptor drugs in asthma: full, partial and inverse agonism" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ …3] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/MCP.0b013e328333def8" "Revista" => array:6 [ "tituloSerie" => "Curr Opin Pulm Med" "fecha" => "2010" "volumen" => "16" "paginaInicial" => "1" "paginaFinal" => "5" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 39 => array:3 [ "identificador" => "bib0560" "etiqueta" => "40" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Tiotropium in asthma poorly controlled with standard combination therapy" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa1208606" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2012" "volumen" => "367" "paginaInicial" => "1198" "paginaFinal" => "1207" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 40 => array:3 [ "identificador" => "bib0565" "etiqueta" => "41" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Tiotropium bromide is effective for severe asthma with noneosinophilic phenotype" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1183/09031936.00014108" "Revista" => array:6 [ "tituloSerie" => "Eur Respir J" "fecha" => "2008" "volumen" => "31" "paginaInicial" => "1379" "paginaFinal" => "1382" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 41 => array:3 [ "identificador" => "bib0570" "etiqueta" => "42" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Additive role of tiotropium in severe asthmatics and Arg16Gly in ADRB2 as a potential marker to predict response" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1398-9995.2008.01876.x" "Revista" => array:6 [ "tituloSerie" => "Allergy" "fecha" => "2009" "volumen" => "64" "paginaInicial" => "778" "paginaFinal" => "783" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 42 => array:3 [ "identificador" => "bib0575" "etiqueta" => "43" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Vitamin D and asthma" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1164/rccm.201108-1502CI" "Revista" => array:6 [ "tituloSerie" => "Am J Respir Crit Care Med" "fecha" => "2012" "volumen" => "185" "paginaInicial" => "124" "paginaFinal" => "132" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 43 => array:3 [ "identificador" => "bib0580" "etiqueta" => "44" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The role of macrolides in asthma: current evidence and future directions" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ …4] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S2213-2600(14)70107-9" "Revista" => array:6 [ "tituloSerie" => "Lancet Respir Med" "fecha" => "2014" "volumen" => "2" "paginaInicial" => "657" "paginaFinal" => "670" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 44 => array:3 [ "identificador" => "bib0585" "etiqueta" => "45" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Azythromicin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/thoraxjnl-2012-202698" "Revista" => array:6 [ "tituloSerie" => "Thorax" "fecha" => "2013" "volumen" => "68" "paginaInicial" => "322" "paginaFinal" => "329" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 45 => array:3 [ "identificador" => "bib0590" "etiqueta" => "46" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Protection of leukotriene receptor antagonist against aspirin-induced bronchospasm in asthmatics" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.4168/aair.2010.2.1.48" "Revista" => array:6 [ "tituloSerie" => "Allergy Asthma Immunol Res" "fecha" => "2010" "volumen" => "2" "paginaInicial" => "48" "paginaFinal" => "54" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 46 => array:3 [ "identificador" => "bib0595" "etiqueta" => "47" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Montelukast improves air trapping, not airway remodeling, in patients with moderate-to-severe asthma: a pilot study" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ …5] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Chin Med J" "fecha" => "2013" "volumen" => "126" "paginaInicial" => "2229" "paginaFinal" => "2234" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 47 => array:3 [ "identificador" => "bib0600" "etiqueta" => "48" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Anti-IgE for chronic asthma in adults and childrens" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ …5] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/14651858.CD003559.pub4" "Revista" => array:5 [ "tituloSerie" => "Cochrane Database Syst Rev" "fecha" => "2014" "volumen" => "1" "paginaInicial" => "CD003559" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 48 => array:3 [ "identificador" => "bib0605" "etiqueta" => "49" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effects of omalizumab in non-atopic asthma: results from a Spanish multicenter registry" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3109/02770903.2012.757780" "Revista" => array:6 [ "tituloSerie" => "J Asthma" "fecha" => "2013" "volumen" => "50" "paginaInicial" => "296" "paginaFinal" => "301" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 49 => array:3 [ "identificador" => "bib0610" "etiqueta" => "50" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma. A multicenter, randomized, double-blind, sham-controlled clinical trial" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Am J Med Respir Crit Care Med" "fecha" => "2010" "volumen" => "181" "paginaInicial" => "116" "paginaFinal" => "124" ] ] ] ] ] ] 50 => array:3 [ "identificador" => "bib0615" "etiqueta" => "51" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Bronchial thermoplasty: long-term safety and effectiveness in patients with severe persistent asthma" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Allergy Clin Immunol" "fecha" => "2013" "volumen" => "132" "paginaInicial" => "1295" "paginaFinal" => "1302" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 51 => array:3 [ "identificador" => "bib0620" "etiqueta" => "52" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Bronchial thermoplasty: reappraising the evidence (or lack thereof)" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ …2] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1378/chest.14-0536" "Revista" => array:6 [ "tituloSerie" => "Chest" "fecha" => "2014" "volumen" => "146" "paginaInicial" => "17" "paginaFinal" => "21" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 52 => array:3 [ "identificador" => "bib0625" "etiqueta" => "53" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Bronchial thermoplasty for moderate or severe persistent asthma in adults" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/14651858.CD009910.pub2" "Revista" => array:5 [ "tituloSerie" => "Cochrane Database Syst Rev" "fecha" => "2014" "volumen" => "3" "paginaInicial" => "CD009910" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 53 => array:3 [ "identificador" => "bib0630" "etiqueta" => "54" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Theophylline new perspectives for and old drug" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ …1] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1164/rccm.200210-1142PP" "Revista" => array:6 [ "tituloSerie" => "Am J Respir Crit Care Med" "fecha" => "2003" "volumen" => "167" "paginaInicial" => "813" "paginaFinal" => "818" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 54 => array:3 [ "identificador" => "bib0635" "etiqueta" => "55" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Efficacy and safety of roflumilast in the treatment of asthma" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S1081-1206(10)61065-4" "Revista" => array:6 [ "tituloSerie" => "Ann Allergy Asthma Immunol" "fecha" => "2006" "volumen" => "96" "paginaInicial" => "679" "paginaFinal" => "686" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 55 => array:3 [ "identificador" => "bib0640" "etiqueta" => "56" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Spanish Guideline for COPD (GesEPOC). Update 2014" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0300-2896(14)70070-5" "Revista" => array:7 [ "tituloSerie" => "Arch Bronconeumol" "fecha" => "2014" "volumen" => "50" "numero" => "Suppl 1" "paginaInicial" => "1" "paginaFinal" => "16" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 56 => array:3 [ "identificador" => "bib0645" "etiqueta" => "57" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Efficacy of anti-interleukin-5 therapy with mepolizumab in patients with asthma: a meta-analysis of randomized placebo-controlled trials" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ …4] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1371/journal.pone.0059872" "Revista" => array:5 [ "tituloSerie" => "PLOS ONE" "fecha" => "2013" "volumen" => "8" "paginaInicial" => "e59872" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 57 => array:3 [ "identificador" => "bib0650" "etiqueta" => "58" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mepolizumab treatment in patients with severe eosinophilic asthma" "autores" => array:1 [ 0 => array:3 [ "colaboracion" => "MENSA Investigators" "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa1403290" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2014" "volumen" => "371" "paginaInicial" => "1198" "paginaFinal" => "1207" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 58 => array:3 [ "identificador" => "bib0655" "etiqueta" => "59" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma" "autores" => array:1 [ 0 => array:3 [ "colaboracion" => "SIRIUS Investigators" "etal" => false "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa1403291" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2014" "volumen" => "371" "paginaInicial" => "1189" "paginaFinal" => "1197" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 59 => array:3 [ "identificador" => "bib0660" "etiqueta" => "60" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Reslizumab for poorly controlled, eosinophilic asthma: a randomized, placebo-controlled study" "autores" => array:1 [ 0 => array:3 [ "colaboracion" => "Res-5-0010 Study Group" "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1164/rccm.201103-0396OC" "Revista" => array:6 [ "tituloSerie" => "Am J Respir Crit Care Med" "fecha" => "2011" "volumen" => "184" "paginaInicial" => "1125" "paginaFinal" => "1132" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 60 => array:3 [ "identificador" => "bib0665" "etiqueta" => "61" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Dupilumab in persistent asthma with elevated eosinophil levels" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa1304048" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2013" "volumen" => "368" "paginaInicial" => "2455" "paginaFinal" => "2466" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 61 => array:3 [ "identificador" => "bib0670" "etiqueta" => "62" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Lebrikizumab treatment in adults with asthma" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa1106469" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2011" "volumen" => "365" "paginaInicial" => "1088" "paginaFinal" => "1098" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 62 => array:3 [ "identificador" => "bib0675" "etiqueta" => "63" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A randomized, controlled, phase 2 study of AMG 317, an IL-4Ralpha antagonist, in patients with asthma" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1164/rccm.200909-1448OC" "Revista" => array:6 [ "tituloSerie" => "Am J Respir Crit Care Med" "fecha" => "2010" "volumen" => "181" "paginaInicial" => "788" "paginaFinal" => "796" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 63 => array:3 [ "identificador" => "bib0680" "etiqueta" => "64" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Daclizumab improve asthma control in patients with moderate to severe persistent asthma: a randomized, controlled trial" "autores" => array:1 [ 0 => array:3 [ "colaboracion" => "Daclizumab Asthma Study Group" "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1164/rccm.200708-1200OC" "Revista" => array:6 [ "tituloSerie" => "Am J Respir Crit Care Med" "fecha" => "2008" "volumen" => "178" "paginaInicial" => "1002" "paginaFinal" => "1008" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 64 => array:3 [ "identificador" => "bib0685" "etiqueta" => "65" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Randomized, double-blind placebo-controlled study of brodalumab, a human anti–IL-17 receptor monoclonal antibody, in moderate to severe asthma" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1164/rccm.201212-2318OC" "Revista" => array:6 [ "tituloSerie" => "Am J Respir Crit Care Med" "fecha" => "2013" "volumen" => "188" "paginaInicial" => "1294" "paginaFinal" => "1302" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 65 => array:3 [ "identificador" => "bib0690" "etiqueta" => "66" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A systematic review and meta-analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils)" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/thx.2010.135574" "Revista" => array:6 [ "tituloSerie" => "Thorax" "fecha" => "2012" "volumen" => "67" "paginaInicial" => "199" "paginaFinal" => "208" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 66 => array:3 [ "identificador" => "bib0695" "etiqueta" => "67" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Economic burden of impairment in children with severe or difficult to treat asthma" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.anai.2011.04.008" "Revista" => array:6 [ "tituloSerie" => "Ann Allergy Asthma Immunol" "fecha" => "2011" "volumen" => "107" "paginaInicial" => "110" "paginaFinal" => "119" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 67 => array:3 [ "identificador" => "bib0700" "etiqueta" => "68" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Is a two-week trial of oral prednisolone predictive of target lung function in pediatric asthma?" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/ppul.20189" "Revista" => array:6 [ "tituloSerie" => "Pediatr Pulmonol" "fecha" => "2005" "volumen" => "39" "paginaInicial" => "521" "paginaFinal" => "527" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 68 => array:3 [ "identificador" => "bib0705" "etiqueta" => "69" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Assessment of inhalation technique and determinants of incorrect performance among children with asthma" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/ppul.20498" "Revista" => array:6 [ "tituloSerie" => "Pediatr Pulmonol" "fecha" => "2006" "volumen" => "41" "paginaInicial" => "1082" "paginaFinal" => "1087" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 69 => array:3 [ "identificador" => "bib0710" "etiqueta" => "70" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Guía de diagnóstico y tratamiento del asma de control difícil en el niño" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "An Pediatr (Barc)" "fecha" => "2009" "volumen" => "71" "paginaInicial" => "548" "paginaFinal" => "567" ] ] ] ] ] ] 70 => array:3 [ "identificador" => "bib0715" "etiqueta" => "71" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Management of severe asthma in children" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ …2] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0140-6736(10)61054-9" "Revista" => array:6 [ "tituloSerie" => "Lancet" "fecha" => "2010" "volumen" => "376" "paginaInicial" => "814" "paginaFinal" => "825" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 71 => array:3 [ "identificador" => "bib0720" "etiqueta" => "72" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Macrolide antibiotics for cystic fibrosis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ …4] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/14651858.CD002203.pub4" "Revista" => array:5 [ "tituloSerie" => "Cochrane Database Syst Rev" "fecha" => "2012" "volumen" => "11" "paginaInicial" => "CD002203" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/15792129/0000005100000005/v2_201504270531/S1579212915000774/v2_201504270531/en/main.assets" "Apartado" => array:4 [ "identificador" => "14583" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Special article" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/15792129/0000005100000005/v2_201504270531/S1579212915000774/v2_201504270531/en/main.pdf?idApp=UINPBA00003Z&text.app=https://archbronconeumol.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212915000774?idApp=UINPBA00003Z"]

Statistics

Special article

Guidelines for Severe Uncontrolled Asthma

Normativa sobre asma grave no controlada

Carolina Cisneros Serranoa,

Corresponding author

Carol9199@yahoo.es

Corresponding author.

, Carlos Melero Morenob, Carlos Almonacid Sánchezc, Miguel Perpiñá Torderad, César Picado Vallese, Eva Martínez Moragónf, Luis Pérez de Llanog, José Gregorio Soto Camposh, Isabel Urrutia Landai, Gloria García Hernándezj

a Servicio de Neumología, Hospital Universitario La Princesa, Madrid, Spain

b Servicio de Neumología, Hospital Universitario 12 de Octubre, Madrid, Spain

c Servicio de Neumología, Hospital Universitario de Guadalajara, Guadalajara, Spain

d Servicio de Neumología, Hospital Universitario y Politécnico La Fe, Valencia, Spain

e Servicio de Neumología y Alergia Respiratoria, Hospital Clinic, Universitat de Barcelona, Barcelona, Spain

f Servicio de Neumología, Hospital Universitario Dr. Peset, Valencia, Spain

g Servicio de Neumología, Hospital Lucus Augusti, Lugo, Spain

h Servicio de Neumología, Hospital de Galdakao-Usansolo, Galdakao, Spain

i UGC Neumología y Alergia, Hospital de Jerez, Cádiz, Spain

j Servicio de Pediatría, Hospital Universitario 12 de Octubre, Madrid, Spain

Read

20768

Times
was read the article

3979

Total PDF

16789

Total HTML

Share statistics

 array:23 [
  "pii" => "S1579212915000774"
  "issn" => "15792129"
  "doi" => "10.1016/j.arbr.2015.03.010"
  "estado" => "S300"
  "fechaPublicacion" => "2015-05-01"
  "aid" => "1109"
  "copyright" => "SEPAR"
  "copyrightAnyo" => "2014"
  "documento" => "article"
  "subdocumento" => "fla"
  "cita" => "Arch Bronconeumol. 2015;51:235-46"
  "abierto" => array:3 [
    "ES" => false
    "ES2" => false
    "LATM" => false
  ]
  "gratuito" => false
  "lecturas" => array:2 [
    "total" => 9859
    "formatos" => array:3 [
      "EPUB" => 205
      "HTML" => 7917
      "PDF" => 1737
    ]
  ]
  "Traduccion" => array:1 [
    "es" => array:19 [
      "pii" => "S030028961400492X"
      "issn" => "03002896"
      "doi" => "10.1016/j.arbres.2014.12.007"
      "estado" => "S300"
      "fechaPublicacion" => "2015-05-01"
      "aid" => "1109"
      "copyright" => "SEPAR"
      "documento" => "article"
      "crossmark" => 1
      "subdocumento" => "fla"
      "cita" => "Arch Bronconeumol. 2015;51:235-46"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 34957
        "formatos" => array:3 [
          "EPUB" => 159
          "HTML" => 30958
          "PDF" => 3840
        ]
      ]
      "es" => array:13 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Art&#237;culo especial</span>"
        "titulo" => "Normativa sobre asma grave no controlada"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "tieneResumen" => array:2 [
          0 => "es"
          1 => "en"
        ]
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "235"
            "paginaFinal" => "246"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "Guidelines for Severe Uncontrolled Asthma"
          ]
        ]
        "contieneResumen" => array:2 [
          "es" => true
          "en" => true
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "resumenGrafico" => array:2 [
          "original" => 0
          "multimedia" => array:7 [
            "identificador" => "fig0005"
            "etiqueta" => "Figura 1"
            "tipo" => "MULTIMEDIAFIGURA"
            "mostrarFloat" => true
            "mostrarDisplay" => false
            "figura" => array:1 [
              0 => array:4 [
                "imagen" => "gr1.jpeg"
                "Alto" => 3333
                "Ancho" => 2391
                "Tamanyo" => 880392
              ]
            ]
            "descripcion" => array:1 [
              "es" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Evaluaci&#243;n y calidad de la evidencia e implicaci&#243;n de las recomendaciones seg&#250;n GRADE&#46;</p>"
            ]
          ]
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "Carolina Cisneros Serrano, Carlos Melero Moreno, Carlos Almonacid S&#225;nchez, Miguel Perpi&#241;&#225; Tordera, C&#233;sar Picado Valles, Eva Mart&#237;nez Morag&#243;n, Luis P&#233;rez de Llano, Jos&#233; Gregorio Soto Campos, Isabel Urrutia Landa, Gloria Garc&#237;a Hern&#225;ndez"
            "autores" => array:10 [
              0 => array:2 [
                "nombre" => "Carolina"
                "apellidos" => "Cisneros Serrano"
              ]
              1 => array:2 [
                "nombre" => "Carlos"
                "apellidos" => "Melero Moreno"
              ]
              2 => array:2 [
                "nombre" => "Carlos"
                "apellidos" => "Almonacid S&#225;nchez"
              ]
              3 => array:2 [
                "nombre" => "Miguel"
                "apellidos" => "Perpi&#241;&#225; Tordera"
              ]
              4 => array:2 [
                "nombre" => "C&#233;sar"
                "apellidos" => "Picado Valles"
              ]
              5 => array:2 [
                "nombre" => "Eva"
                "apellidos" => "Mart&#237;nez Morag&#243;n"
              ]
              6 => array:2 [
                "nombre" => "Luis"
                "apellidos" => "P&#233;rez de Llano"
              ]
              7 => array:2 [
                "nombre" => "Jos&#233; Gregorio"
                "apellidos" => "Soto Campos"
              ]
              8 => array:2 [
                "nombre" => "Isabel"
                "apellidos" => "Urrutia Landa"
              ]
              9 => array:2 [
                "nombre" => "Gloria"
                "apellidos" => "Garc&#237;a Hern&#225;ndez"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S1579212915000774"
          "doi" => "10.1016/j.arbr.2015.03.010"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => false
            "ES2" => false
            "LATM" => false
          ]
          "gratuito" => false
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212915000774?idApp=UINPBA00003Z"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S030028961400492X?idApp=UINPBA00003Z"
      "url" => "/03002896/0000005100000005/v2_201504291226/S030028961400492X/v2_201504291226/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:18 [
    "pii" => "S1579212915000646"
    "issn" => "15792129"
    "doi" => "10.1016/j.arbr.2015.02.031"
    "estado" => "S300"
    "fechaPublicacion" => "2015-05-01"
    "aid" => "1018"
    "copyright" => "SEPAR"
    "documento" => "simple-article"
    "subdocumento" => "crp"
    "cita" => "Arch Bronconeumol. 2015;51:e23-4"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:2 [
      "total" => 2649
      "formatos" => array:3 [
        "EPUB" => 161
        "HTML" => 1734
        "PDF" => 754
      ]
    ]
    "en" => array:12 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Case Report</span>"
      "titulo" => "Thrombotic Microangiopathy Associated With Tacrolimus in Lung Transplantation"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "e23"
          "paginaFinal" => "e24"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Microangiopat&#237;a tromb&#243;tica asociada a tacrolimus en trasplante pulmonar"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Juan Pablo Reig Mezquida, Amparo Sol&#233; Jover, Emilio Ans&#243;tegui Barrera, Juan Escriv&#225; Peir&#243;, Maria Desamparados Pastor Colom, Juan Pastor Guillem"
          "autores" => array:6 [
            0 => array:2 [
              "nombre" => "Juan Pablo"
              "apellidos" => "Reig Mezquida"
            ]
            1 => array:2 [
              "nombre" => "Amparo"
              "apellidos" => "Sol&#233; Jover"
            ]
            2 => array:2 [
              "nombre" => "Emilio"
              "apellidos" => "Ans&#243;tegui Barrera"
            ]
            3 => array:2 [
              "nombre" => "Juan"
              "apellidos" => "Escriv&#225; Peir&#243;"
            ]
            4 => array:2 [
              "nombre" => "Maria Desamparados"
              "apellidos" => "Pastor Colom"
            ]
            5 => array:2 [
              "nombre" => "Juan"
              "apellidos" => "Pastor Guillem"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S0300289614002774"
        "doi" => "10.1016/j.arbres.2014.07.004"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289614002774?idApp=UINPBA00003Z"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212915000646?idApp=UINPBA00003Z"
    "url" => "/15792129/0000005100000005/v2_201504270531/S1579212915000646/v2_201504270531/en/main.assets"
  ]
  "itemAnterior" => array:18 [
    "pii" => "S1579212915000580"
    "issn" => "15792129"
    "doi" => "10.1016/j.arbr.2015.02.025"
    "estado" => "S300"
    "fechaPublicacion" => "2015-05-01"
    "aid" => "955"
    "copyright" => "SEPAR"
    "documento" => "article"
    "subdocumento" => "ssu"
    "cita" => "Arch Bronconeumol. 2015;51:227-34"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:2 [
      "total" => 7110
      "formatos" => array:3 [
        "EPUB" => 175
        "HTML" => 5628
        "PDF" => 1307
      ]
    ]
    "en" => array:13 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Review</span>"
      "titulo" => "Chronic Obstructive Pulmonary Disease and Left Ventricle"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "227"
          "paginaFinal" => "234"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Enfermedad pulmonar obstructiva cr&#243;nica y ventr&#237;culo izquierdo"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Fig&#46; 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 1796
              "Ancho" => 2353
              "Tamanyo" => 245278
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Figure summarizing the pathophysiological mechanisms involved and their effects on the left ventricle in COPD&#46; CF&#58; cardiac frequency&#59; FEV1&#58; forced expiratory volume in the first second&#59; IC&#47;TLC&#58; ratio between the inspiratory capacity and total lung capacity&#59; PH&#58; pulmonary hypertension&#59; RV&#58; right ventricle&#59; RVol&#58; residual volume&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Karina Portillo, Jorge Abad-Capa, Juan Ruiz-Manzano"
          "autores" => array:3 [
            0 => array:2 [
              "nombre" => "Karina"
              "apellidos" => "Portillo"
            ]
            1 => array:2 [
              "nombre" => "Jorge"
              "apellidos" => "Abad-Capa"
            ]
            2 => array:2 [
              "nombre" => "Juan"
              "apellidos" => "Ruiz-Manzano"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S0300289614001240"
        "doi" => "10.1016/j.arbres.2014.03.012"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289614001240?idApp=UINPBA00003Z"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212915000580?idApp=UINPBA00003Z"
    "url" => "/15792129/0000005100000005/v2_201504270531/S1579212915000580/v2_201504270531/en/main.assets"
  ]
  "en" => array:20 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Special article</span>"
    "titulo" => "Guidelines for Severe Uncontrolled Asthma"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "235"
        "paginaFinal" => "246"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Carolina Cisneros Serrano, Carlos Melero Moreno, Carlos Almonacid S&#225;nchez, Miguel Perpi&#241;&#225; Tordera, C&#233;sar Picado Valles, Eva Mart&#237;nez Morag&#243;n, Luis P&#233;rez de Llano, Jos&#233; Gregorio Soto Campos, Isabel Urrutia Landa, Gloria Garc&#237;a Hern&#225;ndez"
        "autores" => array:10 [
          0 => array:4 [
            "nombre" => "Carolina"
            "apellidos" => "Cisneros Serrano"
            "email" => array:1 [
              0 => "Carol9199&#64;yahoo&#46;es"
            ]
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          1 => array:3 [
            "nombre" => "Carlos"
            "apellidos" => "Melero Moreno"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
            ]
          ]
          2 => array:3 [
            "nombre" => "Carlos"
            "apellidos" => "Almonacid S&#225;nchez"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "aff0015"
              ]
            ]
          ]
          3 => array:3 [
            "nombre" => "Miguel"
            "apellidos" => "Perpi&#241;&#225; Tordera"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">d</span>"
                "identificador" => "aff0020"
              ]
            ]
          ]
          4 => array:3 [
            "nombre" => "C&#233;sar"
            "apellidos" => "Picado Valles"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">e</span>"
                "identificador" => "aff0025"
              ]
            ]
          ]
          5 => array:3 [
            "nombre" => "Eva"
            "apellidos" => "Mart&#237;nez Morag&#243;n"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">f</span>"
                "identificador" => "aff0030"
              ]
            ]
          ]
          6 => array:3 [
            "nombre" => "Luis"
            "apellidos" => "P&#233;rez de Llano"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">g</span>"
                "identificador" => "aff0035"
              ]
            ]
          ]
          7 => array:3 [
            "nombre" => "Jos&#233; Gregorio"
            "apellidos" => "Soto Campos"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">h</span>"
                "identificador" => "aff0040"
              ]
            ]
          ]
          8 => array:3 [
            "nombre" => "Isabel"
            "apellidos" => "Urrutia Landa"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">i</span>"
                "identificador" => "aff0045"
              ]
            ]
          ]
          9 => array:3 [
            "nombre" => "Gloria"
            "apellidos" => "Garc&#237;a Hern&#225;ndez"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">j</span>"
                "identificador" => "aff0050"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:10 [
          0 => array:3 [
            "entidad" => "Servicio de Neumolog&#237;a&#44; Hospital Universitario La Princesa&#44; Madrid&#44; Spain"
            "etiqueta" => "a"
            "identificador" => "aff0005"
          ]
          1 => array:3 [
            "entidad" => "Servicio de Neumolog&#237;a&#44; Hospital Universitario 12 de Octubre&#44; Madrid&#44; Spain"
            "etiqueta" => "b"
            "identificador" => "aff0010"
          ]
          2 => array:3 [
            "entidad" => "Servicio de Neumolog&#237;a&#44; Hospital Universitario de Guadalajara&#44; Guadalajara&#44; Spain"
            "etiqueta" => "c"
            "identificador" => "aff0015"
          ]
          3 => array:3 [
            "entidad" => "Servicio de Neumolog&#237;a&#44; Hospital Universitario y Polit&#233;cnico La Fe&#44; Valencia&#44; Spain"
            "etiqueta" => "d"
            "identificador" => "aff0020"
          ]
          4 => array:3 [
            "entidad" => "Servicio de Neumolog&#237;a y Alergia Respiratoria&#44; Hospital Clinic&#44; Universitat de Barcelona&#44; Barcelona&#44; Spain"
            "etiqueta" => "e"
            "identificador" => "aff0025"
          ]
          5 => array:3 [
            "entidad" => "Servicio de Neumolog&#237;a&#44; Hospital Universitario Dr&#46; Peset&#44; Valencia&#44; Spain"
            "etiqueta" => "f"
            "identificador" => "aff0030"
          ]
          6 => array:3 [
            "entidad" => "Servicio de Neumolog&#237;a&#44; Hospital Lucus Augusti&#44; Lugo&#44; Spain"
            "etiqueta" => "g"
            "identificador" => "aff0035"
          ]
          7 => array:3 [
            "entidad" => "Servicio de Neumolog&#237;a&#44; Hospital de Galdakao-Usansolo&#44; Galdakao&#44; Spain"
            "etiqueta" => "h"
            "identificador" => "aff0040"
          ]
          8 => array:3 [
            "entidad" => "UGC Neumolog&#237;a y Alergia&#44; Hospital de Jerez&#44; C&#225;diz&#44; Spain"
            "etiqueta" => "i"
            "identificador" => "aff0045"
          ]
          9 => array:3 [
            "entidad" => "Servicio de Pediatr&#237;a&#44; Hospital Universitario 12 de Octubre&#44; Madrid&#44; Spain"
            "etiqueta" => "j"
            "identificador" => "aff0050"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Corresponding author&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Normativa sobre asma grave no controlada"
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 0
      "multimedia" => array:7 [
        "identificador" => "fig0015"
        "etiqueta" => "Fig&#46; 3"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr3.jpeg"
            "Alto" => 1822
            "Ancho" => 2829
            "Tamanyo" => 231541
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Treatment proposal for severe&#44; uncontrolled asthma according to phenotype&#46; ACOS&#58; asthma&#47;COPD overlap syndrome&#59; AERD&#58; aspirin-exacerbated respiratory disease&#59; CAFL&#58; chronic airflow limitation&#46;</p>"
        ]
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">Asthma is a worldwide problem&#44; and severe uncontrolled asthma &#40;SUCA&#41; in particular has far-reaching socioeconomic repercussions&#46; For this reason&#44; all healthcare professionals treating these patients must be aware of the situation&#44; and have the proper tools for providing the best approach to this problem&#46;</p><p id="par0010" class="elsevierStylePara elsevierViewall">The first obstacle encountered is the exact terminology for defining these patients&#44; since there is no common agreement&#46;</p><p id="par0015" class="elsevierStylePara elsevierViewall">&#8220;Difficult-to-treat asthma&#8221; is a term used for patients who find it difficult to achieve control as a result of poor compliance&#44; incorrect inhalation techniques&#44; exposure to allergens or other triggers&#44; or associated comorbidities&#46; The term &#8220;refractory or treatment-resistant asthma&#8221; refers to subjects who&#44; when a diagnosis of asthma has been confirmed and comorbidities identified and treated&#44; require treatment with high-dose inhaled corticosteroids &#40;IC&#41; plus another second controller &#40;long-acting &#946;<span class="elsevierStyleInf">2</span>-agonist &#91;LABA&#93; and&#47;or systemic corticosteroids &#91;SC&#93;&#41; to prevent their asthma becoming uncontrolled&#44; or who remain uncontrolled despite this therapy&#46; SUCA includes patients with refractory asthma and those with incomplete response to treatment&#46;<a class="elsevierStyleCrossRef" href="#bib0365"><span class="elsevierStyleSup">1</span></a></p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Methodology</span><p id="par0020" class="elsevierStylePara elsevierViewall">These guidelines were drawn up following SEPAR recommendations for the development of guidelines&#46; All citations used by the various authors&#44; experts in severe asthma&#44; were recorded in an EndNote database and classified according to their levels of evidence&#44; using the Grading of Recommendations &#40;GRADE&#41; approach&#46;<a class="elsevierStyleCrossRef" href="#bib0370"><span class="elsevierStyleSup">2</span></a></p><p id="par0025" class="elsevierStylePara elsevierViewall">Among the studies selected from a systematic search as a basis for these guidelines&#44; very few were identified as randomized controlled trials with a low risk of bias that would provide direct&#44; consistent and precise evidence&#46; Most recommendations proposed are based on indirect evidence&#44; retrieved from studies performed in moderate persistent asthma&#44; and to a lesser extent&#44; studies in patients with severe asthma&#46; The result is imprecise levels of evidence and recommendations&#44; although all the studies were evaluated and classified using the GRADE system&#46;</p><p id="par0030" class="elsevierStylePara elsevierViewall">Quality of evidence was classified as high&#44; moderate&#44; low and very low&#44; based on different considerations for presence of direct bias &#40;and the direction&#41;&#44; consistency and directness of the estimates &#40;<a class="elsevierStyleCrossRef" href="#fig0005">Fig&#46; 1</a>&#41;&#46;</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Definition</span><p id="par0035" class="elsevierStylePara elsevierViewall">The definition set out in the ATS&#47;ERS consensus statement<a class="elsevierStyleCrossRef" href="#bib0365"><span class="elsevierStyleSup">1</span></a> was used throughout this paper&#46; This defines severe asthma as &#8220;asthma requiring treatment with high-dose IC&#44; plus a second controller and&#47;or SC to prevent it from becoming uncontrolled or that remains uncontrolled despite this therapy&#8221; &#40;evidence D-R2&#41;&#46; Severe uncontrolled asthma is defined in <a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>&#46;</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Epidemiology</span><p id="par0040" class="elsevierStylePara elsevierViewall">The lack of well-designed studies using homogeneous definitions means that available data on the epidemiology of severe asthma are disparate&#44; particularly in adults&#46; Severe asthma varies in prevalence between one country and another &#40;18&#37; in Western Europe&#44; 19&#37; in the United States and 32&#37; in Central Europe&#41;<a class="elsevierStyleCrossRef" href="#bib0375"><span class="elsevierStyleSup">3</span></a> and about 50&#37; of these severe patients are thought to have poor disease control&#46;<a class="elsevierStyleCrossRef" href="#bib0375"><span class="elsevierStyleSup">3</span></a> In Spain in 2011&#44; the prevalence of severe uncontrolled asthma&#44; according to medical criteria&#44; was reported to be 3&#46;9&#37; of all asthma cases<a class="elsevierStyleCrossRef" href="#bib0380"><span class="elsevierStyleSup">4</span></a> &#40;evidence C&#41;&#46; Moreover&#44; this small proportion of patients is responsible for much higher use of resources than other asthmatic patients<a class="elsevierStyleCrossRef" href="#bib0385"><span class="elsevierStyleSup">5</span></a> &#40;evidence D-R2&#41;&#46;</p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Genetics</span><p id="par0045" class="elsevierStylePara elsevierViewall">Asthma is a complex syndrome resulting from the interaction of numerous genes and environmental exposure&#46; The lack of studies in severe asthma make it impossible to determine precisely which genes are responsible for making an individual susceptible to developing severe asthma&#46; Currently&#44; genome wide association approaches &#40;GWAS&#41; are analyzing hundreds of thousands of polymorphisms located throughout the genome in the search for variants associated with susceptibility to developing severe asthma<a class="elsevierStyleCrossRef" href="#bib0390"><span class="elsevierStyleSup">6</span></a> &#40;evidence C-R2&#41;&#46; Single nucleotide polymorphisms &#40;SNPs&#41; in the interleukin-4 receptor subunit alpha &#40;IL4R&#945;&#41; are associated with poorer lung function&#44; higher immunoglobulin E &#40;IgE&#41; levels&#44; severe asthma exacerbations and tissue inflammation<a class="elsevierStyleCrossRef" href="#bib0395"><span class="elsevierStyleSup">7</span></a> &#40;evidence C-R2&#41;&#46; An IL-6 receptor &#40;IL6R&#41; variant is associated with severe asthma phenotypes and poorer lung function<a class="elsevierStyleCrossRef" href="#bib0400"><span class="elsevierStyleSup">8</span></a> &#40;evidence C-R2&#41;&#46; Other genetic mutations associated with severe asthma are variations in genes involved in tumor necrosis factor &#40;TNF&#41; and multiple SNPs in the RAD50-IL13 regions of chromosome 5q31&#46;1 and the HLA-DR&#47;DQ region of chromosome 6p21&#46;3&#44; respectively<a class="elsevierStyleCrossRef" href="#bib0405"><span class="elsevierStyleSup">9</span></a> &#40;evidence C-R2&#41;&#46;</p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Severe Asthma Phenotypes</span><p id="par0050" class="elsevierStylePara elsevierViewall">Clinicians have identified markedly different asthma patient subtypes or profiles&#44; suggesting that asthma remains a poorly classified syndrome&#46;</p><p id="par0055" class="elsevierStylePara elsevierViewall">Several studies that merge objective clinical variables have been performed in an attempt to categorize patients into clinical phenotypes&#44; or on their pathophysiological basis &#40;endotypes&#41;<a class="elsevierStyleCrossRef" href="#bib0410"><span class="elsevierStyleSup">10</span></a> which&#44; in the case of SUCA&#44; will have therapeutic implications &#40;evidence D-R2&#41;&#46;</p><p id="par0060" class="elsevierStylePara elsevierViewall">These studies share several multivariate statistical techniques&#44; especially cluster analyses<a class="elsevierStyleCrossRefs" href="#bib0415"><span class="elsevierStyleSup">11&#8211;13</span></a> &#40;evidence C-R2&#41;&#46; The overall conclusion is that there are at least 4 reasonably well defined phenotypes&#47;endotypes in severe asthma&#44; characterized according to natural history&#44; pathobiology&#44; clinical features and therapeutic response&#46;</p><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0055">Severe Allergic Asthma</span><p id="par0065" class="elsevierStylePara elsevierViewall">About 40&#37;&#8211;50&#37; of cases of severe asthma are due to allergies&#46; They begin in infancy&#44; are clearly atopic and appear to progress from mild-moderate asthma&#44; although some patients present the severe form from onset&#46; The most severe cases within this cluster are those with a greater number of positive skin pricks or higher IgE levels in blood&#44; those with a family history of asthma&#44; and a longer time since disease onset&#46; However&#44; not all patients have eosinophil predominance&#59; indeed&#44; the most severe forms of the phenotype &#40;in terms of lung function&#44; frequency and intensity of symptoms and use of healthcare resources&#41; are accompanied by increases in both eosinophils and neutrophils in sputum<a class="elsevierStyleCrossRef" href="#bib0430"><span class="elsevierStyleSup">14</span></a> &#40;evidence C-R2&#41;&#46;</p><p id="par0070" class="elsevierStylePara elsevierViewall">From a pathobiological point of view&#44; <span class="elsevierStyleItalic">severe allergic asthma</span> is orchestrated by the activation of type 2 helper T-cells &#40;Th2&#41;&#44; the production of specific cytokines&#44; IL-4&#44; IL-5 and IL-13&#44; and B-cell isotype switching to produce IgE&#44; although it must be pointed out that not all atopic asthmas have a highly active Th2 component &#40;&#8220;high&#8221; Th2 endotype&#41;&#46; Periostine and fractionated exhaled nitric oxide &#40;FeNO&#41; have been shown to be good biomarkers in this &#8220;high&#8221; Th2 variant<a class="elsevierStyleCrossRef" href="#bib0435"><span class="elsevierStyleSup">15</span></a> &#40;evidence C-R2&#41;&#46;</p></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0060">Late Onset Eosinophilic Asthma</span><p id="par0075" class="elsevierStylePara elsevierViewall">Over 25&#37; of cases of severe asthma are thought to belong to this phenotype&#46; They are characterized by persistent eosinophils in bronchial biopsies and induced sputum&#44; despite high-dose IC or SC&#46; Levels of eosinophils and cysteinyl leukotrienes are higher than in severe allergic asthma&#46; In general&#44; the disease occurs in patients older than 20 years&#44; and may be preceded by symptoms of chronic rhinosinusitis and nasal polyps&#46; A subgroup of these patients also develops intolerance to non-steroidal anti-inflammatory drugs &#40;NSAIDs&#41;&#44; designated as &#8220;aspirin-exacerbated respiratory disease&#8221; &#40;AERD&#41;&#46; Clinical symptoms are florid from onset&#44; airway obstruction is considerable and exacerbations are frequent&#46; These patients are generally less atopic than those in whom the disease appears at younger ages and they have little family history of asthma&#44; but their IgE levels and FeNO measurements may be equally high&#46; Its pathogenesis is related to changes in arachidonic acid metabolism &#40;decreased production of prostaglandin E2 and increased cysteinyl leukotriene synthesis&#41;&#44; associated with inflammation that appears to related with Th2 activation&#46;<a class="elsevierStyleCrossRef" href="#bib0435"><span class="elsevierStyleSup">15</span></a></p></span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0065">Severe Non-Atopic Asthma in the Obese Adult</span><p id="par0080" class="elsevierStylePara elsevierViewall">This population mainly comprises women with a high body mass index and abundant clinical signs and symptoms&#46; Onset occurs between 50 and 60 years of age&#44; or even later&#46; Sputum eosinophilia is not always detected&#59; exacerbations are frequent and lung function is not overly compromised&#46; The genetic basis and etiology of the disease are not well understood&#44; nor is the role of hormonal factors&#44; although onset after natural or surgical menopause has often been reported&#46; The association between asthma and obesity raises numerous questions&#44; and a number of mechanisms have been proposed as its cause&#58; immunoinflammatory factors&#44; mechanical factors&#44; loss of corticosteroid efficacy&#44; vitamin D deficiency&#44; and the additional burden of other comorbidities&#44; such as obstructive sleep apnea&#8211;hypopnea syndrome<a class="elsevierStyleCrossRef" href="#bib0440"><span class="elsevierStyleSup">16</span></a> &#40;evidence D-R2&#41;&#46;</p></span><span id="sec0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0070">Adult-Onset Neutrophilic Asthma</span><p id="par0085" class="elsevierStylePara elsevierViewall">The natural history of adult-onset neutrophilic asthma is not well understood&#46; Increased matrix metalloproteinase-9 levels have been found in bronchoalveolar lavage&#44; and a history of smoking and chronic airflow limitation &#40;CAFL&#41; with significant air trapping have also been observed&#46; SC provide little disease control&#46; Neutrophil predominance in the airways may be due to modifications in the expression of genes responsible for their activation and mobilization&#44; concomitant diseases &#40;bronchiolitis obliterans&#41;&#44; or residual airway inflammation after continuous use of SC&#44; inhibiting neutrophil apoptosis&#46;<a class="elsevierStyleCrossRef" href="#bib0435"><span class="elsevierStyleSup">15</span></a></p></span></span><span id="sec0055" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Diagnosis of the Patient With Severe Uncontrolled Asthma</span><p id="par0090" class="elsevierStylePara elsevierViewall">Diagnosis of SUCA requires systematic stepwise assessment to ensure that no relevant areas are left unexplored&#46; According to the previous SEPAR guidelines<a class="elsevierStyleCrossRef" href="#bib0445"><span class="elsevierStyleSup">17</span></a> &#40;evidence D-R2&#41; and the recommendations of the current consensus statements<a class="elsevierStyleCrossRefs" href="#bib0365"><span class="elsevierStyleSup">1&#44;18&#44;19</span></a> &#40;evidence D-R2&#41;&#44; this assessment must be performed in accredited units or in reference centers&#44; by professionals with documented clinical experience in the management of these patients&#44; in follow-up visits over a period of not less than 6 months &#40;<a class="elsevierStyleCrossRef" href="#fig0010">Fig&#46; 2</a>&#41;&#46;</p><elsevierMultimedia ident="fig0010"></elsevierMultimedia><span id="sec0060" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Step 1&#58; Determine if the Patient has Asthma</span><p id="par0095" class="elsevierStylePara elsevierViewall">A diagnosis reached in the past by other clinicians and provided by the patient must not be accepted unless the objective test results necessary for confirming the diagnosis are available&#46; This attitude has been supported in several studies which found that a previous diagnosis of asthma was overturned in almost one third of patients after a new systematic assessment<a class="elsevierStyleCrossRef" href="#bib0460"><span class="elsevierStyleSup">20</span></a> &#40;evidence D-R2&#41;&#46;</p><span id="sec0065" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Clinical History and Tests to Confirm Asthma</span><p id="par0100" class="elsevierStylePara elsevierViewall">Re-assessment is recommended&#44; with a full clinical history investigating the onset of symptoms&#44; their variability over time&#44; and their association with specific triggers that would raise the suspicion of asthma or any other confounding disease&#46; Variable airflow obstruction should be confirmed with standard lung function testing &#40;LFT&#41;&#44; according to the recently revised criteria in the latest GINA update<a class="elsevierStyleCrossRef" href="#bib0465"><span class="elsevierStyleSup">21</span></a> &#40;evidence D-R2<span class="elsevierStyleSup">GPC</span>&#41;&#46;</p></span><span id="sec0070" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">Differential Diagnosis</span><p id="par0105" class="elsevierStylePara elsevierViewall">Correct differential diagnosis &#40;DD&#41; should consider other diseases that might mimic asthma&#44; but are not true asthma&#44; also known as &#8220;pseudo-asthmas or false asthmas&#8221;&#46; Diseases that can mimic asthma are listed in <a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>&#46;</p><elsevierMultimedia ident="tbl0010"></elsevierMultimedia><p id="par0110" class="elsevierStylePara elsevierViewall">False asthmas are often diagnosed months or even years after the onset of clinical symptoms&#46; This delay in diagnosis often leads to excessive use of anti-asthmatic medications&#44; including SC&#44; that cause major side effects &#40;osteoporosis&#44; glaucoma&#44; obesity&#44; hypertension&#41;&#46; These patients also repeatedly attend the emergency department&#44; where they are given high dose combinations of anti-asthma drugs&#44; even if these are obviously ineffective in controlling the disease&#46;<a class="elsevierStyleCrossRef" href="#bib0450"><span class="elsevierStyleSup">18</span></a></p><p id="par0115" class="elsevierStylePara elsevierViewall">The diagnostic tests to be performed in DD are shown in <a class="elsevierStyleCrossRef" href="#tbl0015">Table 3</a>&#46;</p><elsevierMultimedia ident="tbl0015"></elsevierMultimedia></span><span id="sec0075" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0095">Upper Airway Disease</span><p id="par0120" class="elsevierStylePara elsevierViewall">In this group&#44; diseases with an organic origin must be distinguished from functional conditions&#46;</p><span id="sec0080" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0100">Organic Causes</span><p id="par0125" class="elsevierStylePara elsevierViewall">Stridor suggests that the obstruction is located in the upper airways&#44; perhaps due to altered morphology &#40;flattening&#41; of the flow-volume loops&#46; If this is suspected in an asthma patient who does not respond to treatment&#44; end-inspiratory and expiratory computed tomography &#40;CT&#41; is justified to quantify the degree of tracheo- and bronchomalacia&#46; Another alternative is fiberoptic bronchoscopy&#46;</p></span><span id="sec0085" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0105">Functional Causes</span><p id="par0130" class="elsevierStylePara elsevierViewall">Some individuals&#44; for reasons unknown&#44; have vocal cords that remain partially closed during inhalation&#44; causing a sensation of dyspnea in the form of acute asphyxia&#44; often accompanied by stridor&#46; Vocal cord dysfunction can occur without any apparent triggering factor&#44; or as a reaction to various stimuli&#44; such as physical exercise&#44; as is often seen in athletes<a class="elsevierStyleCrossRef" href="#bib0470"><span class="elsevierStyleSup">22</span></a> &#40;evidence D-R2&#41;&#46; It occurs in children and adults and is more common in women and subjects with high scores on anxiety questionnaires&#46; Despite the apparent severity of some episodes&#44; it rarely leads to loss of consciousness and&#44; in the vast majority of cases&#44; abates in minutes&#46; Up to 50&#37; of patients referred to a DCA specialist clinic have vocal cord dysfunction<a class="elsevierStyleCrossRef" href="#bib0475"><span class="elsevierStyleSup">23</span></a> &#40;evidence C-R2&#41;&#46; Ideally&#44; the diagnosis is confirmed from poor functioning of the cords&#44; when an episode coincides with laryngoscopy or video laryngo-stroboscopy&#46; As this is not always possible&#44; the event can be induced by methacholine challenge testing&#46; If dysfunction occurs during exercise&#44; it can be reproduced in the laboratory by means of an exercise tolerance test&#46;<a class="elsevierStyleCrossRef" href="#bib0470"><span class="elsevierStyleSup">22</span></a></p><p id="par0135" class="elsevierStylePara elsevierViewall">These patients are often subjected to unnecessary endotracheal intubation&#58; if there is no resistance to ventilation after tube placement&#44; the patient can be extubated after a few minutes and recovery is rapid&#46;</p><p id="par0140" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Lower Airway Diseases&#46;</span> Chronic obstructive pulmonary disease &#40;COPD&#41; is a condition that presents with exacerbations that mimic persistent asthma with a partially reversible obstructive component&#46; An asthmatic smoker can simultaneously develop COPD&#59; this presentation is known as asthma&#47;COPD overlap syndrome &#40;ACOS&#41;&#46;<a class="elsevierStyleCrossRef" href="#bib0465"><span class="elsevierStyleSup">21</span></a> Clinical history&#44; radiological examinations&#44; and LFT can help differentiate between asthma and COPD&#46; In these cases&#44; lesions indicative of emphysema&#44; absent in asthma&#44; may be seen on CT&#46; LFT may show marked reversibility&#44; associated with other findings more typical of COPD&#47;emphysema&#44; such as air trapping or reduced carbon monoxide diffusion capacity &#40;DLCO&#41;&#46; SC testing may also be performed&#46;<a class="elsevierStyleCrossRef" href="#bib0450"><span class="elsevierStyleSup">18</span></a></p><p id="par0145" class="elsevierStylePara elsevierViewall">Lower airway compromise due to other diseases&#44; such as bronchiolitis obliterans&#44; should be suspected in patients with a mosaic pattern on CT or signs suggestive of hyperinflation on LFT&#46; Lung biopsy should be considered for confirming diagnosis in these patients&#46;</p><p id="par0150" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Functional Dyspnea&#46;</span> Dyspnea is a subjective sensation of breathlessness that can be described by the patient in a variety of ways&#58; difficulty inhaling&#44; difficulty exhaling&#44; chest tightness&#46; Dyspnea not associated with any organic disease is called functional dyspnea or breathing dysfunction<a class="elsevierStyleCrossRef" href="#bib0480"><span class="elsevierStyleSup">24</span></a> &#40;evidence C-R2&#41;&#46;</p><p id="par0155" class="elsevierStylePara elsevierViewall">This entity can vary widely in intensity&#44; from a feeling of moderate difficulty in filling the lungs to acute hyperventilation attacks&#46; About 10&#37;&#8211;20&#37; of the general population suffer sighing dyspnea&#44; but for unknown reasons&#44; this figure rises to 30&#37;&#8211;40&#37; in asthma sufferers&#46; Functional dyspnea is more common in women&#44; particularly those with high scores on anxiety questionnaires&#46;<a class="elsevierStyleCrossRef" href="#bib0480"><span class="elsevierStyleSup">24</span></a> When sighing dyspnea occurs along with asthma&#44; severity is often misjudged&#44; and the condition is over-treated&#46; To distinguish between dyspnea caused by asthma or a functional disorder&#44; objective data on the degree of lung function compromise must be collected and peak expiratory flow must be determined to help correlate symptoms and changes in lung function&#46; Functional dyspnea and vocal cord dysfunction may occur concomitantly in some patients&#46;</p><p id="par0160" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Diseases Affecting Other Organs</span>&#46; Left heart failure may cause apparent worsening of asthma&#46; Onset of atrial fibrillation or mildly decompensated hypertensive heart disease or coronary artery disease can turn well-controlled bronchial asthma into a treatment-refractory problem&#46; In these cases&#44; correcting the arrhythmia or heart failure can lead to stabilization of the asthma&#46;</p></span></span></span><span id="sec0105" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0110">Step 2&#58; Identify Factors for Poor Control and Evaluate Concomitant Diseases</span><span id="sec0110" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0115">Check Compliance</span><p id="par0165" class="elsevierStylePara elsevierViewall">Numerous studies have confirmed that lack of treatment compliance or poor adherence is more common than thought&#46; Up to 46&#37; of asthma patients fail to comply adequately with their prescribed treatment<a class="elsevierStyleCrossRef" href="#bib0485"><span class="elsevierStyleSup">25</span></a> &#40;evidence C-R2&#41;&#46;</p><p id="par0170" class="elsevierStylePara elsevierViewall">Measuring treatment compliance is a complex task in any chronic disease&#44; and perhaps even more so when adherence to an inhaled medication is being evaluated&#46; In practice&#44; compliance is determined according to clinical judgment&#44; therapeutic response or validated questionnaires&#44; although these methods are all known to overestimate the level of treatment adherence&#46; FeNO has been proposed for measuring compliance&#44; given the good response of this marker to inhaled corticosteroids&#44; and various procedures for determining this parameter have been described &#40;<a class="elsevierStyleCrossRef" href="#fig0010">Fig&#46; 2</a>&#41;&#46;</p></span><span id="sec0115" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0120">Check Inhalation Technique</span><p id="par0175" class="elsevierStylePara elsevierViewall">Errors in inhalation technique are much more common than might be imagined&#46; A recent study<a class="elsevierStyleCrossRef" href="#bib0490"><span class="elsevierStyleSup">26</span></a> &#40;evidence D-R2&#41; found that critical errors were being made by 12&#37; of metered dose inhaler &#40;MDI&#41; users&#44; 35&#37; of Diskus<span class="elsevierStyleSup">&#174;</span> and HandiHaler<span class="elsevierStyleSup">&#174;</span> users and 44&#37; of Turbuhaler<span class="elsevierStyleSup">&#174;</span> users&#46; Incorrect inhaler use was associated with increased hospital admission&#44; visits to emergency departments&#44; SC treatment and antibiotics&#44; and worse scores in the Asthma Control Test &#40;ACT&#41;&#46;</p><p id="par0180" class="elsevierStylePara elsevierViewall">In this respect&#44; GEMA recommends the use of MDI with a chamber to improve the distribution and amount of drug reaching the bronchial Tree<a class="elsevierStyleCrossRef" href="#bib0495"><span class="elsevierStyleSup">27</span></a> &#40;evidence D-R2<span class="elsevierStyleSup">GPC</span>&#41;&#46;</p><p id="par0185" class="elsevierStylePara elsevierViewall">Inhalation technique training and verification is a necessary step in the education of asthma patients&#46; The inhalation device must be selected on the basis of various considerations&#58; patient preference&#44; peak inspiratory flow&#44; device resistance&#44; and local adverse effects&#46;</p></span><span id="sec0120" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0125">Check Environmental and&#47;or Workplace Exposure</span><p id="par0190" class="elsevierStylePara elsevierViewall">No established consensus statement is available for identifying exposure to environmental triggers&#44; even if these are known to play an important role in patients with severe asthma&#46; The role of exposure to agents in the workplace must also be taken into account &#40;over 200 have been identified&#41;&#44; particularly in adult-onset asthma&#46; Exposure to allergens known to trigger allergies should be avoided&#44; although the evidence remains insufficient&#46;<a class="elsevierStyleCrossRef" href="#bib0465"><span class="elsevierStyleSup">21</span></a></p></span><span id="sec0125" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0130">Check Bronchoconstrictor Drugs</span><p id="par0195" class="elsevierStylePara elsevierViewall">In some patients&#44; uncontrolled asthma may be due to the use of medications &#40;NSAIDs&#44; angiotensin-converting enzyme inhibitors &#91;ACEIs&#93;&#44; non-selective beta-blockers&#41; that can cause persistent asthma symptoms&#46;<a class="elsevierStyleCrossRef" href="#bib0450"><span class="elsevierStyleSup">18</span></a></p></span><span id="sec0130" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0135">Evaluate Comorbidities</span><p id="par0200" class="elsevierStylePara elsevierViewall">Some conditions or diseases occur more commonly in asthma patients than in the general population &#40;<a class="elsevierStyleCrossRef" href="#tbl0020">Table 4</a>&#41;&#46; While these relationships are known to contribute to insufficient asthma control&#44; they have not been precisely identified&#44; and still need to be fully characterized&#46;</p><elsevierMultimedia ident="tbl0020"></elsevierMultimedia><p id="par0205" class="elsevierStylePara elsevierViewall">Although the impact of treatment of comorbidities on severe asthma remains to be determined&#44; they should be treated as appropriate to improve them as far as possible&#46;<a class="elsevierStyleCrossRef" href="#bib0365"><span class="elsevierStyleSup">1</span></a></p></span></span><span id="sec0135" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0140">Step 3&#58; Identify Severe Asthma Phenotypes</span><p id="par0210" class="elsevierStylePara elsevierViewall">To date&#44; there is no generally accepted definition of what has become known as asthma phenotypes&#44; but there does seem to be consensus with regard to certain clinical profiles of patients with distinct pathophysiological characteristics that cause them to respond better to certain medications&#46; Attempting to define these phenotypes may be of use in optimizing treatment&#44; and to this end&#44; certain clinical characteristics may be of interest&#44; e&#46;g&#46;&#44; age of onset&#44; obesity&#44; NSAID intolerance&#44; in addition to laboratory parameters&#44; such as eosinophils in induced sputum and blood&#44; FeNO determinations&#44; and skin prick tests &#40;<a class="elsevierStyleCrossRef" href="#fig0010">Fig&#46; 2</a>&#41;&#46;</p></span></span><span id="sec0140" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0145">Treatment of Severe Uncontrolled Asthma</span><p id="par0215" class="elsevierStylePara elsevierViewall">Until recently&#44; few clinical trials were specifically designed for evaluating the efficacy of different treatments in the SUCA population&#46; Now&#44; however&#44; the identification of new therapeutic targets has led to the development of studies with some scientific evidence of efficacy in these patients&#44; albeit with short follow-up&#46;</p><span id="sec0145" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0150">Corticosteroid Insensitivity</span><p id="par0220" class="elsevierStylePara elsevierViewall">Although SC are very effective in controlling inflammation in asthma&#44; the spectrum of response to these agents among asthmatics is broad&#44; and a small percentage of subjects fail to respond at all&#44; despite the administration of high doses&#46; Total resistance to SC is uncommon&#59; partial resistance or &#8220;lack of sensitivity&#8221; is more common among severe asthmatics&#44; making high SC doses necessary&#44; although not even with these is full control achieved&#46; Some patients do improve notably with the use of SC&#44; but when they are discontinued&#44; the asthma worsens &#40;corticosteroid-dependent asthma&#41;&#46; In a study of 102 SUCA children&#44; only 11&#37; did not respond to an intramuscular &#40;IM&#41; dose of triamcinolone&#44; suggesting that 89&#37; had some degree of response to SC<a class="elsevierStyleCrossRef" href="#bib0500"><span class="elsevierStyleSup">28</span></a> &#40;evidence D-R2&#41;&#46; Accordingly&#44; the recent ATS&#47;ERS consensus<a class="elsevierStyleCrossRef" href="#bib0365"><span class="elsevierStyleSup">1</span></a> uses the expression &#8220;SC insensitivity&#8221; instead of &#8220;resistance&#8221;&#44; and we have adhered to this nomenclature in these guidelines&#46;</p><p id="par0225" class="elsevierStylePara elsevierViewall">From a clinical point of view&#44; SC-insensitive asthma is defined by forced expiratory volume in the first second &#40;FEV1&#41; less than 75&#37; of the predicted value and a response &#60;15&#37; and 200<span class="elsevierStyleHsp" style=""></span>ml after the administration of a 2-week cycle of 40<span class="elsevierStyleHsp" style=""></span>mg&#47;day prednisone or prednisolone<a class="elsevierStyleCrossRef" href="#bib0505"><span class="elsevierStyleSup">29</span></a> &#40;evidence D-R2&#41;&#46; These patients have normal plasma cortisol and adrenal suppression response to exogenous cortisol&#44; so they are prone to the side effects of these agents&#46; Factors contributing to asthma insensitivity to SC are not well defined&#46; Some studies report weak associations between certain genetic changes and environmental factors &#40;continuous exposure to allergens&#44; smoking&#44; NSAID intolerance&#44; low vitamin D levels&#44; and chlamydia&#44; mycoplasma or viral infections&#41;&#44; but these cannot be considered as clearly established risk factors&#46; The most significant environmental factor in SC insensitivity is exposure to tobacco smoke&#46; This may act by various mechanisms&#58; by altering the inflammatory pattern &#40;increased neutrophils and CD8 lymphocytes and reduced eosinophil levels&#41;&#44; by impairing mucociliary function&#44; thus allowing excessive mucous deposition in the airways&#44; or by tobacco-induced oxidative stress&#44; which inactivates histone deacetylase&#44; reducing nuclear translocation and the number of corticosteroid receptors and their affinity<a class="elsevierStyleCrossRef" href="#bib0510"><span class="elsevierStyleSup">30</span></a> &#40;evidence D-R2&#41;&#46;</p><p id="par0230" class="elsevierStylePara elsevierViewall">SC act at different levels&#44; but their greatest anti-inflammatory effect is produced by inhibition of the genetic transcription of numerous genes that code for proinflammatory proteins &#40;cytokines&#44; chemokines&#44; adhesion molecules&#41; and by increased transcription of anti-inflammatory mediators&#46; They act by binding to a specific intracytoplasmic receptor with 2 molecular isoforms &#40;&#945; and &#946;&#41;&#46; The &#946; receptor cannot bind to the hormone&#44; and&#44; as such&#44; is inactive<a class="elsevierStyleCrossRef" href="#bib0515"><span class="elsevierStyleSup">31</span></a> &#40;evidence D-R2&#41;&#46; Lack of sensitivity to SC cannot be explained by pharmacokinetic changes or malabsorption&#44; and is probably due to a range of different mechanisms<a class="elsevierStyleCrossRef" href="#bib0520"><span class="elsevierStyleSup">32</span></a> &#40;evidence C-R2&#41; &#40;<a class="elsevierStyleCrossRef" href="#tbl0025">Table 5</a>&#41;&#46;</p><elsevierMultimedia ident="tbl0025"></elsevierMultimedia></span><span id="sec0150" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0155">Inhaled Corticosteroids</span><p id="par0235" class="elsevierStylePara elsevierViewall">Response to IC varies notably among individuals<a class="elsevierStyleCrossRef" href="#bib0415"><span class="elsevierStyleSup">11</span></a> &#40;evidence C-R2&#41;&#46; However&#44; there is some evidence to suggest that SUCA patients may respond to higher doses than normally recommended<a class="elsevierStyleCrossRef" href="#bib0525"><span class="elsevierStyleSup">33</span></a> &#40;evidence A-R1&#41;&#46; Although some studies support the greater therapeutic efficacy of fine particle IC &#40;related with their effect on the peripheral airways&#41;&#44; there is no evidence of their superiority in SUCA<a class="elsevierStyleCrossRef" href="#bib0530"><span class="elsevierStyleSup">34</span></a> &#40;evidence C-R2&#41;&#46;</p><p id="par0240" class="elsevierStylePara elsevierViewall">Among the new glucocorticoids&#44; ciclesonide has fewer local and systemic side effects since it is a prodrug converted to its active form in the lung parenchyma<a class="elsevierStyleCrossRef" href="#bib0535"><span class="elsevierStyleSup">35</span></a> &#40;evidence B-R2&#41;&#46; New steroids&#44; known as &#8220;dissociated&#8221; compounds &#40;mapracorat&#41;&#44; that aim to separate the anti-inflammatory mechanisms from the side effects&#44; are currently under development<a class="elsevierStyleCrossRef" href="#bib0540"><span class="elsevierStyleSup">36</span></a> &#40;evidence D-R2&#41;&#46;</p></span><span id="sec0155" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0160">Systemic Corticosteroids</span><p id="par0245" class="elsevierStylePara elsevierViewall">The best time for introducing maintenance treatment with SC is not well defined&#44; nor is there evidence that continuous treatment with low-dose SC is more effective than cycles of SC in reducing the number of exacerbations&#46; IM triamcinolone administration &#40;Trigon<span class="elsevierStyleSup">&#174;</span> depot 40<span class="elsevierStyleHsp" style=""></span>mg&#41; in asthmatics with corticosteroid insensitivity improves control&#44; reduces eosinophils in sputum&#44; increases FEV1 and prevents exacerbations&#46; Reasons for its efficacy may include reinforced compliance or the higher dosage of triamcinolone compared to other corticosteroids used in the clinic<a class="elsevierStyleCrossRef" href="#bib0545"><span class="elsevierStyleSup">37</span></a> &#40;C-R2&#41;&#46;</p></span><span id="sec0160" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0165">Long-Acting &#946;2-Adrenergic Agonists</span><p id="par0250" class="elsevierStylePara elsevierViewall">Adding a LABA to an IC has been shown to be more effective than doubling the dose of the IC or adding an antileukotriene&#44; although there may be notable variability in response&#44; which needs to be monitored<a class="elsevierStyleCrossRef" href="#bib0550"><span class="elsevierStyleSup">38</span></a> &#40;evidence A-R1&#41;&#46; Formoterol as a complete agonist has greater intrinsic efficacy and causes a greater number of adverse effects<a class="elsevierStyleCrossRef" href="#bib0555"><span class="elsevierStyleSup">39</span></a> &#40;evidence D-R2&#41;&#44; the most common of which are tachycardia and hypokalemia&#44; which can be more pronounced in individuals homozygous for arginine in position 16 of &#946;2-AR&#46;</p></span><span id="sec0165" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0170">Long-Acting Anticholinergics</span><p id="par0255" class="elsevierStylePara elsevierViewall">Recent studies have shown that long-acting anticholinergics &#40;LAMA&#41; may be useful in patients with severe asthma and concomitant CAFL<a class="elsevierStyleCrossRef" href="#bib0560"><span class="elsevierStyleSup">40</span></a> &#40;evidence B-R2&#41;&#44; in cases of ACOS&#44; in severe asthma with a non-eosinophilic inflammatory profile<a class="elsevierStyleCrossRef" href="#bib0565"><span class="elsevierStyleSup">41</span></a> &#40;evidence D-R2&#41;&#44; and in asthmatics with the ArgGly variant in codon 16 of the &#946;2-receptor<a class="elsevierStyleCrossRef" href="#bib0570"><span class="elsevierStyleSup">42</span></a> &#40;evidence B-R2&#41;&#46; There is an increasing trend in the use of LAMA as a treatment for bronchial asthma&#44; and some CPG suggest their use in the higher stages of severity&#44; when control cannot be achieved&#46;</p></span><span id="sec0170" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0175">Vitamin D</span><p id="par0260" class="elsevierStylePara elsevierViewall">Levels of 25-hydroxyvitamin D&#60;30<span class="elsevierStyleHsp" style=""></span>ng&#47;ml are related with asthma severity&#44; increased risk of exacerbations and poor lung function&#44; and are also implicated in the mechanisms of steroid insensitivity&#46; However&#44; no definitive results are available to support supplementation with this vitamin<a class="elsevierStyleCrossRef" href="#bib0575"><span class="elsevierStyleSup">43</span></a> &#40;evidence D-R2&#41;&#46;</p></span><span id="sec0175" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0180">Macrolides</span><p id="par0265" class="elsevierStylePara elsevierViewall">Treatment with macrolides for 3 weeks or more in severe asthma is not associated with a significant improvement in FEV<span class="elsevierStyleInf">1</span>&#44; although improvement has been reported in morning PEF&#44; symptom control&#44; bronchial hyperreactivity&#44; and health-related quality of life &#40;HRQoL&#41;<a class="elsevierStyleCrossRef" href="#bib0580"><span class="elsevierStyleSup">44</span></a> &#40;evidence D-R2&#41;&#46; There is insufficient evidence on generalized use for reducing the number of exacerbations&#44; although some studies recommend macrolides in the severe neutrophilic asthma phenotype<a class="elsevierStyleCrossRef" href="#bib0585"><span class="elsevierStyleSup">45</span></a> &#40;evidence B-R2&#41;&#46;</p></span><span id="sec0180" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0185">Antileukotrienes</span><p id="par0270" class="elsevierStylePara elsevierViewall">Patients with AERD generally have excessive basal leukotriene production&#44; so would appear to be ideal candidates for antileukotriene treatment<a class="elsevierStyleCrossRef" href="#bib0590"><span class="elsevierStyleSup">46</span></a> &#40;evidence C-R2&#41;&#46; Some recent studies report findings in air trapping and radiological changes on CT that suggest montelukast may be useful&#44; in general&#44; in patients with severe asthma&#44; so it may tried as an add-on therapy in these patients<a class="elsevierStyleCrossRef" href="#bib0595"><span class="elsevierStyleSup">47</span></a> &#40;evidence C-R2&#41;&#46;</p></span><span id="sec0185" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0190">Omalizumab</span><p id="par0275" class="elsevierStylePara elsevierViewall">Anti-IgE treatment has shown clinical efficacy in inflammatory response markers&#44; frequency of exacerbations&#44; visits to emergency departments&#44; severity of symptoms&#44; use of IC&#44; and HRQoL&#46; Omalizumab is indicated for improving asthma control when administered as add-on treatment in adults and older children &#40;over 6 years of age&#41; with persistent severe uncontrolled allergic asthma with perennial allergies&#44; reduced lung function and documented severe exacerbations&#44; despite appropriate treatment for their level of severity<a class="elsevierStyleCrossRef" href="#bib0600"><span class="elsevierStyleSup">48</span></a> &#40;evidence B-R2&#41;&#46; Data from non-atopic patients receiving omalizumab have been published&#44; which could open a new avenue for treatment in this patient group<a class="elsevierStyleCrossRef" href="#bib0605"><span class="elsevierStyleSup">49</span></a> &#40;evidence D-R2&#41;&#46;</p></span><span id="sec0190" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0195">Thermoplasty</span><p id="par0280" class="elsevierStylePara elsevierViewall">Although early clinical studies performed in asthmatics classified as moderate and severe have not shown particularly favorable results&#44; due to adverse events and the lack of effect on bronchial hyperreactivity<a class="elsevierStyleCrossRef" href="#bib0610"><span class="elsevierStyleSup">50</span></a> &#40;evidence B-R2&#41;&#44; it is not yet clear which subgroup of patients might benefit from this technique&#46; A recent study&#44; with a 5-year follow-up&#44; showed a sustained improvement in disease control &#40;reduction in number of severe exacerbations and visits to the emergency room&#41; and confirmed the safety of the procedure<a class="elsevierStyleCrossRef" href="#bib0615"><span class="elsevierStyleSup">51</span></a> &#40;evidence B-R2&#41;&#46; It is currently recommended only in experienced units and in the research setting<a class="elsevierStyleCrossRefs" href="#bib0365"><span class="elsevierStyleSup">1&#44;52</span></a> &#40;evidence D-R2&#41;<a class="elsevierStyleCrossRef" href="#bib0625"><span class="elsevierStyleSup">53</span></a> &#40;evidence B-R2&#41;&#46;</p></span><span id="sec0195" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0200">Theophylline and Phosphodiesterase-4 Inhibitors</span><p id="par0285" class="elsevierStylePara elsevierViewall">Although no controlled trials have been performed in severe asthma&#44; theophylline as a single agent has relatively weak anti-inflammatory activity&#44; but at low doses it can markedly enhance the action of corticosteroids on the expression of inflammatory genes<a class="elsevierStyleCrossRef" href="#bib0630"><span class="elsevierStyleSup">54</span></a> &#40;evidence D-R2&#41;&#46;</p><p id="par0290" class="elsevierStylePara elsevierViewall">Data are also available on the utility of the new phosphodiesterase-4 inhibitors &#40;roflumilast&#41; in asthmatics<a class="elsevierStyleCrossRef" href="#bib0635"><span class="elsevierStyleSup">55</span></a> &#40;evidence B-R2&#41; and the 2014 Spanish COPD Guidelines &#40;GesEPOC&#41; update continues to suggest these drugs as add-on treatment in ACOS patients with uncontrolled symptoms<a class="elsevierStyleCrossRef" href="#bib0640"><span class="elsevierStyleSup">56</span></a> &#40;evidence D-R2<span class="elsevierStyleSup">CPG</span>&#41;&#46;</p></span><span id="sec0200" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0205">Other Treatments</span><p id="par0295" class="elsevierStylePara elsevierViewall">Studies have confirmed the unfavorable risk&#47;benefit profile of etanercept&#44; methotrexate and cyclosporin&#46;</p><p id="par0300" class="elsevierStylePara elsevierViewall">An anti-IL5 monoclonal antibody&#44; mepolizumab&#44; has been recently investigated in patients with eosinophilic asthma&#44; showing significant improvements in HRQoL&#44; exacerbations and symptoms<a class="elsevierStyleCrossRef" href="#bib0645"><span class="elsevierStyleSup">57</span></a> &#40;evidence A-R1&#41;<a class="elsevierStyleCrossRef" href="#bib0650"><span class="elsevierStyleSup">58</span></a> &#40;evidence B-R2&#41; and reduced use of SC<a class="elsevierStyleCrossRef" href="#bib0655"><span class="elsevierStyleSup">59</span></a> &#40;evidence B-R2&#41;&#46; Studies with reslizumab and benralizumab &#40;anti-IL-5 receptor&#41; are opening up new prospects<a class="elsevierStyleCrossRef" href="#bib0660"><span class="elsevierStyleSup">60</span></a> &#40;evidence B-R2&#41;&#46;</p><p id="par0305" class="elsevierStylePara elsevierViewall">Another immune activation pathway in asthma is IL-13&#46; Molecules are already under development with this target in mind&#58; tralokinumab and lebrikizumab with anti-IL-13 effect&#44; and dupilumab<a class="elsevierStyleCrossRef" href="#bib0665"><span class="elsevierStyleSup">61</span></a> &#40;evidence B-R2&#41; which is directed against the alpha subunit of the IL-4 receptor&#44; a target shared by both IL-4 and IL-13&#46; Lebrikizumab showed a greater positive effect in patients with elevated pre-treatment levels of circulating periostine<a class="elsevierStyleCrossRef" href="#bib0670"><span class="elsevierStyleSup">62</span></a> &#40;evidence B-R2&#41;&#46; Trials have been conducted with pitrakinra&#44; an IL-4 mutein&#44; that works as an antagonist by inhibiting IL-4 and IL-13 binding to the shared IL-4R&#945;&#47;IL-13R&#945;1 complex<a class="elsevierStyleCrossRef" href="#bib0675"><span class="elsevierStyleSup">63</span></a> &#40;evidence B-R2&#41;&#46; Daclizumab&#44; a humanized IgG1 monoclonal antibody against the IL-2R-&#945; chain of activated T-lymphocytes&#44; has been shown to be useful in moderate and severe asthma inadequately controlled on IC<a class="elsevierStyleCrossRef" href="#bib0680"><span class="elsevierStyleSup">64</span></a> &#40;evidence B-R2&#41;&#46;</p><p id="par0310" class="elsevierStylePara elsevierViewall">Molecules that act on the IL-17 &#40;brodalumab&#41; and the IL-17A receptor &#40;secukinumab&#41; in neutrophilic asthma are currently under investigation&#44; since IL-17 induces IL-8 expression&#44; the main neutrophil-attracting factor&#44; but results to date have been disappointing<a class="elsevierStyleCrossRef" href="#bib0685"><span class="elsevierStyleSup">65</span></a> &#40;evidence B-R2&#41;&#46;</p></span><span id="sec0205" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0210">Phenotype-based Treatment</span><p id="par0315" class="elsevierStylePara elsevierViewall">If the inflammatory phenotype is identified&#44; treatment response can be predicted&#46; In this respect&#44; there is sufficient data to confirm that eosinophilic inflammation has a high predictive value for response to IC in patients with this type of airway disease&#44; irrespective of their diagnosis&#46; There is evidence for adjusting treatment in SUCA patients on the basis of induced sputum testing &#40;in experienced clinics&#41;&#44; although this could not be shown for FeNO<a class="elsevierStyleCrossRef" href="#bib0690"><span class="elsevierStyleSup">66</span></a> &#40;evidence A-R1&#41;&#46;</p><p id="par0320" class="elsevierStylePara elsevierViewall">Triamcinolone could be an alternative in patients with refractory eosinophilia&#44;<a class="elsevierStyleCrossRef" href="#bib0500"><span class="elsevierStyleSup">28</span></a> and its effect may be enhanced with low-dose theophylline&#46;<a class="elsevierStyleCrossRef" href="#bib0630"><span class="elsevierStyleSup">54</span></a> Therapeutic options&#44; such as omalizumab&#44; are available&#44; and mepolizumab&#44; reslizumab&#44; lebrikizumab or dupilumab could be used in this patient group in the near future&#46;</p><p id="par0325" class="elsevierStylePara elsevierViewall">Some selected patients with neutrophilic asthma may be candidates for macrolide treatment&#46;<a class="elsevierStyleCrossRef" href="#bib0580"><span class="elsevierStyleSup">44</span></a></p><p id="par0330" class="elsevierStylePara elsevierViewall">Tiotropium is another alternative for patients with CAFL&#46;<a class="elsevierStyleCrossRef" href="#bib0565"><span class="elsevierStyleSup">41</span></a> Finally&#44; thermoplasty can be considered in carefully selected patients in experienced units &#40;<a class="elsevierStyleCrossRef" href="#fig0015">Fig&#46; 3</a>&#41;&#46;</p><elsevierMultimedia ident="fig0015"></elsevierMultimedia></span></span><span id="sec0210" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0215">Severe Uncontrolled Asthma in Childhood</span><p id="par0335" class="elsevierStylePara elsevierViewall">Less than 5&#37; of asthmatic children have SUCA&#46; However&#44; the care of children with SUCA accounts for more than twice the direct &#40;medication&#44; visit to the emergency room&#44; hospitalization&#41; and indirect resources &#40;missing school&#44; parents&#8217; absenteeism from work&#44; etc&#46;&#41; used by the others<a class="elsevierStyleCrossRef" href="#bib0695"><span class="elsevierStyleSup">67</span></a> &#40;evidence B-R1&#41;&#46;</p><p id="par0340" class="elsevierStylePara elsevierViewall">Since there are insufficient follow-up studies&#44; no clear relationship can be established between asthma phenotypes in children and in adults&#44; but severe asthma in childhood does seem to continue into adulthood&#44; and very few individuals manage to control their disease&#46;<a class="elsevierStyleCrossRef" href="#bib0385"><span class="elsevierStyleSup">5</span></a></p><p id="par0345" class="elsevierStylePara elsevierViewall">Most children referred to specialists for SUCA may belong to one of the following groups&#44; or indeed more&#44; as there may be some overlap&#44; or a patient may be classified into different groups at different ages&#58;</p><p id="par0350" class="elsevierStylePara elsevierViewall">Persistent asthma&#44; occurring most days&#44; for at least 3 months&#44; despite high-dose IC and other controllers&#44; such as LABA&#44; montelukast&#44; and less frequently&#44; low-dose oral theophylline or long-term SC&#46;</p><p id="par0355" class="elsevierStylePara elsevierViewall">Recurrent severe exacerbations requiring at least ICU admission or 2 hospital admissions&#44; or more than 2 courses of SC in the last year&#44; despite appropriate background treatment for asthma&#46;</p><p id="par0360" class="elsevierStylePara elsevierViewall">CAFL due to anatomical reduction of airway caliber&#44; occurring either before birth &#40;maternal smoking&#44; hypertension or gestational diabetes&#41; or postnatal &#40;viral infections&#44; reflux aspiration&#41;&#44; detected by lack of improvement in respiratory function &#40;FEV<span class="elsevierStyleInf">1</span>&#60;&#8722;1&#46;96 of the Z <span class="elsevierStyleItalic">score</span>&#41; after administration of 1 dose of IM triamcinolone or 2 weeks of oral SC &#40;although the choice of SC and dose remain unclear&#41;<a class="elsevierStyleCrossRef" href="#bib0700"><span class="elsevierStyleSup">68</span></a> &#40;evidence D-R2&#41;&#46;</p><p id="par0365" class="elsevierStylePara elsevierViewall">As in adults&#44; if a child presents with apparent SUCA&#44; a number of considerations must be made&#58;</p><span id="sec0215" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0220">Is the Diagnosis of Asthma Correct&#63;</span><p id="par0370" class="elsevierStylePara elsevierViewall">Other diagnostic possibilities must be considered&#44; and extra tests performed&#44; according to the degree of suspicion &#40;<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>&#41;&#46;</p></span><span id="sec0220" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0225">Are the Prescribed Treatment and Compliance Adequate&#63;</span><p id="par0375" class="elsevierStylePara elsevierViewall">SUCA was ruled out in 75&#37; of children after a review of inhalation techniques and treatment compliance<a class="elsevierStyleCrossRef" href="#bib0705"><span class="elsevierStyleSup">69</span></a> &#40;evidence D-R2&#41;&#46;</p></span><span id="sec0225" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0230">Are There Aggravating Environmental Factors&#63;</span><p id="par0380" class="elsevierStylePara elsevierViewall">Both repeated exposure to airborne allergens to which the child is sensitized and exposure to tobacco smoke or atmospheric pollution contribute to poor asthma control&#44; due to increased bronchial reactivity and reduced response to SC&#46; If these factors are combined with a respiratory viral infection&#44; severe asthma exacerbations may be easily triggered&#46;</p></span><span id="sec0230" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0235">Are There Comorbidities&#63;</span><p id="par0385" class="elsevierStylePara elsevierViewall">Rhinosinusitis&#44; obesity&#44; gastroesophageal reflux and psychosocial factors worsen asthma&#44; although their degree of influence and mechanism of action are disputed&#46; Food allergies behave more as a marker for severity&#44; while breathing dysfunction syndromes may present concomitantly and lead to overtreatment if they are not correctly identified&#46;</p><p id="par0390" class="elsevierStylePara elsevierViewall">After analyzing the above-mentioned factors&#44; an attempt should be made to determine if the patient has corticosteroid-sensitive SUCA &#40;the most common pediatric presentation&#41;&#44; or not &#40;even if the patient has an eosinophilic inflammatory pattern in the airway&#41;&#44; or if they have a neutrophilic or mixed pattern&#44; or if there is CAFL&#46;</p><p id="par0395" class="elsevierStylePara elsevierViewall">To this end&#44; the various tests listed in <a class="elsevierStyleCrossRef" href="#tbl0030">Table 6</a> should be scheduled in a series of visits&#46; In the first visit&#44; allergy tests should be repeated&#44; to determine if the patient has become sensitized to other airborne allergens&#44; and cotinine in saliva should be analyzed to detect exposure to tobacco smoke<a class="elsevierStyleCrossRef" href="#bib0710"><span class="elsevierStyleSup">70</span></a> &#40;evidence D-R2<span class="elsevierStyleSup">CPG</span>&#41;&#46;</p><elsevierMultimedia ident="tbl0030"></elsevierMultimedia><p id="par0400" class="elsevierStylePara elsevierViewall">To confirm corticosteroid response&#44; and since there is no agreement as regards the optimal dose&#44; duration and route of administration in children&#44; we suggest using triamcinolone&#44; 40&#8211;80<span class="elsevierStyleHsp" style=""></span>mg IM&#44; depending on age and weight<a class="elsevierStyleCrossRef" href="#bib0715"><span class="elsevierStyleSup">71</span></a> &#40;evidence D-R2&#41;&#46; Response should be confirmed 2 weeks later &#40;<a class="elsevierStyleCrossRef" href="#tbl0035">Table 7</a>&#41;&#46; Responders are patients who improve in all 3 domains&#44; non-responders are those who do not improve in any domains&#44; and partial responders are those who improve in 1 or 2 domains&#46; The latter category is the most common&#46;<a class="elsevierStyleCrossRef" href="#bib0545"><span class="elsevierStyleSup">37</span></a></p><elsevierMultimedia ident="tbl0035"></elsevierMultimedia><p id="par0405" class="elsevierStylePara elsevierViewall">Patients who respond to SC may benefit from omalizumab&#44; which has been shown to be safe and effective in comparative trials in children over the age of 6&#46;<a class="elsevierStyleCrossRef" href="#bib0600"><span class="elsevierStyleSup">48</span></a> Any other treatment should also be maintained&#44; including SC&#44; until symptoms are controlled&#46;</p><p id="par0410" class="elsevierStylePara elsevierViewall">Non-responders who have persistent neutrophilic airway inflammation may benefit from macrolides&#44; although there is insufficient evidence&#46; Use of azithromycin has been suggested with the same regimen as for cystic fibrosis&#58; 250<span class="elsevierStyleHsp" style=""></span>mg&#47;day for children weighing &#60;40<span class="elsevierStyleHsp" style=""></span>kg and 500<span class="elsevierStyleHsp" style=""></span>mg&#47;day for those &#62;40<span class="elsevierStyleHsp" style=""></span>kg&#44; 3 times a week for 6 months&#44; followed by a reevaluation of efficacy<a class="elsevierStyleCrossRef" href="#bib0720"><span class="elsevierStyleSup">72</span></a> &#40;evidence A-R1&#41;&#46; Low-dose oral theophylline may also be tried&#58; target blood concentrations are 5&#8211;10<span class="elsevierStyleHsp" style=""></span>mg&#47;l&#46;</p></span></span><span id="sec0235" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0240">Conflict of Interest</span><p id="par0415" class="elsevierStylePara elsevierViewall">Carolina Cisneros Serrano has received fees for lectures and participation in advisory boards from Astra-Zeneca&#44; GSK&#44; Boheringer&#44; Novartis&#44; Takeda&#44; ViforPharma and Chiesi&#46; The other authors declare that they do not have any conflict of interests&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:15 [
        0 => array:3 [
          "identificador" => "xres484712"
          "titulo" => "Abstract"
          "secciones" => array:1 [
            0 => array:1 [
              "identificador" => "abst0005"
            ]
          ]
        ]
        1 => array:2 [
          "identificador" => "xpalclavsec506944"
          "titulo" => "Keywords"
        ]
        2 => array:3 [
          "identificador" => "xres484713"
          "titulo" => "Resumen"
          "secciones" => array:1 [
            0 => array:1 [
              "identificador" => "abst0010"
            ]
          ]
        ]
        3 => array:2 [
          "identificador" => "xpalclavsec506945"
          "titulo" => "Palabras clave"
        ]
        4 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Introduction"
        ]
        5 => array:2 [
          "identificador" => "sec0010"
          "titulo" => "Methodology"
        ]
        6 => array:2 [
          "identificador" => "sec0015"
          "titulo" => "Definition"
        ]
        7 => array:2 [
          "identificador" => "sec0020"
          "titulo" => "Epidemiology"
        ]
        8 => array:2 [
          "identificador" => "sec0025"
          "titulo" => "Genetics"
        ]
        9 => array:3 [
          "identificador" => "sec0030"
          "titulo" => "Severe Asthma Phenotypes"
          "secciones" => array:4 [
            0 => array:2 [
              "identificador" => "sec0035"
              "titulo" => "Severe Allergic Asthma"
            ]
            1 => array:2 [
              "identificador" => "sec0040"
              "titulo" => "Late Onset Eosinophilic Asthma"
            ]
            2 => array:2 [
              "identificador" => "sec0045"
              "titulo" => "Severe Non-Atopic Asthma in the Obese Adult"
            ]
            3 => array:2 [
              "identificador" => "sec0050"
              "titulo" => "Adult-Onset Neutrophilic Asthma"
            ]
          ]
        ]
        10 => array:3 [
          "identificador" => "sec0055"
          "titulo" => "Diagnosis of the Patient With Severe Uncontrolled Asthma"
          "secciones" => array:3 [
            0 => array:3 [
              "identificador" => "sec0060"
              "titulo" => "Step 1&#58; Determine if the Patient has Asthma"
              "secciones" => array:3 [
                0 => array:2 [
                  "identificador" => "sec0065"
                  "titulo" => "Clinical History and Tests to Confirm Asthma"
                ]
                1 => array:2 [
                  "identificador" => "sec0070"
                  "titulo" => "Differential Diagnosis"
                ]
                2 => array:3 [
                  "identificador" => "sec0075"
                  "titulo" => "Upper Airway Disease"
                  "secciones" => array:2 [
                    0 => array:2 [
                      "identificador" => "sec0080"
                      "titulo" => "Organic Causes"
                    ]
                    1 => array:2 [
                      "identificador" => "sec0085"
                      "titulo" => "Functional Causes"
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "sec0105"
              "titulo" => "Step 2&#58; Identify Factors for Poor Control and Evaluate Concomitant Diseases"
              "secciones" => array:5 [
                0 => array:2 [
                  "identificador" => "sec0110"
                  "titulo" => "Check Compliance"
                ]
                1 => array:2 [
                  "identificador" => "sec0115"
                  "titulo" => "Check Inhalation Technique"
                ]
                2 => array:2 [
                  "identificador" => "sec0120"
                  "titulo" => "Check Environmental and&#47;or Workplace Exposure"
                ]
                3 => array:2 [
                  "identificador" => "sec0125"
                  "titulo" => "Check Bronchoconstrictor Drugs"
                ]
                4 => array:2 [
                  "identificador" => "sec0130"
                  "titulo" => "Evaluate Comorbidities"
                ]
              ]
            ]
            2 => array:2 [
              "identificador" => "sec0135"
              "titulo" => "Step 3&#58; Identify Severe Asthma Phenotypes"
            ]
          ]
        ]
        11 => array:3 [
          "identificador" => "sec0140"
          "titulo" => "Treatment of Severe Uncontrolled Asthma"
          "secciones" => array:13 [
            0 => array:2 [
              "identificador" => "sec0145"
              "titulo" => "Corticosteroid Insensitivity"
            ]
            1 => array:2 [
              "identificador" => "sec0150"
              "titulo" => "Inhaled Corticosteroids"
            ]
            2 => array:2 [
              "identificador" => "sec0155"
              "titulo" => "Systemic Corticosteroids"
            ]
            3 => array:2 [
              "identificador" => "sec0160"
              "titulo" => "Long-Acting &#946;2-Adrenergic Agonists"
            ]
            4 => array:2 [
              "identificador" => "sec0165"
              "titulo" => "Long-Acting Anticholinergics"
            ]
            5 => array:2 [
              "identificador" => "sec0170"
              "titulo" => "Vitamin D"
            ]
            6 => array:2 [
              "identificador" => "sec0175"
              "titulo" => "Macrolides"
            ]
            7 => array:2 [
              "identificador" => "sec0180"
              "titulo" => "Antileukotrienes"
            ]
            8 => array:2 [
              "identificador" => "sec0185"
              "titulo" => "Omalizumab"
            ]
            9 => array:2 [
              "identificador" => "sec0190"
              "titulo" => "Thermoplasty"
            ]
            10 => array:2 [
              "identificador" => "sec0195"
              "titulo" => "Theophylline and Phosphodiesterase-4 Inhibitors"
            ]
            11 => array:2 [
              "identificador" => "sec0200"
              "titulo" => "Other Treatments"
            ]
            12 => array:2 [
              "identificador" => "sec0205"
              "titulo" => "Phenotype-based Treatment"
            ]
          ]
        ]
        12 => array:3 [
          "identificador" => "sec0210"
          "titulo" => "Severe Uncontrolled Asthma in Childhood"
          "secciones" => array:4 [
            0 => array:2 [
              "identificador" => "sec0215"
              "titulo" => "Is the Diagnosis of Asthma Correct&#63;"
            ]
            1 => array:2 [
              "identificador" => "sec0220"
              "titulo" => "Are the Prescribed Treatment and Compliance Adequate&#63;"
            ]
            2 => array:2 [
              "identificador" => "sec0225"
              "titulo" => "Are There Aggravating Environmental Factors&#63;"
            ]
            3 => array:2 [
              "identificador" => "sec0230"
              "titulo" => "Are There Comorbidities&#63;"
            ]
          ]
        ]
        13 => array:2 [
          "identificador" => "sec0235"
          "titulo" => "Conflict of Interest"
        ]
        14 => array:1 [
          "titulo" => "References"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "fechaRecibido" => "2014-09-19"
    "fechaAceptado" => "2014-12-06"
    "PalabrasClave" => array:2 [
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec506944"
          "palabras" => array:4 [
            0 => "Severe asthma"
            1 => "Uncontrolled asthma"
            2 => "Asthma phenotype"
            3 => "Asthma treatment"
          ]
        ]
      ]
      "es" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec506945"
          "palabras" => array:4 [
            0 => "Asma grave"
            1 => "Asma no controlada"
            2 => "Fenotipado del asma"
            3 => "Tratamiento del asma"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "en" => array:2 [
        "titulo" => "Abstract"
        "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Since the publication&#44; 9 years ago&#44; of the latest SEPAR &#40;Spanish Society of Pulmonology and Thoracic Surgery&#41; Guidelines on Difficult-to-Control Asthma &#40;DCA&#41;&#44; much progress has been made in the understanding of asthmatic disease&#46; These new data need to be reviewed&#44; analyzed and incorporated into the guidelines according to their level of evidence and recommendation&#46; Recently&#44; consensus documents and clinical practice guidelines &#40;CPG&#41; addressing this issue have been published&#46; In these guidelines&#44; specific mention will be made of what the previous DCA guidelines defined as &#8220;true difficult-to-control asthma&#8221;&#46; This is asthma that remains uncontrolled after diagnosis and a systematic evaluation to rule out factors unrelated to the disease itself that lead to poor control &#40;&#8220;false difficult-to-control asthma&#8221;&#41;&#44; and despite an appropriate treatment strategy &#40;Spanish Guidelines for the Management of Asthma &#91;GEMA&#93; steps 5 and 6&#41;&#58; severe uncontrolled asthma&#46; In this respect&#44; the guidelines propose a revised definition&#44; an attempt to classify the various manifestations of this type of asthma&#44; a proposal for a stepwise diagnostic procedure&#44; and phenotype-targeted treatment&#46; A specific section has also been included on DCA in childhood&#44; aimed at assisting healthcare professionals to improve the care of these patients&#46;</p></span>"
      ]
      "es" => array:2 [
        "titulo" => "Resumen"
        "resumen" => "<span id="abst0010" class="elsevierStyleSection elsevierViewall"><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Desde la publicaci&#243;n&#44; hace ya 9 a&#241;os&#44; de la &#250;ltima normativa de la Sociedad Espa&#241;ola de Neumolog&#237;a y Cirug&#237;a Tor&#225;cica &#40;SEPAR&#41; sobre asma de control dif&#237;cil &#40;ACD&#41;&#44; se han producido avances en los conocimientos de la enfermedad asm&#225;tica&#44; que hacen necesario realizar una puesta al d&#237;a de los datos disponibles e incorporarlos tras su an&#225;lisis en el nivel de evidencia y recomendaci&#243;n m&#225;s adecuado&#46; Recientemente han aparecido documentos de consenso y gu&#237;as de pr&#225;ctica cl&#237;nica &#40;GPC&#41; que abordan este problema&#46; En esta normativa se har&#225; menci&#243;n expl&#237;cita a lo que la previa gu&#237;a de ACD defin&#237;a como &#171;verdadera asma de control dif&#237;cil&#187;&#59; es decir&#44; al asma que tras haber verificado su diagn&#243;stico&#44; realizado un abordaje sistematizado para descartar factores ajenos a la propia enfermedad que conducen a un mal control de la misma &#40;&#171;falsa asma de control dif&#237;cil&#187;&#41;&#44; y realizar una estrategia de tratamiento adecuado &#40;escalones 5 y 6 de la Gu&#237;a espa&#241;ola para el manejo del asma &#91;GEMA&#93;&#41;&#44; no se consigue alcanzar el control&#58; &#171;asma grave no controlada&#187; &#40;AGNC&#41;&#46; En esta l&#237;nea la normativa propone una revisi&#243;n de la definici&#243;n&#44; un intento de clasificaci&#243;n de las diferentes manifestaciones de este tipo de asma&#44; una propuesta del abordaje diagn&#243;stico por pasos y un tratamiento dirigido seg&#250;n fenotipo&#44; conjuntamente con un apartado espec&#237;fico sobre este arquetipo de asma en la infancia&#44; con el objetivo de que pueda servir de ayuda a los profesionales sanitarios y repercutir en el cuidado de estos pacientes&#46;</p></span>"
      ]
    ]
    "NotaPie" => array:1 [
      0 => array:2 [
        "etiqueta" => "&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as&#58; Cisneros Serrano C&#44; Melero Moreno C&#44; Almonacid S&#225;nchez C&#44; Perpi&#241;&#225; Tordera M&#44; Picado Valles C&#44; Mart&#237;nez Morag&#243;n E&#44; et al&#46; Normativa sobre asma grave no controlada&#46; Arch Bronconeumol&#46; 2015&#59;51&#58;235&#8211;246&#46;</p>"
      ]
    ]
    "multimedia" => array:10 [
      0 => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Fig&#46; 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 3333
            "Ancho" => 2391
            "Tamanyo" => 820367
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Grading and quality of evidence and implication of recommendations according to GRADE&#46;</p>"
        ]
      ]
      1 => array:7 [
        "identificador" => "fig0010"
        "etiqueta" => "Fig&#46; 2"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr2.jpeg"
            "Alto" => 3333
            "Ancho" => 2506
            "Tamanyo" => 593743
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Algorithm for evaluation of patient with severe&#44; uncontrolled asthma&#46;</p>"
        ]
      ]
      2 => array:7 [
        "identificador" => "fig0015"
        "etiqueta" => "Fig&#46; 3"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr3.jpeg"
            "Alto" => 1822
            "Ancho" => 2829
            "Tamanyo" => 231541
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Treatment proposal for severe&#44; uncontrolled asthma according to phenotype&#46; ACOS&#58; asthma&#47;COPD overlap syndrome&#59; AERD&#58; aspirin-exacerbated respiratory disease&#59; CAFL&#58; chronic airflow limitation&#46;</p>"
        ]
      ]
      3 => array:7 [
        "identificador" => "tbl0005"
        "etiqueta" => "Table 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "tabla" => array:2 [
          "leyenda" => "<p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">ACQ&#58; <span class="elsevierStyleItalic">Asthma Control Questionnaire</span>&#59; ACT&#58; <span class="elsevierStyleItalic">Asthma Control Test</span>&#59; CFC&#58; chlorofluorocarbons&#59; DPI&#58; dry powder inhaler&#59; FEV<span class="elsevierStyleInf">1</span>&#58; forced expired volume in 1<span class="elsevierStyleHsp" style=""></span>s&#59; FVC&#58; forced vital capacity&#59; GINA&#58; Global Initiative for Asthma&#59; HFA&#58; hydrofluoroalkanes&#59; MDI&#58; measured dose inhaler&#59; NAEPP&#58; National Asthma Education and Prevention Program&#59; ICU&#58; intensive care unit&#46;</p><p id="spar0105" class="elsevierStyleSimplePara elsevierViewall">Adapted from ATS&#47;ERS&#46;<a class="elsevierStyleCrossRef" href="#bib0365"><span class="elsevierStyleSup">1</span></a></p>"
          "tablatextoimagen" => array:2 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">The ATS&#47;ERS Consensus defines severe asthma as asthma requiring treatment at steps 4&#8211;5 of the Global Initiative for Asthma &#40;GINA&#41; clinical practice guidelines&#44; namely high-dose inhaled corticosteroids and a long-acting beta-antagonist&#44; or a leukotriene modifier&#44; or theophylline use in the previous year&#44; or systemic corticosteroids for &#8805;50&#37; of the last year&#44; to prevent the disease from becoming uncontrolled&#44; or disease that remains uncontrolled despite this treatment&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">The Consensus defines uncontrolled asthma as at least one of the following&#58;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">Poor control of symptoms measured on questionnaires evaluating disease control&#44; such as the ACT and ACQ&#46; ACQ scores &#62;1&#46;5 or ACT &#8804;19 are considered criteria for poor control according to clinical practice guidelines&#44; such as GINA&#47;National Asthma Education and Prevention Program &#40;NAEPP&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">Frequent severe exacerbations&#58; 2 or more exacerbations requiring bursts of systemic corticosteroids for 3 or more days each in the previous year&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">Exacerbations requiring at least 1 hospitalization&#44; ICU admission or need for non-invasive mechanical ventilation in the previous year&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">Airflow limitation&#58; FEV<span class="elsevierStyleInf">1</span> remains &#60;80&#37; predicted value after use of an appropriate bronchodilator and FEV<span class="elsevierStyleInf">1</span>&#47;FVC ratio below the lower limit of normal &#40;when best FEV<span class="elsevierStyleInf">1</span> is &#62;80&#37;&#41;&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">Controlled asthma that worsens after reducing high-dose inhaled or systemic corticosteroids or new biologics&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab767386.png"
              ]
            ]
            1 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="left" valign="top" scope="col">Inhaled Corticosteroid&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " colspan="2" align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Threshold Dose &#40;&#956;g&#41; Considered High</th></tr><tr title="table-row"><th class="td" title="table-head  " align="" valign="top" scope="col" style="border-bottom: 2px solid black">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Age 6&#8211;12 years&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Age &#62;12 years&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry  " rowspan="2" align="left" valign="top">Beclomethasone dipropionate</td><td class="td" title="table-entry  " align="char" valign="top">&#8805;800 &#40;DPI or CFC MDI&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">&#8805;2000 &#40;DPI or CFC MDI&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="char" valign="top">&#8805;320 &#40;HFA MDI&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">&#8805;1000 &#40;HFA MDI&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">Budesonide&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">&#8805;800 &#40;MDI or DPI&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">&#8805;1600 &#40;MDI or DPI&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">Ciclesonide&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">&#8805;160 &#40;HFA MDI&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">&#8805;320 &#40;HFA MDI&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">Fluticasone dipropionate&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">&#8805;500 &#40;HFA MDI or DPI&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">&#8805;1000 &#40;HFA MDI or DPI&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">Momethasone furoate&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">&#8805;500 &#40;DPI&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">&#8805;1000 &#40;DPI&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">Triamcinolone acetonide&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">&#8805;1200&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">&#8805;2000&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab767383.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Definition of Severe Asthma in Patients Older Than 6 years&#46;</p>"
        ]
      ]
      4 => array:7 [
        "identificador" => "tbl0010"
        "etiqueta" => "Table 2"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "tabla" => array:2 [
          "leyenda" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">IBD&#58; inflammatory bowel disease&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="left" valign="top" scope="col">Adults&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col">Children&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleBold">Upper airway diseases</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Organic causes</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Tumors of the trachea<span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Congenital airway abnormalities<span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Congenital vascular abnormalities<span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Tracheobronchomalacia<span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Idiopathic relapsing polychondritis<span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Tracheal amyloidosis<span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>IBD-associated airway stenosis<span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Endothoracic goiter<span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Chronic fibrosing mediastinitis<span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Functional causes<span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Vocal cord dysfunction<span class="elsevierStyleBold">Lower airway diseases</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Chronic obstructive pulmonary disease</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Bronchiolitis obliterans</span><span class="elsevierStyleBold">Functional or psychogenic dyspnea</span><span class="elsevierStyleBold">Other organ disease</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Left heart failure</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleBold">Upper airway diseases</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Adenotonsillar hypertrophy</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Laryngomalacia&#44; vocal cord paralysis</span>&#44; <span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">laryngeal membrane</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Vocal cord dysfunction</span><span class="elsevierStyleBold">Large airway obstruction</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Tracheomalacia&#44; bronchomalacia</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Tracheal or bronchial stenosis</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Foreign body</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Vascular rings</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Lymphadenopathies&#44; tumors</span><span class="elsevierStyleBold">Suppurative lung disease</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Cystic fibrosis</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Bronchiectasis</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Primary ciliary dyskinesia</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Persistent bacterial bronchitis</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Immune deficiencies</span><span class="elsevierStyleBold">Aspirative syndromes</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Gastroesophageal reflux</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Uncoordinated swallowing</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Tracheoesophageal fistula</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Laryngeal cleft</span><span class="elsevierStyleBold">Other</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Bronchopulmonary dysplasia</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Bronchiolitis obliterans</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Pulmonary edema</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Psychogenic cough</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab767381.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">Differential Diagnosis of Asthma in Adults and Children&#46;</p>"
        ]
      ]
      5 => array:7 [
        "identificador" => "tbl0015"
        "etiqueta" => "Table 3"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "tabla" => array:2 [
          "leyenda" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">ABPA&#58; allergic bronchopulmonary aspergillosis&#59; pANCA&#58; perinuclear anti-neutrophil cytoplasmic antibodies&#59; ECG&#58; electrocardiogram&#59; IgE&#58; immunoglobulin E&#59; BAL&#58; bronchoalveolar lavage&#59; CT&#58; computed tomography&#46; HRCT&#58; high-resolution CT&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">Upper airway organic diseaseBronchial obstruction&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Spirometry with flow-volume loopUpper airway inspiratory&#47;expiratory CTFiberoptic bronchoscopy&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">Vocal cord dysfunction&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Laryngoscopy during attack or after methacholine challenge or after ergometry&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">Chronic obstructive pulmonary disease &#40;emphysema&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Chest HRCTPlethysmography and diffusion&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">Bronchiolitis obliterans&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Inspiratory&#47;expiratory chest HRCTPlethysmography&#47;air trappingTransbronchial&#47;pulmonary biopsy&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">Functional dyspnea&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Nijmegen hyperventilation questionnairePsychological assessment&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">Left heart failure&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Chest HRCTECG&#47;echocardiogram&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">BronchiectasisCystic fibrosisABPA&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Chest HRCTSweat testTotal and Aspergillus specific IgE&#47;precipitin&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">Churg-Strauss syndromePulmonary eosinophilia&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">pANCA&#47;biopsy of affected organ&#40;s&#41;Fiberoptic bronchoscopy &#40;BAL&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab767387.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">Differential Diagnosis of Severe&#44; Uncontrolled Asthma in Adults&#46; Pseudo-Asthmas and Diagnostic Tests&#46;</p>"
        ]
      ]
      6 => array:7 [
        "identificador" => "tbl0020"
        "etiqueta" => "Table 4"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "tabla" => array:2 [
          "leyenda" => "<p id="spar0065" class="elsevierStyleSimplePara elsevierViewall">CPAP&#58; continuous positive airway pressure&#59; PPI&#58; proton pump inhibitors&#59; BMI&#58; body mass index&#58; OSAHS&#58; obstructive sleep apnea&#8211;hypopnea syndrome&#59; CT&#58; computed tomography&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Comorbidity&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Diagnostic tests&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Treatment&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">Rhinosinusitis&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">RhinoendoscopyCT of paranasal sinuses&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">AntileukotrienesIntranasal corticosteroidsNasal saline washingNasal endoscopic surgery&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">Gastroesophageal reflux&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Esophageal pH testing&#47;manometryTherapeutic trial with PPI&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Health and dietary advicePPISurgery&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">Obesity&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">BMI&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Weight lossBariatric surgery&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">OSAHS&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Polysomnography&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">CPAPWeight loss&#44; if applicable&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">Psychiatric disease&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Assessment by psychologist&#47;psychiatrist&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">PsychotherapySpecific treatment&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">Functional dyspnea&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Specific questionnaires&#40;Nijmegen&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">PsychotherapyRespiratory re-education&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">Vocal cord dysfunction&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Laryngoscopy during attack or methacholine challenge&#47;exercise test&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Speech therapy rehabilitation&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab767382.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">Evaluation and Treatment of Comorbidities&#46;</p>"
        ]
      ]
      7 => array:7 [
        "identificador" => "tbl0025"
        "etiqueta" => "Table 5"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "tabla" => array:2 [
          "leyenda" => "<p id="spar0075" class="elsevierStyleSimplePara elsevierViewall">GC&#58; glucocorticoids&#46;</p><p id="spar0080" class="elsevierStyleSimplePara elsevierViewall">Taken from Reddy and Little&#46;<a class="elsevierStyleCrossRef" href="#bib0520"><span class="elsevierStyleSup">32</span></a></p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">Reduced number of GC receptors&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">Increased GC &#946;-receptor expression&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">Cytokines inducing suppression of GC activity&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">Alteration in the GC receptor affinity&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">Reduced GC-receptor nuclear translocation&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">Reduced histone acetylation and increased activation of the protein-1 &#40;AP-1&#41; pathway and nuclear factor &#954;B &#40;NF-&#954;B&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">Predominantly neutrophil inflammation&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab767388.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0070" class="elsevierStyleSimplePara elsevierViewall">Glucocorticoid Resistance Mechanisms in Severe Asthma&#46;</p>"
        ]
      ]
      8 => array:7 [
        "identificador" => "tbl0030"
        "etiqueta" => "Table 6"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "tabla" => array:2 [
          "leyenda" => "<p id="spar0090" class="elsevierStyleSimplePara elsevierViewall">ACT&#58; Asthma Control Test&#59; FeNO&#58; fractional exhaled nitric oxide&#59; IM&#58; intramuscular&#59; BAL&#58; bronchoalveolar lavage&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="" valign="top" scope="col" style="border-bottom: 2px solid black">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Visit 1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Visit 2&#40;at 2 weeks&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Visit 3&#40;at 2 weeks&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">ACT questionnaire&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">&#8730;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">&#8730;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">&#8730;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">Spirometry and bronchodilator test&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">&#8730;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">&#8730;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">&#8730;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">Induced sputum&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">&#8730;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">&#8730;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">&#8730;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">FeNO&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">&#8730;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">&#8730;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">&#8730;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">Bronchoscopy with BAL and endobronchial biopsy&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">&#8730;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">Triamcinolone IM&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">&#8730;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab767384.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0085" class="elsevierStyleSimplePara elsevierViewall">Evaluation of Severe Uncontrolled Asthma in Children&#46;</p>"
        ]
      ]
      9 => array:7 [
        "identificador" => "tbl0035"
        "etiqueta" => "Table 7"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "tabla" => array:2 [
          "leyenda" => "<p id="spar0100" class="elsevierStyleSimplePara elsevierViewall">ACT&#58; Asthma Control Test&#59; FeNO&#58; fractional exhaled nitric oxide&#59; FEV<span class="elsevierStyleInf">1</span>&#58; forced expiratory volume in 1<span class="elsevierStyleHsp" style=""></span>s&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Clinical response&#58; ACT questionnaire score&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Score &#62;20&#8211;25 points or increase &#8805;5 points&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">Lung function tests&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">FEV<span class="elsevierStyleInf">1</span> normal or increase &#62;15&#37;Negative bronchodilator test&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">Induced sputum&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Normalization of eosinophil count&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">FeNO&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">&#60;24<span class="elsevierStyleHsp" style=""></span>ppb&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab767385.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0095" class="elsevierStyleSimplePara elsevierViewall">Positive Response to Triamcinolone in Children&#46;</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:72 [
            0 => array:3 [
              "identificador" => "bib0365"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "International ERS&#47;ATS guidelines on definition&#44; evaluation and treatment of severe asthma"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "K&#46;F&#46; Chung"
                            1 => "S&#46;E&#46; Wenzel"
                            2 => "J&#46;L&#46; Brozek"
                            3 => "A&#46; Bush"
                            4 => "M&#46; Castro"
                            5 => "P&#46;J&#46; Sterk"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1183/09031936.00202013"
                      "Revista" => array:6 [
                        "tituloSerie" => "Eur Respir J"
                        "fecha" => "2014"
                        "volumen" => "43"
                        "paginaInicial" => "343"
                        "paginaFinal" => "373"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24337046"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0370"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "An official ATS statement&#58; grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "H&#46;J&#46; Sch&#252;nemann"
                            1 => "R&#46; Jaeschke"
                            2 => "D&#46;J&#46; Cook"
                            3 => "W&#46;F&#46; Bria"
                            4 => "A&#46;A&#46; El-Solh"
                            5 => "A&#46; Ernst"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1164/rccm.200602-197ST"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Respir Crit Care Med"
                        "fecha" => "2006"
                        "volumen" => "174"
                        "paginaInicial" => "605"
                        "paginaFinal" => "614"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16931644"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0375"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Worldwide severity and control of asthma in children and adults&#58; the global asthma insights and reality surveys"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "K&#46;F&#46; Rabe"
                            1 => "M&#46; Adachi"
                            2 => "K&#46; Lai"
                            3 => "J&#46;B&#46; Soriano"
                            4 => "P&#46;A&#46; Vermeire"
                            5 => "K&#46;B&#46; Weiss"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jaci.2004.04.042"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Allergy Clin Immunol"
                        "fecha" => "2004"
                        "volumen" => "114"
                        "paginaInicial" => "40"
                        "paginaFinal" => "47"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15241342"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0380"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Prevalence of uncontrolled severe persistent asthma in pneumology and allergy hospital units in Spain"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "S&#46; Quirce"
                            1 => "V&#46; Plaza"
                            2 => "C&#46; Picado"
                            3 => "M&#46; Vennera"
                            4 => "J&#46; Casafont"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Investig Allergol Clin Immunol"
                        "fecha" => "2011"
                        "volumen" => "21"
                        "paginaInicial" => "466"
                        "paginaFinal" => "471"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21995180"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0385"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Extent&#44; patterns&#44; and burden of uncontrolled disease in severe or difficult-to-treat asthma"
                      "autores" => array:1 [
                        0 => array:3 [
                          "colaboracion" => "TENOR Study Group"
                          "etal" => false
                          "autores" => array:5 [
                            0 => "S&#46;D&#46; Sullivan"
                            1 => "L&#46; Rasouliyan"
                            2 => "P&#46;A&#46; Russo"
                            3 => "T&#46; Kamath"
                            4 => "B&#46;E&#46; Chipps"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1398-9995.2006.01254.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Allergy"
                        "fecha" => "2007"
                        "volumen" => "62"
                        "paginaInicial" => "126"
                        "paginaFinal" => "133"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17298420"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0390"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Genome-wide association studies for discovery of genes involved in asthma"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "L&#46; Akhabir"
                            1 => "A&#46;J&#46; Sandford"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1440-1843.2011.01939.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Respirology"
                        "fecha" => "2011"
                        "volumen" => "16"
                        "paginaInicial" => "396"
                        "paginaFinal" => "406"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21276132"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0395"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "IL4R alpha mutations are associated with asthma exacerbations and mast cell&#47;IgE expression"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "S&#46;E&#46; Wenzel"
                            1 => "S&#46; Balzar"
                            2 => "E&#46; Ampleford"
                            3 => "G&#46;A&#46; Hawkins"
                            4 => "W&#46;W&#46; Busse"
                            5 => "W&#46;J&#46; Calhoun"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1164/rccm.200607-909OC"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Respir Crit Care Med"
                        "fecha" => "2007"
                        "volumen" => "175"
                        "paginaInicial" => "570"
                        "paginaFinal" => "576"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17170387"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0400"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The IL6R variation Asp&#40;358&#41;Ala is a potential modifier of lung function in subjects with asthma"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "G&#46;A&#46; Hawkins"
                            1 => "M&#46;B&#46; Robinson"
                            2 => "A&#46;T&#46; Hastie"
                            3 => "X&#46; Li"
                            4 => "H&#46; Li"
                            5 => "W&#46;C&#46; Moore"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jaci.2012.03.018"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Allergy Clin Immunol"
                        "fecha" => "2012"
                        "volumen" => "130"
                        "paginaInicial" => "510"
                        "paginaFinal" => "515"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22554704"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0405"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Genome-wide association study of asthma identifies RAD50-IL13 and HLA-DR&#47;DQ regions"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "X&#46; Li"
                            1 => "T&#46;D&#46; Howard"
                            2 => "S&#46;L&#46; Zheng"
                            3 => "T&#46; Haselkorn"
                            4 => "S&#46;P&#46; Peters"
                            5 => "D&#46;A&#46; Meyers"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jaci.2009.11.018"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Allergy Clin Immunol"
                        "fecha" => "2010"
                        "volumen" => "125"
                        "paginaInicial" => "328"
                        "paginaFinal" => "335"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20159242"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0410"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Untangling asthma phenotypes and endotypes"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "I&#46; Agache"
                            1 => "C&#46; Akdis"
                            2 => "M&#46; Jutel"
                            3 => "J&#46;C&#46; Virchow"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1398-9995.2012.02832.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Allergy"
                        "fecha" => "2012"
                        "volumen" => "67"
                        "paginaInicial" => "835"
                        "paginaFinal" => "846"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22594878"
                             …1
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            10 => array:3 [
              "identificador" => "bib0415"
              "etiqueta" => "11"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Cluster analysis and clinical asthma phenotypes"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1164/rccm.200711-1754OC"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Respir Crit Care Med"
                        "fecha" => "2008"
                        "volumen" => "178"
                        "paginaInicial" => "218"
                        "paginaFinal" => "234"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            11 => array:3 [
              "identificador" => "bib0420"
              "etiqueta" => "12"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1164/rccm.200906-0896OC"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Respir Crit Care Med"
                        "fecha" => "2010"
                        "volumen" => "181"
                        "paginaInicial" => "315"
                        "paginaFinal" => "323"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            12 => array:3 [
              "identificador" => "bib0425"
              "etiqueta" => "13"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Identifying adult asthma phenotypes using a clustering approach"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1183/09031936.00120810"
                      "Revista" => array:6 [
                        "tituloSerie" => "Eur Respir J"
                        "fecha" => "2011"
                        "volumen" => "38"
                        "paginaInicial" => "310"
                        "paginaFinal" => "317"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            13 => array:3 [
              "identificador" => "bib0430"
              "etiqueta" => "14"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Ana-lyses of asthma severity phenotypes and inflammatory proteins in subjects stratified by sputum granulocytes"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jaci.2010.02.008"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Allergy Clin Immunol"
                        "fecha" => "2010"
                        "volumen" => "125"
                        "paginaInicial" => "1028"
                        "paginaFinal" => "1036"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            14 => array:3 [
              "identificador" => "bib0435"
              "etiqueta" => "15"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Complex phenotypes in asthma&#58; current definitions"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [ …1]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.pupt.2013.07.003"
                      "Revista" => array:6 [
                        "tituloSerie" => "Pulm Pharmacol Ther"
                        "fecha" => "2013"
                        "volumen" => "26"
                        "paginaInicial" => "710"
                        "paginaFinal" => "715"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            15 => array:3 [
              "identificador" => "bib0440"
              "etiqueta" => "16"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Linking obesity and asthma"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [ …1]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/nyas.12357"
                      "Revista" => array:6 [
                        "tituloSerie" => "Ann NY Acad Sci"
                        "fecha" => "2014"
                        "volumen" => "1311"
                        "paginaInicial" => "31"
                        "paginaFinal" => "41"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            16 => array:3 [
              "identificador" => "bib0445"
              "etiqueta" => "17"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Normativa para el asma de control dif&#237;cil"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Arch Bronconeumol"
                        "fecha" => "2005"
                        "volumen" => "41"
                        "paginaInicial" => "513"
                        "paginaFinal" => "523"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            17 => array:3 [
              "identificador" => "bib0450"
              "etiqueta" => "18"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Diagnosis and definition of severe refractory asthma&#58; an international consensus statement from the Innovative Medicine Initiative &#40;IMI&#41;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1136/thx.2010.153643"
                      "Revista" => array:6 [
                        "tituloSerie" => "Thorax"
                        "fecha" => "2011"
                        "volumen" => "66"
                        "paginaInicial" => "910"
                        "paginaFinal" => "917"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            18 => array:3 [
              "identificador" => "bib0455"
              "etiqueta" => "19"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Consensus document on the diagnosis of severe uncontrolled asthma"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Investig Allergol Clin Immunol"
                        "fecha" => "2012"
                        "volumen" => "22"
                        "paginaInicial" => "460"
                        "paginaFinal" => "475"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            19 => array:3 [
              "identificador" => "bib0460"
              "etiqueta" => "20"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Systematic assessment of difficult-to-treat asthma"
                      "autores" => array:1 [
                        0 => array:3 [
                          "colaboracion" => "Asthma and Allergy Research Group of the National Heart and Lung Institute"
                          "etal" => false
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Eur Respir J"
                        "fecha" => "2003"
                        "volumen" => "20"
                        "paginaInicial" => "478"
                        "paginaFinal" => "483"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            20 => array:3 [
              "identificador" => "bib0465"
              "etiqueta" => "21"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Global strategy for asthma management and prevention"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [ …1]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Libro" => array:1 [
                        "fecha" => "2014"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            21 => array:3 [
              "identificador" => "bib0470"
              "etiqueta" => "22"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Vocal cord dysfunction in athletes&#58; clinical presentation and review of the literature"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.3810/psm.2012.05.1961"
                      "Revista" => array:6 [
                        "tituloSerie" => "Phys Sportsmed"
                        "fecha" => "2012"
                        "volumen" => "40"
                        "paginaInicial" => "22"
                        "paginaFinal" => "27"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            22 => array:3 [
              "identificador" => "bib0475"
              "etiqueta" => "23"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Abnormal vocal cord function in difficult-to-treat asthma"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1164/rccm.201010-1604OC"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Respir Crit Care Med"
                        "fecha" => "2011"
                        "volumen" => "184"
                        "paginaInicial" => "50"
                        "paginaFinal" => "56"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            23 => array:3 [
              "identificador" => "bib0480"
              "etiqueta" => "24"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Psychological profile of patients with bronchial asthma and functional dyspnea&#58; a comparison with a non-asthmatic population and impact on the disease"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [ …5]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.arbres.2010.10.003"
                      "Revista" => array:6 [
                        "tituloSerie" => "Arch Bronconeumol"
                        "fecha" => "2011"
                        "volumen" => "47"
                        "paginaInicial" => "73"
                        "paginaFinal" => "78"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            24 => array:3 [
              "identificador" => "bib0485"
              "etiqueta" => "25"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Patients with asthma who do not fill their inhaled corticosteroids&#58; a study of primary nonadherence"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jaci.2007.08.020"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Allergy Clin Immunol"
                        "fecha" => "2007"
                        "volumen" => "120"
                        "paginaInicial" => "1153"
                        "paginaFinal" => "1159"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            25 => array:3 [
              "identificador" => "bib0490"
              "etiqueta" => "26"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Inhaler mishandling remains common in real life and is associated with reduced disease control"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [ …3]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.rmed.2011.01.005"
                      "Revista" => array:6 [
                        "tituloSerie" => "Respir Med"
                        "fecha" => "2011"
                        "volumen" => "105"
                        "paginaInicial" => "930"
                        "paginaFinal" => "938"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            26 => array:3 [
              "identificador" => "bib0495"
              "etiqueta" => "27"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "Gu&#237;a espa&#241;ola para el manejo del asma &#40;GEMA&#41;&#46; Available from&#58; <a href="http://www.gemasma.com/">www&#46;gemasma&#46;com</a> &#91;accessed 28&#46;07&#46;14&#93;&#46;"
                ]
              ]
            ]
            27 => array:3 [
              "identificador" => "bib0500"
              "etiqueta" => "28"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Corticosteroid responsiveness and clinical characteristics in childhood difficult asthma"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1183/09031936.00186508"
                      "Revista" => array:6 [
                        "tituloSerie" => "Eur Respir J"
                        "fecha" => "2009"
                        "volumen" => "34"
                        "paginaInicial" => "1052"
                        "paginaFinal" => "1059"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            28 => array:3 [
              "identificador" => "bib0505"
              "etiqueta" => "29"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Glucocorticoid resistance asthma"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [ …3]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Am J Respir Crit Care Med"
                        "fecha" => "1995"
                        "volumen" => "152"
                        "paginaInicial" => "125"
                        "paginaFinal" => "140"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            29 => array:3 [
              "identificador" => "bib0510"
              "etiqueta" => "30"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Asthma and cigarette smoking"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [ …1]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1183/09031936.04.00039004"
                      "Revista" => array:6 [
                        "tituloSerie" => "Eur Respir J"
                        "fecha" => "2004"
                        "volumen" => "24"
                        "paginaInicial" => "822"
                        "paginaFinal" => "833"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            30 => array:3 [
              "identificador" => "bib0515"
              "etiqueta" => "31"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Mecanismos moleculares de los glucocorticoides"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [ …3]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Arch Bronconeumol"
                        "fecha" => "2005"
                        "volumen" => "41"
                        "paginaInicial" => "34"
                        "paginaFinal" => "41"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            31 => array:3 [
              "identificador" => "bib0520"
              "etiqueta" => "32"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Glucocorticoid-resistant asthma&#58; more than meets the eye"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.3109/02770903.2013.831870"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Asthma"
                        "fecha" => "2013"
                        "volumen" => "50"
                        "paginaInicial" => "1036"
                        "paginaFinal" => "1044"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            32 => array:3 [
              "identificador" => "bib0525"
              "etiqueta" => "33"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Fluticasone at different doses for chronic asthma in adults and children"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/14651858.CD003534.pub3"
                      "Revista" => array:3 [
                        "tituloSerie" => "Cochrane Database Syst Rev"
                        "fecha" => "2008"
                        "paginaInicial" => "CD003534"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            33 => array:3 [
              "identificador" => "bib0530"
              "etiqueta" => "34"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Effects of extra-fine inhaled beclomethasone&#47;formoterol on both large and small airways in asthma"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1398-9995.2009.02306.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Allergy"
                        "fecha" => "2010"
                        "volumen" => "65"
                        "paginaInicial" => "897"
                        "paginaFinal" => "902"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            34 => array:3 [
              "identificador" => "bib0535"
              "etiqueta" => "35"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Randomized comparison of ciclesonide 160 and microg&#47;day in severe asthma"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.pupt.2007.11.002"
                      "Revista" => array:6 [
                        "tituloSerie" => "Pulm Pharmacol Ther"
                        "fecha" => "2008"
                        "volumen" => "21"
                        "paginaInicial" => "489"
                        "paginaFinal" => "498"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            35 => array:3 [
              "identificador" => "bib0540"
              "etiqueta" => "36"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Targeting inflammation using selective glucocorticoid receptor modulators"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [ …3]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.coph.2010.04.007"
                      "Revista" => array:6 [
                        "tituloSerie" => "Curr Opin Pharmacol"
                        "fecha" => "2010"
                        "volumen" => "10"
                        "paginaInicial" => "497"
                        "paginaFinal" => "504"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            36 => array:3 [
              "identificador" => "bib0545"
              "etiqueta" => "37"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "High-dose intramuscular triamcinolone in severe&#44; chronic&#44; life-threatening asthma"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJM199102283240903"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med"
                        "fecha" => "1991"
                        "volumen" => "324"
                        "paginaInicial" => "585"
                        "paginaFinal" => "589"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            37 => array:3 [
              "identificador" => "bib0550"
              "etiqueta" => "38"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/14651858.CD005533.pub2"
                      "Revista" => array:3 [
                        "tituloSerie" => "Cochrane Database Syst Rev"
                        "fecha" => "2005"
                        "paginaInicial" => "CD005533"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            38 => array:3 [
              "identificador" => "bib0555"
              "etiqueta" => "39"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Clinical implications of the intrinsic efficacy of beta-adrenoceptor drugs in asthma&#58; full&#44; partial and inverse agonism"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [ …3]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1097/MCP.0b013e328333def8"
                      "Revista" => array:6 [
                        "tituloSerie" => "Curr Opin Pulm Med"
                        "fecha" => "2010"
                        "volumen" => "16"
                        "paginaInicial" => "1"
                        "paginaFinal" => "5"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            39 => array:3 [
              "identificador" => "bib0560"
              "etiqueta" => "40"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Tiotropium in asthma poorly controlled with standard combination therapy"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMoa1208606"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med"
                        "fecha" => "2012"
                        "volumen" => "367"
                        "paginaInicial" => "1198"
                        "paginaFinal" => "1207"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            40 => array:3 [
              "identificador" => "bib0565"
              "etiqueta" => "41"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Tiotropium bromide is effective for severe asthma with noneosinophilic phenotype"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1183/09031936.00014108"
                      "Revista" => array:6 [
                        "tituloSerie" => "Eur Respir J"
                        "fecha" => "2008"
                        "volumen" => "31"
                        "paginaInicial" => "1379"
                        "paginaFinal" => "1382"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            41 => array:3 [
              "identificador" => "bib0570"
              "etiqueta" => "42"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Additive role of tiotropium in severe asthmatics and Arg16Gly in ADRB2 as a potential marker to predict response"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1398-9995.2008.01876.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Allergy"
                        "fecha" => "2009"
                        "volumen" => "64"
                        "paginaInicial" => "778"
                        "paginaFinal" => "783"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            42 => array:3 [
              "identificador" => "bib0575"
              "etiqueta" => "43"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Vitamin D and asthma"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1164/rccm.201108-1502CI"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Respir Crit Care Med"
                        "fecha" => "2012"
                        "volumen" => "185"
                        "paginaInicial" => "124"
                        "paginaFinal" => "132"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            43 => array:3 [
              "identificador" => "bib0580"
              "etiqueta" => "44"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The role of macrolides in asthma&#58; current evidence and future directions"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [ …4]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S2213-2600(14)70107-9"
                      "Revista" => array:6 [
                        "tituloSerie" => "Lancet Respir Med"
                        "fecha" => "2014"
                        "volumen" => "2"
                        "paginaInicial" => "657"
                        "paginaFinal" => "670"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            44 => array:3 [
              "identificador" => "bib0585"
              "etiqueta" => "45"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Azythromicin for prevention of exacerbations in severe asthma &#40;AZISAST&#41;&#58; a multicentre randomised double-blind placebo-controlled trial"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1136/thoraxjnl-2012-202698"
                      "Revista" => array:6 [
                        "tituloSerie" => "Thorax"
                        "fecha" => "2013"
                        "volumen" => "68"
                        "paginaInicial" => "322"
                        "paginaFinal" => "329"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            45 => array:3 [
              "identificador" => "bib0590"
              "etiqueta" => "46"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Protection of leukotriene receptor antagonist against aspirin-induced bronchospasm in asthmatics"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.4168/aair.2010.2.1.48"
                      "Revista" => array:6 [
                        "tituloSerie" => "Allergy Asthma Immunol Res"
                        "fecha" => "2010"
                        "volumen" => "2"
                        "paginaInicial" => "48"
                        "paginaFinal" => "54"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            46 => array:3 [
              "identificador" => "bib0595"
              "etiqueta" => "47"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Montelukast improves air trapping&#44; not airway remodeling&#44; in patients with moderate-to-severe asthma&#58; a pilot study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [ …5]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Chin Med J"
                        "fecha" => "2013"
                        "volumen" => "126"
                        "paginaInicial" => "2229"
                        "paginaFinal" => "2234"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            47 => array:3 [
              "identificador" => "bib0600"
              "etiqueta" => "48"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Anti-IgE for chronic asthma in adults and childrens"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [ …5]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/14651858.CD003559.pub4"
                      "Revista" => array:5 [
                        "tituloSerie" => "Cochrane Database Syst Rev"
                        "fecha" => "2014"
                        "volumen" => "1"
                        "paginaInicial" => "CD003559"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            48 => array:3 [
              "identificador" => "bib0605"
              "etiqueta" => "49"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Effects of omalizumab in non-atopic asthma&#58; results from a Spanish multicenter registry"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.3109/02770903.2012.757780"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Asthma"
                        "fecha" => "2013"
                        "volumen" => "50"
                        "paginaInicial" => "296"
                        "paginaFinal" => "301"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            49 => array:3 [
              "identificador" => "bib0610"
              "etiqueta" => "50"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma&#46; A multicenter&#44; randomized&#44; double-blind&#44; sham-controlled clinical trial"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Am J Med Respir Crit Care Med"
                        "fecha" => "2010"
                        "volumen" => "181"
                        "paginaInicial" => "116"
                        "paginaFinal" => "124"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            50 => array:3 [
              "identificador" => "bib0615"
              "etiqueta" => "51"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Bronchial thermoplasty&#58; long-term safety and effectiveness in patients with severe persistent asthma"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Allergy Clin Immunol"
                        "fecha" => "2013"
                        "volumen" => "132"
                        "paginaInicial" => "1295"
                        "paginaFinal" => "1302"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            51 => array:3 [
              "identificador" => "bib0620"
              "etiqueta" => "52"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Bronchial thermoplasty&#58; reappraising the evidence &#40;or lack thereof&#41;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1378/chest.14-0536"
                      "Revista" => array:6 [
                        "tituloSerie" => "Chest"
                        "fecha" => "2014"
                        "volumen" => "146"
                        "paginaInicial" => "17"
                        "paginaFinal" => "21"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            52 => array:3 [
              "identificador" => "bib0625"
              "etiqueta" => "53"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Bronchial thermoplasty for moderate or severe persistent asthma in adults"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/14651858.CD009910.pub2"
                      "Revista" => array:5 [
                        "tituloSerie" => "Cochrane Database Syst Rev"
                        "fecha" => "2014"
                        "volumen" => "3"
                        "paginaInicial" => "CD009910"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            53 => array:3 [
              "identificador" => "bib0630"
              "etiqueta" => "54"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Theophylline new perspectives for and old drug"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [ …1]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1164/rccm.200210-1142PP"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Respir Crit Care Med"
                        "fecha" => "2003"
                        "volumen" => "167"
                        "paginaInicial" => "813"
                        "paginaFinal" => "818"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            54 => array:3 [
              "identificador" => "bib0635"
              "etiqueta" => "55"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Efficacy and safety of roflumilast in the treatment of asthma"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S1081-1206(10)61065-4"
                      "Revista" => array:6 [
                        "tituloSerie" => "Ann Allergy Asthma Immunol"
                        "fecha" => "2006"
                        "volumen" => "96"
                        "paginaInicial" => "679"
                        "paginaFinal" => "686"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            55 => array:3 [
              "identificador" => "bib0640"
              "etiqueta" => "56"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Spanish Guideline for COPD &#40;GesEPOC&#41;&#46; Update 2014"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S0300-2896(14)70070-5"
                      "Revista" => array:7 [
                        "tituloSerie" => "Arch Bronconeumol"
                        "fecha" => "2014"
                        "volumen" => "50"
                        "numero" => "Suppl 1"
                        "paginaInicial" => "1"
                        "paginaFinal" => "16"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            56 => array:3 [
              "identificador" => "bib0645"
              "etiqueta" => "57"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Efficacy of anti-interleukin-5 therapy with mepolizumab in patients with asthma&#58; a meta-analysis of randomized placebo-controlled trials"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [ …4]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1371/journal.pone.0059872"
                      "Revista" => array:5 [
                        "tituloSerie" => "PLOS ONE"
                        "fecha" => "2013"
                        "volumen" => "8"
                        "paginaInicial" => "e59872"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            57 => array:3 [
              "identificador" => "bib0650"
              "etiqueta" => "58"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Mepolizumab treatment in patients with severe eosinophilic asthma"
                      "autores" => array:1 [
                        0 => array:3 [
                          "colaboracion" => "MENSA Investigators"
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMoa1403290"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med"
                        "fecha" => "2014"
                        "volumen" => "371"
                        "paginaInicial" => "1198"
                        "paginaFinal" => "1207"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            58 => array:3 [
              "identificador" => "bib0655"
              "etiqueta" => "59"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma"
                      "autores" => array:1 [
                        0 => array:3 [
                          "colaboracion" => "SIRIUS Investigators"
                          "etal" => false
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMoa1403291"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med"
                        "fecha" => "2014"
                        "volumen" => "371"
                        "paginaInicial" => "1189"
                        "paginaFinal" => "1197"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            59 => array:3 [
              "identificador" => "bib0660"
              "etiqueta" => "60"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Reslizumab for poorly controlled&#44; eosinophilic asthma&#58; a randomized&#44; placebo-controlled study"
                      "autores" => array:1 [
                        0 => array:3 [
                          "colaboracion" => "Res-5-0010 Study Group"
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1164/rccm.201103-0396OC"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Respir Crit Care Med"
                        "fecha" => "2011"
                        "volumen" => "184"
                        "paginaInicial" => "1125"
                        "paginaFinal" => "1132"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            60 => array:3 [
              "identificador" => "bib0665"
              "etiqueta" => "61"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Dupilumab in persistent asthma with elevated eosinophil levels"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMoa1304048"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med"
                        "fecha" => "2013"
                        "volumen" => "368"
                        "paginaInicial" => "2455"
                        "paginaFinal" => "2466"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            61 => array:3 [
              "identificador" => "bib0670"
              "etiqueta" => "62"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Lebrikizumab treatment in adults with asthma"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMoa1106469"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med"
                        "fecha" => "2011"
                        "volumen" => "365"
                        "paginaInicial" => "1088"
                        "paginaFinal" => "1098"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            62 => array:3 [
              "identificador" => "bib0675"
              "etiqueta" => "63"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A randomized&#44; controlled&#44; phase 2 study of AMG 317&#44; an IL-4Ralpha antagonist&#44; in patients with asthma"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1164/rccm.200909-1448OC"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Respir Crit Care Med"
                        "fecha" => "2010"
                        "volumen" => "181"
                        "paginaInicial" => "788"
                        "paginaFinal" => "796"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            63 => array:3 [
              "identificador" => "bib0680"
              "etiqueta" => "64"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Daclizumab improve asthma control in patients with moderate to severe persistent asthma&#58; a randomized&#44; controlled trial"
                      "autores" => array:1 [
                        0 => array:3 [
                          "colaboracion" => "Daclizumab Asthma Study Group"
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1164/rccm.200708-1200OC"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Respir Crit Care Med"
                        "fecha" => "2008"
                        "volumen" => "178"
                        "paginaInicial" => "1002"
                        "paginaFinal" => "1008"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            64 => array:3 [
              "identificador" => "bib0685"
              "etiqueta" => "65"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Randomized&#44; double-blind placebo-controlled study of brodalumab&#44; a human anti&#8211;IL-17 receptor monoclonal antibody&#44; in moderate to severe asthma"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1164/rccm.201212-2318OC"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Respir Crit Care Med"
                        "fecha" => "2013"
                        "volumen" => "188"
                        "paginaInicial" => "1294"
                        "paginaFinal" => "1302"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            65 => array:3 [
              "identificador" => "bib0690"
              "etiqueta" => "66"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A systematic review and meta-analysis&#58; tailoring asthma treatment on eosinophilic markers &#40;exhaled nitric oxide or sputum eosinophils&#41;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1136/thx.2010.135574"
                      "Revista" => array:6 [
                        "tituloSerie" => "Thorax"
                        "fecha" => "2012"
                        "volumen" => "67"
                        "paginaInicial" => "199"
                        "paginaFinal" => "208"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            66 => array:3 [
              "identificador" => "bib0695"
              "etiqueta" => "67"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Economic burden of impairment in children with severe or difficult to treat asthma"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.anai.2011.04.008"
                      "Revista" => array:6 [
                        "tituloSerie" => "Ann Allergy Asthma Immunol"
                        "fecha" => "2011"
                        "volumen" => "107"
                        "paginaInicial" => "110"
                        "paginaFinal" => "119"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            67 => array:3 [
              "identificador" => "bib0700"
              "etiqueta" => "68"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Is a two-week trial of oral prednisolone predictive of target lung function in pediatric asthma&#63;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/ppul.20189"
                      "Revista" => array:6 [
                        "tituloSerie" => "Pediatr Pulmonol"
                        "fecha" => "2005"
                        "volumen" => "39"
                        "paginaInicial" => "521"
                        "paginaFinal" => "527"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            68 => array:3 [
              "identificador" => "bib0705"
              "etiqueta" => "69"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Assessment of inhalation technique and determinants of incorrect performance among children with asthma"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/ppul.20498"
                      "Revista" => array:6 [
                        "tituloSerie" => "Pediatr Pulmonol"
                        "fecha" => "2006"
                        "volumen" => "41"
                        "paginaInicial" => "1082"
                        "paginaFinal" => "1087"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            69 => array:3 [
              "identificador" => "bib0710"
              "etiqueta" => "70"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Gu&#237;a de diagn&#243;stico y tratamiento del asma de control dif&#237;cil en el ni&#241;o"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "An Pediatr &#40;Barc&#41;"
                        "fecha" => "2009"
                        "volumen" => "71"
                        "paginaInicial" => "548"
                        "paginaFinal" => "567"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            70 => array:3 [
              "identificador" => "bib0715"
              "etiqueta" => "71"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Management of severe asthma in children"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S0140-6736(10)61054-9"
                      "Revista" => array:6 [
                        "tituloSerie" => "Lancet"
                        "fecha" => "2010"
                        "volumen" => "376"
                        "paginaInicial" => "814"
                        "paginaFinal" => "825"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            71 => array:3 [
              "identificador" => "bib0720"
              "etiqueta" => "72"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Macrolide antibiotics for cystic fibrosis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [ …4]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/14651858.CD002203.pub4"
                      "Revista" => array:5 [
                        "tituloSerie" => "Cochrane Database Syst Rev"
                        "fecha" => "2012"
                        "volumen" => "11"
                        "paginaInicial" => "CD002203"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/15792129/0000005100000005/v2_201504270531/S1579212915000774/v2_201504270531/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "14583"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Special article"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/15792129/0000005100000005/v2_201504270531/S1579212915000774/v2_201504270531/en/main.pdf?idApp=UINPBA00003Z&text.app=https://archbronconeumol.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212915000774?idApp=UINPBA00003Z"
]

Article information

ISSN: 15792129
Original language: English

DOI:10.1016/j.arbr.2015.03.010

The statistics are updated each day

Year/Month	Html	Pdf	Total

2024 November	23	5	28
2024 October	163	40	203
2024 September	143	30	173
2024 August	171	45	216
2024 July	149	38	187
2024 June	138	40	178
2024 May	206	37	243
2024 April	110	41	151
2024 March	120	24	144
2024 February	54	23	77
2023 November	1	0	1
2023 May	1	3	4
2023 March	26	2	28
2023 February	114	26	140
2023 January	125	30	155
2022 December	131	35	166
2022 November	186	50	236
2022 October	231	60	291
2022 September	185	65	250
2022 August	169	86	255
2022 July	135	46	181
2022 June	135	48	183
2022 May	173	48	221
2022 April	199	50	249
2022 March	179	49	228
2022 February	214	44	258
2022 January	230	41	271
2021 December	206	64	270
2021 November	217	48	265
2021 October	184	70	254
2021 September	305	68	373
2021 August	141	57	198
2021 July	157	48	205
2021 June	215	73	288
2021 May	174	56	230
2021 April	459	156	615
2021 March	568	61	629
2021 February	242	48	290
2021 January	182	43	225
2020 December	161	47	208
2020 November	218	42	260
2020 October	198	40	238
2020 September	190	60	250
2020 August	152	37	189
2020 July	192	42	234
2020 June	186	22	208
2020 May	196	35	231
2020 April	277	52	329
2020 March	269	48	317
2020 February	220	43	263
2020 January	250	64	314
2019 December	243	27	270
2019 November	258	32	290
2019 October	401	30	431
2019 September	482	40	522
2019 August	243	41	284
2019 July	226	51	277
2019 June	301	48	349
2019 May	341	43	384
2019 April	283	65	348
2019 March	263	59	322
2019 February	264	65	329
2019 January	196	64	260
2018 December	226	30	256
2018 November	504	69	573
2018 October	282	53	335
2018 September	123	23	146
2018 May	72	1	73
2018 April	183	19	202
2018 March	137	16	153
2018 February	100	13	113
2018 January	81	13	94
2017 December	86	12	98
2017 November	80	22	102
2017 October	90	22	112
2017 September	92	24	116
2017 August	95	58	153
2017 July	92	33	125
2017 June	109	48	157
2017 May	149	73	222
2017 April	97	44	141
2017 March	117	68	185
2017 February	163	71	234
2017 January	70	31	101
2016 December	95	25	120
2016 November	114	62	176
2016 October	171	50	221
2016 September	216	55	271
2016 August	176	42	218
2016 July	73	44	117
2016 March	3	0	3
2016 February	1	0	1
2015 December	3	0	3
2015 October	81	5	86
2015 September	53	19	72
2015 August	80	36	116
2015 July	0	1	1
2015 June	1	1	2
2015 May	0	1	1
2015 April	3	0	3

Show all

Indexed in:

Follow us:

Subscribe:

Statistics

Indexed in:

Follow us:

Subscribe:

Statistics

Subscribe to our newsletter